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SUMMARY
Many seven transmembrane (7TM) receptors exert their influence upon 
cellular processes through G-protein stimulated activation of adenylyl cyclase 
leading to an increase in intracellular concentration of the second messenger 
cAMP which exists ubiquitously in mammalian cells. The sole role of cAMP is 
to activate cAMP-dependent protein kinase by binding to its regulatory subunits 
thus causing their dissociation from and activation of the catalytic subunits. 
Modulation of cAMP levels has been implicated in a variety of metabolic 
processes as diverse as muscle contraction, neurotransmission, exocytosis, cell 
growth and differentiation and platelet aggregation. In addition, reductions in 
intracellular cAMP concentrations have been observed in a variety of disease 
states and conditions such as congestive heart failure, diabetes, and cancer as 
well as a number of inflammatory conditions including asthma, rheumatoid 
athritis and atopic dermatitis.
It is apparent that distinct intracellular pools of cAMP can exist within a 
cell due, in part, to the fact that mammalian cells can express at least 9 forms of 
adenylyl cyclase and several splice variants of the G-protein Gs subunit 
responsible for the regulation of this enzyme. The sole means of degradation of 
cAMP is through its hydrolysis to 5'AMP by cAMP phosphodiesterases 
(PDEs). Of the five families of PDEs known to hydrolyse cAMP the largest and 
best characterised are the PDE4 cAMP-specific phosphodiesterases. To date, 
four distinct PDE4 genes have been identified and further diversity is added by 
differential splicing and post-translational processing of some genes. Moreover, 
these splice variants display distinct regulatory properties, tissue, cell type and 
spaciotemporal patterns of expression. Recent studies on the members of the 
PDE4 gene family has revealed that the various splice variants arise as a result of 
amino terminal domain swaps on a highly conserved central domain which is 
thought to contain the catalytic site.
(xx)
The rat PDE4A gene product RD1 (RNPDE4A1) which was originally 
isolated from a rat brain cDNA library has been shown to be membrane 
associated upon expression of the cDNA in transfected COS cells. Sequence 
analysis has shown that the extreme N-terminal 1-23 amino acids of RD1 are 
exclusive to this enzyme. Deletion of this unique sequence resulted in the 
generation of a catalytically active PDE species known as Met26 RD1. In 
contrast to RD1, met26RDl is exclusively cytosolic thus leading to the 
contention that the subcellular localization of RD1 is determined by information 
contained within its unique amino terminal region.
The principle aim of this study was to determine whether the extreme N- 
terminal region of RD1 was indeed responsible for membrane association or 
whether its removal merely disrupted a larger structural conformation of the 
enzyme responsible for its subcellular localization. This was approached by the 
generation of a novel eukaryotic expression vector that facilitated construction of 
gene fusions between various N-terminal regions of RD1 and the soluble 
bacterial reporter enzyme CAT. By employing this strategy I have demonstrated 
conclusively that the N-terminal 25 amio acids are sufficient to target the 
normally soluble CAT to the plasma membrane upon expression in COS cells. 
Moreover, I have shown by site-specific mutagenesis that membrane association 
is not due to post-translational modification but is determined by the presence of 
a unique tryptophan-rich motif within the first 25 amino acids of RD1.
During the course of this study I have also developed a novel assay for 
the investigation of membrane association based on expression of novel 
chimeric protein species in a cell-free coupled transcription/translation system.
(xxi)
CHAPTER 1 
Introduction
1.1 The Role of cAMP as a Second Messenger
In 1957 Rail et al (Rail et al. 1957), determined that activation of liver 
phosphorylase (LP) in cell homogenates by epinephrine and glucagon was due 
to the production of a heat-stable factor. This was associated with the 
particulate fraction of the homogenate which, in turn, stimulated the activation 
of LP in the supernatant fractions of homogenates on which the hormones 
themselves were inactive. Such a factor, which was only produced when the 
hormones were incubated in the presence of ATP and Mg2+> was subsequently 
identified as 3',5'-cyclic AMP (Rail and Sutherland 1985) and Fig. 1.1. Cyclic 
AMP, which was shown to be generated from ATP by the enzyme adenylyl 
cyclase, was then proposed to serve as a second messenger, able to mediate the 
effects of a variety of hormones, with the hormones themselves acting as the 
first messengers (Hall 1963; Sutherland 1972; Sutherland et al. 1968). This 
was termed the 'Second Messenger Concept' for which cAMP served as the 
paradigm.
1.2 G-Protein Coupled Signal Transduction
The hormone receptor-producer system for cAMP was originally 
thought to be carried out by one and the same molecule until it was observed 
that these two entities could be separated. Later it was shown that these units 
could be resolved into a receptor and adenylyl cyclase unit following membrane 
solubilization (Rodbell et al. 1971). In addition, it was shown that there existed 
a requirement for GTP (Rodbell et al. 1971). The studies of Ross and Gilman 
(Ross and Gilman 1977) have since shown that the (3-adrenergic receptor is 
coupled to adenylate cyclase through interaction with a third component now 
known to be a G-protein. It is now clear that a large group of receptors elicit 
their responses through their interactions with G-proteins, including receptors 
for amines (catecholamines, acetylcholine and serotonins), proteins
1
Figure 1.1: Cyclic AMP
This figure represents the structure of the second messenger molecule 
cAMP.
NH
O
O
2
(glucagon, leutinizing hormone) and light (rhodopsin). Moreover, the 
application of molecular biology has revealed that these 
receptors display a high degree of structural similarity and membrane topology. 
Structural studies of the p2-adrenergic receptor for example, has revealed the 
presence of 7 hydrophobic segments of 24-48 amino acids which, it has been 
suggested, serve as transmembrane spanning a  helices that are connected by a 
series of extracellular and cytoplasmic loops (O'Dowd et al. 1989). The third 
cytoplasmic loop has been identified as the site of interaction with G-proteins 
(O'Dowd et al. 1989).
Hetrotrimeric G proteins are a subset of a superfamily of proteins which 
bind GTP with high affinity (Linder and Gilman 1992). They consist of three 
distinct subunits a , p and y in descending order of molecular weight and are 
broadly defined by the nature of the a  subunit (Gilman 1987; Kaziro et al. 
1991) which contains the site of guanine nucleotide binding. The a  subunit 
also interacts with the Py subunits through its N-terminus (Neer et al. 1988).
Hetrotrimeric G proteins are located at the plasma membrane of cells by 
virtue of a number of post-translational modifications such as palmitoylation, 
myristoylation and isoprenylation (Degtyarev et al. 1994; Higgins and Casey 
1994; Parenti et al. 1993; Simonds et al. 1991; Spiegel et al. 1991a 
Wedegaertner et al. 1995). To date twenty subtypes of a  subunits, five p 
subunits and seven y subunits have been identified and isolated which play a 
pivotal role in transmembrane signalling as they transduce tramsmembrane 
signals between a wide variety of extracellular signals and intracellular 
responses (Milligan et al. 1995).
Upon hormone binding the receptor undergoes a conformational change 
which promotes the exchange of G protein bound GDP for GTP which, in turn 
causes dissociation of the a  subunit from the hetrodimeric py subunits. The 
activated a  subunit then interacts with adenylyl cyclase whilst py subunits
3
themselve have been implicated in ras and MAPK signalling pathways (Faure et 
al. 1994; Inglese et al. 1995; Mattingly and Macara 1996) and modulation of 
some adenylyl cyclases (Tang and Gilman 1991) and phospholipase C (Camps 
et al. 1992). The interaction between the a  subunit and adenylyl cyclase is 
terminated by the intrinsic GTPase activity of the a  subunit hydrolysing bound 
GTP to GDP thus promoting re association of now inactive a  subunit with the 
Py subunit heterodimer.
1.3 Generation of cAMP bv Adenvlvl Cvclases
1.3.1 Structural Features of Adenylyl Cyclase
A major site for the control of the level of cAMP within cells is 
determined by its synthesis and therefore a great deal of attention has been 
focused on adenylyl cyclase the enzyme responsible for the intracellular 
conversion of ATP to cAMP. Progress in this field was hindered for many 
years by the low levels of expression of the protein ( 0.01-0.001% in 
mammalian cells) and its considerable lability in detergent-containing solutions 
(Taussig and Gilman 1995). However, this problem was to some extent 
circumvented by the observation of Pfeuffer and Metzger (Pfeuffer and Metzger 
1982) that mammalian adenylyl cyclases could be activated by the diterpine 
forskolin, and the subsequent discovery that this compound could be utilised as 
an affinity medium by covalently linking it to an agarose matrix. This approach 
was used by Krupinski and co-workers to purify sufficient amounts of a 
calmodulin sensitive adenylyl cyclase from bovine brain to allow a partial amino 
acid sequence to be determined (Krupinski et al. 1989). An oligonucleotide 
probe was synthesised and used to isolate a cDNA clone of ~ 11.5 kb from a 
bovine brain library.
Hydropathy analysis of this clone suggested a protein of approximately 
120-kDa which could be divided into two alternating sets of hydrophobic and 
hydrophilic domains. Each hydrophobic domain was characterised by six
4
transmembrane spans (Mi & M2) and separated by a large cytoplasmic domain 
of approximately 40kDa (Ci) with a second cytoplasmic domain (C2) located 
after the second transmembrane domain (Krupinski et al. 1989). To date at 
least eight different adenylyl cyclase clones have been reported in the literature 
(Bakalyar and Reed 1990; Cali et al. 1994; Feinstein et al. 1991; Gao and 
Gilman 1991; Krupinski et al. 1992; Premont et al. 1992; Yoshimura and 
Cooper 1992) and there is some evidence for the existence of splice variants 
(Wallach et al. 1994). Comparison of the amino acid sequence amongst the 
different adenylyl cyclase isoforms is approximately 50%, however the 
cytoplasmic domains Ci and C2 appear to be more highly conserved with 
greater that 90% similarity (Taussig and Gilman 1995).
1.3.2 Regulation of Adenylyl Cyclases
Amino acid sequence comparison has suggested that types II, IV, VII 
and IX adenylyl cyclases are more closely related to each other than to others 
(Gao and Gilman 1991; Krupinski et al. 1992) and such criteria suggest that a 
similar relationship exists between the type V and VI isoforms while types I, HI 
and VIII are equally dissimilar from the others (Cooper et al. 1994). Studies on 
the regulation of adenylyl cyclases has shown that all isoforms are activated 
ubiquitiously by both forskolin and the GTP-bound G protein Gsa  subunit. 
However, adenylyl cyclases can also be grouped according to their 
sensitivity/regulation by Ca2+. For example the type I, III and VIII isoforms 
are all stimulated by nanomolar concentrations of Ca2+ in a calmodulin 
dependent manner (Cali et al. 1994; Cooper et al. 1994; Tang et al. 1991) 
whereas types V and VI are inhibited independently of calmodulin (Cooper et 
al. 1994). The remaining three isoforms, type II, IV, and IX, are Ca2+ 
insensitive (Feinstein et al. 1991; Gao and Gilman 1991; Yoshimura and 
Cooper 1992). A further level of complexity relates to the observation that G 
protein py subunits stimulate type II and IV adenylyl cyclases (Cooper et al. 
1994; Gao and Gilman 1991; Tang and Gilman 1991) while inhibiting the type I
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isoform (Cooper et al. 1994; Tang and Gilman 1991). Furthermore, 
Jacobowitz (Jacobowitz et al. 1993) and Kawabe (Kawabe et al. 1994) have 
reported type-specific phosphorylation of adenylyl cyclases upon treatment of 
cells with phorbol esters.
1.3.3 Tissue Distribution of Adenylyl Cyclase Isoforms
The advent of molecular biology has proved instrumental in determining 
the tissue distribution of the various adenylyl cyclase isoforms. Krupinski et al 
(Krupinski et al. 1989) characterised a type I isoform from bovine brain by 
means of an antisense probe derived from a partial amino acid sequence. This 
same approach was employed by Bakalyar to demonstrate that type I and II 
adenylyl cyclases were expressed in high concentrations in brain but absent in 
the olfactory bulb where the type III adenylyl cyclase was the only isoform 
expressed in this tissue, implying a role in olfactory signal transduction. That 
type II adenylyl cyclase is expressed in rat brain was confirmed by Feinstein et 
al (Feinstein et al. 1991) who were also able to show high levels of expression 
in rat brain and low levels in olfactory bulb while moderate expression was 
observed in lung. Type IV adenylyl cyclase has been identified in a wide 
variety of tissues including brain, heart, kidney, liver and lung but undetected in 
testis (Gao and Gilman 1991) whereas the type V and VI isoforms have been 
observed in brain, liver and kidney (Premont et al. 1992). Yoshimura and 
Cooper have also identified and cloned type VI adenylyl cyclase from the mouse 
neuroblastoma-embryonic, Chinese hamster brain explant hybrid NCB-20 cell 
line (Yoshimura and Cooper 1992). A cDNA encoding type VIII adenylyl 
cyclase was isolated from two rat brain libraries by Cali et al (Cali et al. 1994) 
who were also able to demonstrate by in situ hybridization that most abundantly 
expressed in specific cells within the dentate gyrus and hippocampus and less 
abundantly in the neocortex, thalamus and hypothalamus.
In summary, cAMP is generated from ATP in a reaction catalysed by 
adenylyl cyclases, a diverse family of enzymes encompassing at least eight
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isoforms, some of which demonstrate multiple splice variants and which are 
expressed in tissue-specific fashion.
1.4 Cyclic AMP-Dependent Protein Kinase
In order to exert its influence within a cell cAMP must first interact with, 
and secondly activate an effector system, thus converting an extracellular 
hormonal signal into an intracellular response. The first indication that this 
response involved phosphorylation was obtained by the the successful 
purification of a protein kinase from rabbit skeletal muscle which was 
demonstrated to be completely dependent on cAMP for its activity (Walsh et al. 
1968). Cyclic AMP-dependant protein kinase (PK-A) is tightly regulated and 
maintained in an inactive form in the absence of cAMP (Taylor 1989). 
However, the enzyme is unique in that the two forms isolated exist as a 
tetramer comprised of two catalytic (C) subunits and a regulatory (R) dimer 
(R2C2) (Bramson et al. 1984; Taylor 1989). PK-A is activated upon cAMP 
binding to the R-subunits which initiates the release of the two activated 
catalytic subunits from the regulatory subunit complex. This allows them to 
phosphorylate serine residues in a variety of substrate proteins containing the 
consensus sequence RRXS (Bramson et al. 1984; Hausken et al. 1996).
Genes have been identified in mammalian cells encoding three C- 
subunits Ca, Cp and Oy and four R subunits RIa, Rip, R lla and RIip (Scott
1991) resulting in two holoenzyme classes of PKA which share a common 
catalytic subunit but differ in their regulatory subunits. Furthermore, the two 
holoenzymes can be found in different subcellular locations. This is conferred 
by the R subunit. Thus PK-AI isoforms are cytosolic whilst PKAII isoforms 
are predominantly located at a variety of intracellular sites (Cassano et al. 1996; 
Scott and Carr 1992). Subcellular localization of cAMP-dependent protein 
kinase will be discussed in more detail in a later section (section 1.6.1).
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1.4.1 The Catalytic Subunit
The catalytic subunit displays extensive sequence similarity amongst all 
eukaryotic protein kinases. In particular, several amino acid residues in the 
active site have been shown to be highly conserved (Taylor 1989). Affinity 
labelling studies have revealed the existence of a glycine-rich element with the 
consensus sequence GXGXXG near the amino terminus of the catalytic subunit 
which, in conjunction with an invariant lysine (K), is thought to be involved in 
nucleotide binding, indeed, mutation of this lysine results in the generation of 
an inactive kinase (Taylor 1989).
Two different isoforms of the catalytic subunit have been isolated, Ca 
which is present in a wide variety of tissues and Cp which, although 
ubiquitously expressed in several tissues, predominates in brain (Showers and 
Maurer 1986; Uhler et al. 1986a; Uhler et al. 1986b). The two PK-A catalytic 
subunit isoforms display 91% similarity at the amino acid level (Uhler et al. 
1986b) whereas Cp subunits show greater similarity between CP subunits of 
other species than between Ca and Cp subunits of the same species (Showers 
and Maurer 1986).
A conserved amino terminal glycine has been shown to be myristoylated 
in some species but not in others (Taylor 1989) however this post-translational 
modification is not thought to be involved in subcellular localization since a 
murine C a subunit which has a free amino terminal glycine demonstrates 
identical properties to the myristoylated forms (Taylor 1989)
1.4.2 The Regulatory Subunit
The function of the regulatory (R) subunit of cAMP-dependant protein 
kinase is to inhibit the catalytic subunit in the absence of cAMP (Taylor 1989). 
PK-A is regulated by binding of two molecules of cAMP to two sites, termed A 
and B, which are found on the R subunit. Binding of one molecule of cAMP to 
the B site elicits a conformational change and thus exposes the A site to which a
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second cAMP molecule binds and causes the dissociation of the R subunit 
dimer from the two C subunits (Spence et al. 1997). Two distinct classes of R- 
subunit exist of which a  and p isoforms have been identified (Luo et al. 1990), 
RI can be distinguished from the RII holoenzyme by the presence of a high- 
affinity binding site for Mg2+ATP, whereas the RII holoenzyme is susceptible 
to autophosphorylation (Taylor 1989). Both the Rl and RII holoenzymes share 
a common domain structure in which two subunits are dimerized by means of a 
disulphide bridge between their amino terminii (Taylor 1989). Despite the 
observation that the amino terminus is also the site of interaction between the 
regulatory and catalytic subunits this region demonstrates a degree of variability 
in amino acid sequence (Taylor 1989). The different regulatory subunit 
isoforms display differential tissue expression, whilst the RIa subunits can be 
found in almost all tissues (Bregman et al. 1989; Li et al. 1996; Li and Rubin 
1995; Luo et al. 1990). In contrast, Rip is detected predominantly in brain, 
testis and placenta (Luo et al. 1990). Similarly, R lla isoforms are found to be 
expressed in a wide variety of tissues including heart, skeletal muscle, liver and 
kidney (Luo et al. 1990) whereas the Rllb isoform demonstrates a more specific 
pattern of expression, primarily in brain (Li et al. 1996; Li and Rubin 1995; Luo 
et al. 1990). Within cells, the different R subunit isoforms also display 
different subcellular localizations, whereas RIa and Rip isoforms are cytosolic, 
RIip isoforms are bound to specific sites in the cytoskeleton where they are 
anchored by means of specific interactions with a class of high-affinity binding 
proteins known as AKAPs (A Kinase Anchoring Proteins) (Bregman et al. 
1989; Carr et al. 1993; Coghlan et al. 1994; Glantz et al. 1993; Hirsch et al. 
1992; Klauck and Scott 1995; Li et al. 1996; Li and Rubin 1995; Lin et al. 
1995a; McCartney et al. 1995; Ndubuka et al. 1993; Scott and Carr 1992). 
This occurs through an amphipathic a  helix binding motif (Carr et al. 1993). 
Like RIIp, R lla isoforms are also able to bind to AKAPS (Li et al. 1996; Li 
and Rubin 1995).
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In summary, cAMP-dependant protein kinases (PK-As) are a family of 
enzymes which are found in a wide variety of cells and tissue types. They exist 
under basal condidtions as an inactive tetrameric complex consisting of two 
binding , or regulatory (R) subunits and two catalytic (C) subunits. Two 
distinct classes of PK-As have been identified PKA-I and PKA-II each 
possessing a common C subunit but different R subunits. Binding of cAMP to 
the R subunits causes dissociation of the R subunit dimer resulting in the release 
of the now active C-subunit to phosphorylate substrate proteins thus mediating 
the intracellular effects of cAMP.
1.5 Cyclic Nucleotide Phosphodiesterases
The sole means of degradation of cAMP in cells is by its hydrolysis to 
5'AMP by a group of enyzymes known collectively as the cyclic nucleotide 
phosphodiesterases (PDE). Indeed one of the initial pieces of evidence which 
pointed to the role of cAMP as a second messenger in cells was the discovery 
and purification of a PDE which could hydrolyse not only cAMP but also 
cGMP (Butcher and Sutherland 1962). Subsequent development of assays, 
using radio-labelled cAMP and cGMP, allowed measurement of PDE activity at 
near physiological concentrations. These revealed that instead of just one 
enzyme, there existed a family of PDEs in most tissues (Beavo 1995). Many of 
these PDEs have since been purified and characterised (Beavo and Houslay 
1990). More recently, with the advent and application of molecular biology 
techniques, it has become evident that PDEs can be divided into at least seven 
different isoenzyme families based on substrate specificities, kinetic properties 
and inhibition characteristics (Beavo 1990; Beavo 1995; Beavo et al. 1994; 
Beavo and Houslay 1990). The different isozyme families are summarised 
below
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PDE1 Ca2+/Cam stimulated,
PDE2 cyclic GMP-stimulated,
PDE3 cyclic GMP-inhibited,
PDE4 cyclic AMP-specific,
PDE5 cylic GMP-specific,
PDE6 photoreceptor specific,
PDE7 cyclic AMP-specific.
The type 1, 2 and 3 PDE families can hydrolyse both cAMP and cGMP, 
whereas the type 4 and 7 PDEs are specific for cAMP and the type 5 and 6 
PDEs are specific for cGMP. The different isozyme families are described in 
more detail below.
1.5.1 Nomenclature of cyclic nucleotide Phosphodiesterases
Due to the incredibly complex and diverse nature of the PDE gene 
family it soon became clear that the original system of naming PDE isoenzymes, 
based on the observed elution profile from an ion exchange chromatography 
column, was inadequate to cope with the frequent discovery of new genes as 
well as novel splice variants and alternative transcripts of existing genes. The 
current nomenclature (Beavo et al. 1994) is based upon the following criteria. 
The first two letters indicate the species from which the gene was cloned 
followed by the designator 'PDE' for cyclic nucleotide phosphodiesterase, next 
the arabic number defines the gene family followed by a letter to indicate the 
specific gene, finally the splice variant is identified by an arabic numeral with a 
single letter representing the original report.
Thus, for example, RNPDE4A1A was isolated from rat (Rattus 
norvegicus), it is a member of the PDE4 gene family, it was the first splice 
variant identified and is the first of a number of clones of that enzyme.
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1.5.2 Structure of cyclic nucleotide Phosphodiesterases
The cyclic nucleotide phosphodiesterases are a large and diverse group 
of enzymes which have been intensely studied in recent years. At present at 
least 16 different PDE genes have been identified, many of which demonstrate 
an additional level of diversity by the presence of multiple splice variants which 
are expressed in cellular and tissue-specific patterns (Beavo 1995; Beavo et al. 
1994; Beavo and Houslay 1990; Rybalkin and Beavo 1996). Amino acid 
sequence information has now been obtained for many PDEs either from 
directly sequenced proteins or, through the application of molecular biology, 
from isolated cDNA clones (Baehr et al. 1991; Bentley et al. 1992; Bolger et al. 
1993; Michaeli et al. 1993; Monaco et al. 1994; Novack et al. 1991; 
Sonnenburg et al. 1991; Swinnen et al. 1991b; Yan et al. 1996). Such analyses 
have revealed that PDEs contain a modular structure which includes a highly 
conserved region of 250-270 amino acids within the core of the protein (Fig. 
1.2) and which is thought to reflect the catalytic site (Charbonneau 1990; 
Charbonneau et al. 1986; Charbonneau et al. 1991; Sonnenburg et al. 1995). 
Such evidence has been obtained from studies employing limited proteolytic 
digestion, mutagenesis and truncation analysis (Catty and Deterre 1991; 
Charbonneau et al. 1986; Charbonneau et al. 1991; Kincaid et al. 1985; 
Sonnenburg et al. 1995; Stroop et al. 1989).
Charbonneau (Charbonneau 1990) has postulated that the relatively 
large size of PDEs would suggest that they may exist as multidomain proteins. 
Thus they might comprise a single, homologous catalytic domain linked to a 
variable non-catalytic N-terminus which may be involved in regulatory 
functions as well as containing sites for nucleotide binding, membrane 
interaction and dimerization. Indeed there is a growing body of evidence in the 
literature to support this hypothesis. For example, studies on the type 2 cGMP- 
specific PDE and the a  and a ' subunits of type 6 photoreceptor rod and cone
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PDEs have revealed the presence of a second conserved segment of 
approximately 340 amino acids long which contains two internally homologous 
repeats and that this region contains a non-catalytic cGMP binding site (Ahn et 
al. 1991; Charbonneau et al. 1990). In addition, Sonnenburg et al (Sonnenburg 
et al. 1995) have recently demonstrated that the type 1 PDEs from bovine brain 
and lung contains a calmodulin binding site and have confirmed an original 
observation made by Kincaid et al (Kincaid et al.1985) that the N-terminus of 
the type 1 PDEs contains an inhibitory site. Meacci et al (Meacci et al. 1992) 
have suggested that, in addition to the catalytic region, the N-terminal region of 
the type 3 PDE from human sarcoplasmic reticulum may be responsible for 
conferrment of membrane association. Furthermore, the N-termini of some 
members of the PDE4 family have been implicated in their membrane and 
subcellular localization (McPhee et al. 1995; O'Connell et al. 1996; Shakur et 
a l .  1 9 9 3 ;  S h a k u r  e t  a l .
1995).
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Figure 1.2: Structure of Representative Members of the Cyclic
Nucleotide PDE Families
The putative structure of five of the seven PDE families is shown. The 
different domains are represented by boxes connected by wires 
corresponding to putative hinge regions. The open boxes represent 
regulatory domains where several phosphorylation sites and allosteric sites 
have been mapped. The shaded boxes correspond to the catalytic domains.
The letter 'P' in an open circle represents a site of phosphorylation. 
Putative membrane association regions are marked by arrows.
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In addition to the apparent multi-domain structure observed amongst 
several PDEs, there is evidence that many of the mammalian PDEs exist as 
homodimers consisting of two identical catalytic subunits (Beavo 1995; Bloom 
and Beavo 1996; Kincaid et al. 1985; Shenolikar et al. 1985; Sonnenburg et al. 
1995; Stroop et al. 1989). The photoreceptor type 6 PDEs however, are 
unusual in that they exist as a heterotetrameric protein in an apY2 conformation 
(Artemyev et al. 1996; Baehr et al. 1979; Beavo 1995; Gillespie 1990; Liu et al. 
1996). In addition, Artemyev et al have recently demontrated by means of 
subunit specific antibodies that the rod cGMP PDE can also exist as distinct 
0C0CY2 and PPY2 isoforms (Artemyev et al. 1996).
1.5.3 PDE1, Calcium/Calmodulin Stimulated PDE
As the name implies, Ca2+/CaM PDEs are activated by Ca2+ and 
calmodulin (Wang et al. 1990). Kakiuchi and Yamakazi in 1970 discovered 
that in rat brain there existed two cyclic nucleotide PDE activities, the basal 
activity and the calcium dependent activity (Kakiuchi and Yamakazi 1970). The 
calcium dependent activity required the presence of a heat-stable non-dialysable 
factor for which they coined the phrase PAF and was also detected by Cheung 
(Cheung 1971) . PAF was found in a variety of tissues including human, 
porcine and rat brain as well as bovine heart, however Cheung demonstrated 
that PAF purified from one tissue was able to stimulate PDE activity in other 
tissues but at the same time demonstrating that the effect of the activator was 
protein specific (Cheung 1971).
The type 1 Ca2+/CaM-stimulated PDEs are a large group of PDEs which 
originate from three distinct genes (Beavo 1995; Beavo et al. 1994; Rybalkin 
and Beavo 1996). Moreover, there is evidence for the existence of multiple 
splice variants for each of the three separate genes (Bentley et al. 1992; 
Loughney et al. 1996; Polli and Kincaid 1992; Sonnenburg et al. 1993; 
Sonnenburg et al. 1995; Yan et al. 1996; Yan et al. 1995). The members of this
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isozyme family provide the possibility of 'crosstalk' occurring between two 
different intracellular second messenger systems namely the Ca2+ and cAMP- 
signalling pathways.
1.5.3.1 PDE1A
Sharma and Wang (Sharma and Wang 1986) first isolated a 58kDa 
enzyme from bovine lung which demonstrated a higher affinity for cAMP than 
cGMP but a higher Vmax for cGMP than cAMP. It is now known that this 
enzyme is a product of the PDE1A gene (Beavo 1995). Similarly the 59kDa 
bovine heart isozyme islated by Hansen and Beavo can also be classified as 
derived from a PDE1A gene (Hansen and Beavo 1986; Novack et al. 1991). 
Sonnenburg et al have isolated a 61kDa isozyme from bovine brain capable of 
hydrolysing both cAMP and cGMP (Sonnenburg et al. 1993) and has since 
been shown to be an amino terminal splice variant transcribed from the PDE1A2 
gene (Sonnenburg et al. 1995). More recently, Loughney et al (Loughney et al. 
1996) have isolated and extensively characterised a CaM-stimulated PDE splice 
variant PDE 1 A3 which is expressed in a wide variety of tissue types including 
brain, heart, skeletal muscle, liver and kidney. It displays, like the 58kDa lung 
isozyme, a higher affinity for cGMP than cAMP.
1.5.3.2 PDE1B
A second Ca2+/CaM-stimulated PDE gene, PDE IB, has been identified 
which demonstrates some sequence similarity with the 59/6lkDa isozyme but is 
otherwise entirely distinct, Bentley et al (Bentley et al. 1992) by screening a 
bovine brain cDNA library with degenerate oligonucleotides based on partial 
peptide sequences, isolated a cDNA which encoded a 63kDa CaM-stimulated 
PDE. More recntly Spence et al have described that phorbol ester stimulation of 
Chinese hamster ovary (CHO) cells leads to the rapid induction of CaM- 
stimulated PDE activity which was identified as the PDE IB isozyme (Spence et 
a 1 1 9 9 7 ) .
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1.5.3.3 PDE1C
The original evidence for the existence of a third Ca2+/CaM-stimulated 
gene family was postulated by the experiments of Shenolikar et al (Shenolikar et 
al. 1985) who reported the purification and characterization of a 74kDa PDE 
from bovine brain that preferentially hydrolysed cGMP. It has now been 
shown that this enzyme belongs to the PDE 1C isozyme family (Beavo 1995). 
To date, at least five different splice variants of PDE 1C are known to exist and 
it has been shown that at least one isozyme hydrolyses cAMP as well as cGMP, 
Yan et al (Yan et al. 1995) have demonstrated the enrichment of this PDE1C2 
splice variant in rat olfactory epithelium, thus suggesting a role for this isozyme 
in odorant desensitization. The same laboratory has also recently isolated a 
PDE1C1 cDNA from a mouse brain library which, by means of RNAse 
protection assays and in situ hybridization, was shown to have a distinct tissue 
and cellular expression pattern (Yan et al. 1996). More recently, Loughney et al 
(Loughney et al. 1996) have isolated cDNAs for human PDE1C1 and PDE1C3 
splice variants which are expressed preferentially in brain and demonstrate a 
higher affinity of cGMP than cAMP. Two further PDE 1C splice variants have 
been identified, PDE1C4 and PDE1C5 (Yan et al. 1996). Unusually though, 
these two splice variants, whilst having identical coding sequences, differ in 
their 3'-untranslated regions (3'-UTR). This is the first evidence for 3'- splice 
variants and it has been postulated that this may be important in post- 
transcriptional regulation of the isozyme mRNA (Yan et al. 1996)
1.5.3.4 Regulation of Calcium/Calmodulin Stimulated PDE
Kincaid et al (Kincaid et al. 1985) have shown that limited proteolysis
of the 59kDa bovine brain PDE increased the 3' ,5'-phosphodiesterase activity 
of the enzyme in a Ca2+/CaM-independent manner. Similar results have also 
been obtained by Sonnenburg et al (Sonnenburg et al. 1995) for the PDE1A1 
and PDE1A2 splice variants and Loughney et al (Loughney et al. 1996)
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observed very low activity when the PDE1A3, PDE1C1 and PDE1C3 splice 
variants when expressed as full-length proteins in yeast and that activity was not 
increased upon addition of 10|iM calmodulin. However, when amino terminal 
truncated PDE 1 A3 and PDE 1C 1 splice variants were expressed in the yeast 
system, measurable hydrolysis of cAMP amd cGMP was observed (Loughney 
et al. 1996). These studies suggest that calmodulim modulates PDE activity by 
interaction with elements within the amino terminus of the protein, eliciting a 
conformational change which results in increased phosphodiesterase activiy. 
That the amino terminus of the PDE1 isozyme family contains calmodulin 
binding domains has already been discussed above (Section 1.5.1). Indeed 
Sonnenburg et al (Sonnenburg et al. 1995) have recently confirmed this 
postulate by identifying two calmodulin binding domains as well as an 
inhibitory element located within the amino terminus of the PDE1A1 and 
PDE1A2 isozymes.
Calmodulin activation of PDEs is thought to occur in a two-step 
process. The calmodulin molecule exists as a dumbell shaped structure 
comprised of two lobes connected by an a  helix (Wang et al. 1990). Each lobe 
contains two Ca2+ binding sites. Upon binding of four molecules of Ca2+, 
firstly to the high affinity binding sites and finally to the low affinity sites, a 
conformational change is elicited which allows binding of the Ca2+/CaM 
complex to the PDE by means of hydrophobic interactions thought to involve 
specific amino acids within the a  helix (Wang et al. 1990).
It has also been reported that several Ca2+/CaM stimulated PDEs can be 
phosphorylated in a kinase specific manner (Beavo 1995; Florio et al. 1994; 
Hashimoto et al. 1989; Sharma 1991; Sharma and Wang 1985; Wang et al. 
1990). For example, the 59kDa heart PDE1A1 and 61kDA brain PDE1A2 
appear to be phosphorylated by cAMP-dependent protein kinase (Florio et al. 
1994; Sharma 1991) whereas the 63kDa PDE1B1 isozyme is phosphorylated 
only by Ca2+/CaM dependent protein kinase II (Florio et al. 1994; Hashimoto et
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al. 1989; Wang et al. 1990). The effect of phosphorylation is to decrease the 
enzymes affinity for calmodulin thereby increasing the amount of Ca2+/CaM 
required for activation (Wang et al. 1990). Phosphorylation can be inhibited in 
the case of the PDE1A1 and PDE1B1 isozymes by increasing the concentration 
of Ca2+/calmodulin (Sharma and Wang 1985), indeed inclusion of Ca2+ and 
calmodulin in the reaction mixture prior to incubation with kinase completely 
inhibits phosphorylation (Sharma and Wang 1985). This effect for the 
PDE1A1 and PDE1A2 isozymes is substrate directed. If Ca2+ or calmodulin 
are added to the reaction mixture individually these isozymes are 
phosphorylated, but the Ca2+/CaM complex phosphorylation is inhibited thus 
suggesting that the phosphorylation site is in or near the calmodulin binding 
domain (Sharma 1991; Sharma and Wang 1985). Florio et al (Florio et al. 
1994), by a combination of proteolysis and HPLC, have identified serine 120 
as the site of phosphorylation of the PDE1A2 isozyme, which would appear to 
be in excellent agreement with the findings of Sonnenburg et al (Sonnenburg et 
al. 1995) whose results for this isozyme have identified the region between 
amino acids 114-137 as a calmodulin binding site. In contrast to this, the 
binding of calmodulin to the PDE1B1 isozyme did not seem to prevent 
phosphorylation (Hashimoto et al. 1989). Despite the apparent kinase 
specificity observed for the PDE1A1, PDE1A2 and PDE IB 1 isozyme 
dephosphorylation, in contrast, is mediated solely by Ca2+/CaM dependent 
phosphatase (calcineurin) (Beavo 1995; Florio et al. 1994; Hashimoto et al. 
1989; Sharma 1991; Sharma and Wang 1985; Wang et al. 1990). Latterly, it 
has been shown that Ca2+/CaM-stimulated PDE1 activity can be induced in 
CHO cells due to overexpression of specific PKC isoforms upon incubation in 
the presence of PM A (Macfarland et al. 1991) and more recently through 
receptor-mediated stimulation of lipid signalling pathways (Spence et al. 1997).
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1.5.4 PDE2, Cyclic GMP-Stimulated Phosphodiesterases
To date only one gene has been identified encoding for the cGMP- 
stimulated PDE (cGS-PDE) (Beavo 1995; Rybalkin and Beavo 1996). 
However, several investigators have presented evidence for the existence of at 
least two amino terminal splice variants (Murashima et al. 1990; Sonnenburg et 
al. 1991; Yang et al. 1994). Since the original observations of Beavo et al 
(Beavo 1971; Beavo et al. 1970), cGS-PDEs have been identified in both 
particulate and soluble fractions in a wide variety of tissues (Macfarland et al. 
1991; Manganiello et al. 1990; Martins et al. 1982; Murashima et al. 1990; 
Whalinetal. 1991).
Martins et al (Martins et al. 1982) have purified a 105-107 kDa protein 
from bovine aderenal gland which hydrolyses cAMP and cGMP with similar 
maximal rates. Interestingly, this enzyme characteristically displayed the 
positive co-operativity also observed by other investigators (Beavo 1971; 
Rybalkin and Beavo 1996; Sonnenburg et al. 1991; Whalin et al. 1991). 
Furthermore, in the presence of lpM cGMP, cAMP hydrolysis was increased 
some 5 to 6-fold (Martins et al. 1982). The presence of two distinct sites for 
cGMP binding was suggested by the observation that approximately 10% of 
the total cGMP bound at a concentration of 7 nM whilst the remaining 
nucleotide bound at a concentration of around 4 pM. Confirmation of the 
presence of two cGMP binding sites was obtained in the study by Stroop et al 
(Stroop et al. 1989) which, by means of photoaffinity labelling and limited 
proteolytic digestion, identified one binding site in the catalytic region and 
another allosteric site in the non-catalytic domain.
Murashima et al (Murashima et al. 1990) purified a lOOkDa protein from 
bovine brain cerebral cortex grey matter which showed a 10 to 15-fold increase 
in cAMP hydrolysis when the enzyme was assayed in the presence of 0.4 |iM 
cGMP. Photoaffinity labelling in the presence of [32P]-cGMP showed that this
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increase was inhibited by increasing the cGMP concentration to 100 |iM. 
Comparison of peptide fragments of the particulate bovine brain and soluble 
liver enzymes demonstrated the tissue-specific distribution of two distinct splice 
variants (Murashima et al. 1990).
The availability of isozyme-specific antibodies was utilized by 
Macfarland and co-workers to determine that cGMP-stimulated PDE was 
preferentially localized within the glomerulosa layer in bovine adrenal gland 
(Macfarland et al. 1991). This enzyme is responsible for mediating atrial 
natriuretic peptide (ANP) triggered inductions in aldosterone production 
through the reduction of cAMP levels (Macfarland et al. 1991).
The PC 12 cell line is derived from adrenal medulla and contains 
adenosine receptors coupled to cAMP synthesis as well as ANP receptors 
coupled to cGMP synthesis (Whalin et al. 1991). As such this cell line has 
been extensively used in the study of neurotransmitter release. Whalin et al 
(Whalin et al. 1991) have identified cGS-PDE in both particulate and soluble 
fractions of PC 12 cells and subsequently purified a 102kDa PDE from the 
soluble fraction which displayed positive co-operativity. Stimulation of PC 12 
cells with [^H] adenine resulted in the accumulation of cAMP. In contrast, 
treatment of PC 12 cells with either ANP or sodium nitroprusside (SNP) 
generated an increase in cellular cGMP levels with a concomitant decrease in 
cAMP. Whalin et al (Whalin et al. 1991) reported that the decrease in cellular 
cAMP was due to activation of cGS-PDE and confirmed this by showing that 
treatment of PC 12 cells with HL-725, a potent cGS-PDE inhibitor, reversed the 
effects of ANP and SNP.
Sonnenburg and co-workers (Sonnenburg et al. 1991) have cloned and 
expressed a 4.2kb cDNA from a bovine adrenal cortex library which, upon 
transfection in the cell line S49, resulted in the expression of soluble cAMP 
hydrolytic activity. This enzyme displayed positive co-operativity with low (1- 
5 |iM) concentrations of cGMP increasing this activity approximately 3-fold.
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Sonnenburg et al (Sonnenburg et al. 1991) have also demonstrated the existence 
of two distinct splice variants in a variety of bovine tissues. RNase protection 
assays revealed a 452bp band in adrenal cortex and medulla, liver, kidney lung 
and trachea while the detection of a 268bp band in brain suggests the presence 
of a specific isozyme in this tissue. Both the 452bp band and the 268bp band 
were detected in heart. Although unlike brain, heart expressed a substantial 
amount of the adrenal-like cGS-PDE mRNA as detected by the partial protection 
of the 268bp antisense riboprobe corresponding to the 5' end of the adrenal 
cGS-PDE. Furthermore, since the brain isozyme is membrane associated it can 
be inferred that the N-terminus is likely to be responsible for conferrment of 
membrane association on this enzyme (Sonnenburg et al. 1991).
Repaske et al (Repaske et al. 1993) have isolated a 350bp fragment of 
cDNA from rat brain that shows a high degree of homology with the bovine 
cGS-PDEs. By using this fragment as a probe these investigators have detected 
a 4.4kb mRNA in rat brain, liver, heart and kidney. Furthermore, regional 
analysis of brain showed that this isozyme was expressed predominantly in the 
hippocampus and cortex whilst being virtually absent from cerebellum of 
hindbrain (Repaske et al. 1993). Interestingly, Repaske et al (Repaske et al. 
1993) have pointed out that there is very little expression of cGMP-dependent 
protein kinase in brain and therefore have postulated that the mode of action for 
cGMP must be through the hydrolysis of cAMP by cGS-PDE.
Consistent with the observations of Murashima (Murashima et al. 1990) 
and Sonnenburg (Sonnenburg et al. 1991), which allude to the existence of 
alternative splice variants amongst the cGMP-stimulated PDEs, Yang et al 
(Yang et al. 1994) have cloned and characterised a unique isozyme from a rat 
brain cDNA library. The calculated MW of the rat brain isozyme, at ~ 105kDa, 
agrees well with that of the bovine adrenal gland enzyme, at ~103kDa. Indeed, 
the rat brain and bovine adrenal gland cGS-PDEs share 91% amino acid 
sequence similarity . Hydrophilicity analysis, however , has revealed that the
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N-terminal 37 amino acids of the rat brain enzyme, unlike the bovine isozyme, 
are extremely hydrophobic (Yang et al. 1994). Yang and co-workers (Yang et 
al. 1994) have also determined that greater than 75% of the rat brain isozyme 
can be found in the particulate fraction and suggest a role in targeting to 
membranes for the hydrophobic N-terminal region.
The involvement of a cyclic GMP-stimulated PDE in the regulation of 
cardiac contractility was first alluded to by the experiments of Fischmeister and 
Hartzell (Fischmeister and Hartzell 1987) who observed increased Ca2+ current 
(/ Ca) in frog ventricular cardiomyocyctes perfused with cAMP. This was 
subsequently shown to be decreased by the intracellular perfusion of the same 
cells by 20 |iM cGMP. More recently, Mery et al (Mery et al. 1993) reported 
that the increase in /  ca resulted from the phosphorylation of L-type Ca2+ 
channels by cAMP-dependent protein kinase and demonstrated that this effect 
could be modulated in a biphasic manner by the nitric oxide (NO) donor SIN-1. 
Whilst SIN-1 made no difference to basal /  ca in fr°g ventricular cells, an 
increase of -40% I c a was observed when cells stimulated by the cyclase 
activating compounds forskolin or isoprenaline, were perfused with SIN-1 in 
the 0.1-10 nM range. Conversely, SIN-1 concentrations in the range 100 nM-1 
mM led to a subsequent 85% decrease in I ca in the same cells. This observed 
decrease in /  ca is due to activation of the cGMP-stimulated PDE reducing 
intracellular cAMP (Mery et al. 1993).
Further confirmation that cGMP-stimulated PDE is responsible for 
decreasing I ca in frog ventricular cells through c AMP hydrolysis was provide 
by the observation that EHNA, a potent cGS-PDE inhibitor, could reverse this 
trend and also block the inhibitory effect of the NO donors SIN-1 and SNP 
(Mery et al. 1995). Additional confirmation that EHNA acts as a specific cGS- 
PDE inhibitor has been provided by Haynes et al (Haynes et al. 1996) who 
showed that EHNA reversed hypoxic pulmonary vasoconstriction in rat lung, a 
condition originally caused by the cGS-PDE catalysed hydrolysis of cAMP.
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Moreover, Michie et al (Michie et al. 1996) have shown that EHNA causes 
inhibition of a cGS-PDE implicated in the regulation of TCR signal 
transduction.
In summary, the cyclic GMP-stimulated PDEs are a family of PDEs 
which can hydrolyse both cAMP and cGMP. Both substrates demonstrate 
positively co-operative kinetic effects and micromolar concentrations of cGMP 
stimulate hydrolysis of cAMP. Both particulate and soluble cGS-PDEs have 
been characterised for a wide variety of tissues and cells. To date only one gene 
has been identified although there is evidence for the presence of at least two 
splice variants. The cGS-PDEs have been implicated in catecholamine 
secretion, calcium channel control, pulmonary vasoconstricion, aldosterone 
synthesis and T-cell signal transduction while possible involvement in olfaction 
and central nervous system function has been suggested.
1.5.5 PDE3, Cyclic GMP-inhibited Phosphodiesterases
Cyclic GMP-inhibited phosphodiesterases (cGI-PDEs) have been 
identified and characterised from a number of different tissues (Beavo 1995; 
Degerman et al. 1996; Manganiello et al. 1995; Manganiello et al. 1990) 
including adipocytes, where they have been implicated in modulation of the 
anti-lipolytic action of insulin (Brechler et al. 1992; Degerman et al. 1990; 
Gettys et al. 1988; Taira et al. 1993). Cyclic GI-PDEs are also known to play 
an important role in reversing the aggregatory action of cAMP in platelets 
(Lopez-Aparicio et al. 1993; Lopez-Aparicio et al. 1992; Macphee et al. 1988).
Glycogenolyis and gluconeogenesis are two processes that occur in 
hepatocytes due to a glucagon stimulated increase in the level of cAMP. 
Insulin, by contrast, is known to antagonize the effect of glucagon through the 
reduction of cAMP levels by activation of cGI-PDEs in these cells (Heyworth et 
al. 1983; Houslay and Kilgour 1990; Pyne et al. 1987).
Certain agents which exert positive inotropic effects in cardiac tissue are 
known to potentiate myocardial contractility by the selective inhibition of the
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cGI-PDE isozyme family (Brechler et al. 1992; Meacci et al. 1992; Movsesian 
etal. 1991; Smith et al. 1991).
This isozyme family encodes proteins of 105-135kDa MW which 
display high affinities for both c AMP amd cGMP with Km values in the range 
of 0.1-0.8|iM, however, they show V m ax  values which are approximately 4- 
10-fold higher for cAMP than cGMP, thereby effectively conferring specificity 
for cAMP as the preferred substrate (Beavo 1995; Degerman et al. 1996; 
Manganiello et al. 1990). Unlike the PDE4 isozyme family, hydrolysis of 
cAMP is inhibited by the presence of cGMP. Pyne et al (Pyne et al. 1987) for 
example, were able to show that 2|iM cGMP caused approximately 50% 
inhibition of the 'dense-vesicle' PDE isolated from rat hepatocytes, whereas 
Manganiello et al (Manganiello et al. 1990) have reported that cGMP induced 
competitive inhibition with an IC50 in the 0.1-0.6|iM range.
Initial attempts to purify the cyclic GMP-inhibited PDEs were hindered 
by the fact PDEs in general are expressed in cells with low abundance, are 
extremely labile and susceptible to proteolysis and are membrane bound. Thus 
Heyworth et al (Heyworth et al. 1983) and Pyne et al (Pyne et al. 1987) using a 
combination of homogenization and subcellular fractionation, demonstrated 
cGI-PDE activity in both particulate and cytosolic fractions of rat hepatocytes, 
and further resolved the particulate activity into two distinct enzyme 
populations, the plasma membrane bound PDE and the 'dense-vesicle' PDE. 
Subsequent to thse initial studies several groups have managed to purify cGMP- 
inhibited PDEs (Manganiello et al. 1995; Monaco et al. 1994). The 
observation that certain cardiotonic agents such as cilostamide and its derivates 
are specific inhibitors for cGI-PDEs was exploited by Degerman et al 
(Degerman et al. 1987; Degerman et al. 1990) to purify to homogeneity, the 
cGI-PDE from rat adipocytes. Lopez-Aparacio and co-workers (Lopez- 
Aparicio et al. 1992) were also able to purify the human platelet cGI-PDE by 
immunoprecipitation with specific polyclonal antibodies. Such a strategy has
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also been succesfully used by Smith et al (Smith et al. 1993) to prepare cGI- 
PDEs from myocardium from several mammalian species.
Cyclic GMP-inhibited PDEs are found in both particulate and cytosolic 
cell fractions (Beavo 1995; Degerman et al. 1996; Manganiello et al. 1995; 
Meacci et al. 1992; Monaco et al. 1994). Gettys et al (Gettys et al. 1988) in 
their studies on the activation of the rat adipocyte cGI-PDE by the catalytic 
subunit of cAMP-dependent protein kinase, demonstrated that limited 
proteolysis of crude adipocyte microsomes resulted in the transfer of PDE 
catalytic activity from the particulate to the cytosolic fraction. Moreover, it was 
observed that this soluble PDE activity was only minimally activated by the 
addition of the catalytic subunit of PK-A, therefore Gettys and co-workers 
(Gettys et al. 1988) suggested that proteolysis had resulted in the removal of a 
regulatory domain from the PDE. Houslay and Kilgour (Houslay and Kilgour 
1990) have shown that the cGI-PDE activity in hepatocytes was increased by 2- 
3-fold by PK-A but only if the cell fraction was initially treated with Mg2+ 
prior to challenge with PK-A. These investigators have shown that the effect of 
Mg2+ was to stimulate endogenous protein phosphatases
The first substantiated evidence regarding the structure of a cGI-PDE 
was obtained by Meacci and co-workers (Meacci et al. 1992). By using 
degenerate oligonucleotide probes based on the partial amino acid sequence of 
the human platelet cGI-PDE, these investigators isolated a cDNA from a human 
myocardial cDNA library which encoded a 125kDa protein. The deduced 
amino acid sequence revealed the presence of a highly conserved region which, 
upon expression as a fusion protein in a bacterial expression system, 
demonstrated cAMP hydrolytic activity and, furthermore, was immunoreactive 
to antibodies raised against the platelet enzyme. Interestingly, these 
investigators also identified the presence of a unique 44 amino acid within the 
catalytic region which is absent in the other PDE isozyme families (Manganiello 
et al. 1995; Meacci et al. 1992). Taira et al have subsequently confirmed the
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existence of this insert upon isolation of two clones for the rat adipocyte cGI- 
PDE (Taira et al. 1993).
Hydropathy analysis of the amino acid sequence of the cGI-PDEs has 
revealed that the N-terminus contains several hydrophobic regions and it has 
been suggested that these may adopt a transmembrane a  helical conformation 
(Degerman et al. 1996; Leroy et al. 1996; Meacci et al. 1992; Rahn et al. 1996; 
Smith et al. 1993; Taira et al. 1993). Indeed the experiments of Leroy and co­
workers on full-length and truncated forms of the rat adipocyte and human 
myocardial cGI-PDEs have successfully demonstrated that removal of the 
hydrophobic N-terminal region results in the transfer of cAMP hydrolytic 
activity from the particulate to the cytosolic fraction uopn expression of cDNAs 
for these two isozymes in both NIH 3006 fibroblasts and Sf9 insect cells 
(Leroy et al. 1996).
The first indication that there may be more than one gene encoding the 
cGI-PDE isozyme family was provided by the experiments of Taira etal (Taira 
et al. 1993). The cDNA for RcGIPl was cloned from a rat adipocyte cDNA 
library and the putative catalytic domain expressed in E.coli where it displayed 
the inhibition by cilostamide characteristic of the cPI-PDEs. A second distinct, 
but related, partial cDNA was also isolated which demonstrated a high degree of 
sequence similarity to the human cardiac cGI-PDE. It has been suggested that 
this may have beeen derived from RNA from vascular elements within the 
adipose tissue (Taira et al. 1993). Since these initial experiments, the PDE3A 
isozyme has been identified as the predominant form in smooth muscle, 
platelets and cardiac tissue whereas PDE3B, the second gene product, is more 
abundant in adipose tissue and hepatocytes (Beavo 1995; Degerman et al. 
1996).
More recently Reinhardt et al (Reinhardt and Bondy 1996; Reinhardt et 
al. 1995) have shown that the PDE3A and PDE3B genes display distinct 
spaciotemporal patterns of expression during embryonic and postnatal
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development. Reinhardt and co-workers (Reinhardt et al. 1995) have shown by 
means of in situ hybridization, that PDE3A is the gene expressed in rat 
adipocytes and hepatocytes during embryogenesis and throughout adult life, 
whereas PDE3B was highly expressed in rat mycardium throughout myocyte 
differentiation and into adulthood. This evidence appears to be somewhat 
confusing as it is in direct contrast to previous reports (Taira et al. 1993). 
Reinhardt et al (Reinhardt and Bondy 1996) also observed the abundant 
expression of both PDE3A and PDE3B mRNAs in embryonic rat brain and 
have subsequently demonstrated that PDE3B is uniformly expressed in rat brain 
from embryonic day 15 to adulthood, suggesting a fundamentaly metabolic role 
for this isoform. PDE3A mRNA however, displays three distinct patterns of 
expression. Firstly, it is highly abundant in primary and secondary 
neuroepithelial zones suggestive of a role in cell cycle regulation. Secondly, it 
is transiently expressed during early postnatal development in basal forebrain in 
concert with IGF-1 expression, suggesting a possible connection between IGF- 
1 stimulation and neuronal maturation. Finally, the observation that PDE3A 
mRNA is abundantly expressed in subsets of mature striatal and hippocampal 
neurons has implicated this isozyme in neuronal signalling (Reinhardt and 
Bondy 1996).
Evidence has also been presented for the existence of alternative 
transcripts of the human cardiac cGI-PDE which tends to suggest that these 
transcripts may be expressed in a tissue-specific manner. Kasuya and co­
workers isolated a 4.4kb cDNA from a human placental cDNA library which 
encodes a protein of approximately 74kDa MW (Kasuya et al. 1995). 
Comparison of the nucleotide sequence revealed that the 4.4kb transcript is 
virtually identical to the 3' portion of the 7.6kb transcript corresponding to the 
125kDa human cardiac enzyme previously cloned by Meacci etal (Meacci et al.
1992). By means of RNase protection assays and Northern blots and these 
researchers have identified an alternative promoter present within the cardiac
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enzyme mRNA which, when expressed in HeLa cells as an in-frame fusion 
with the bacterial reporter enzyme CAT demonstrated an approximately 6-fold 
increase in CAT activity over the native enzyme (Kasuya et al. 1995). 
Expression of recombinant 80kDa and 125kDa isozymes in Sf9 insect cells also 
revealed differences in their kinetic properties and subcellular localization. The 
Km for cGMP for the 80kDa enzyme was shown to be approximately 7-fold 
higher than the Km for the 125kDa isozyme. Furthermore, the 125kDa isozyme 
was found in the particulate fraction in contrast to the cytosolic location of the 
80kDa species (Kasuya et al. 1995). This observation further strengthens the 
hypothesis that the N-terminus contains elements which confer membrane 
localization upon members of the cGI-PDE, as previously suggested from 
several other studies (Degerman et al. 1996; Leroy et al. 1996; Meacci et al. 
1992; Rahn et al. 1996; Smith et al. 1993; Taira et al. 1993). It would appear 
then that alternative transcription within the cGI-PDE isozyme family may 
provide a mechanism whereby the same gene can by expressed with different 
kinetic charateristics and subcellular localizations within different tissues.
1.5.5.1 Regulation of PDE3
As early as 1966 Butcher etal (Butcher et al. 1966) suggested that the 
anti-lipolytic action of insulin in rat adipose tissue may be due, at least in part, 
to a decrease in cAMP levels. That this process might involve the activation of 
a PDE was strengthened by the observation that epinephrine-stimulated 
increases in cAMP in adipose tissue was enhanced by the inclusion of caffeine, 
a known PDE inhibitor, in the incubation (Butcher et al. 1966). Loten and 
Sneyd (Loten and Sneyd 1970) demonstrated that the decrease in cAMP in 
epididymal fat pads was concommitant with an increase in cyclic nucleotide 
phosphodiesterase activity upon stimulation by insulin (Loten and Sneyd 1970). 
Some years later Heyworth et al (Heyworth et al. 1983) were able to show that 
rat hepatocytes contained two distinct membrane associated PDEs which they 
termed the plasma membrane PDE, presumed to be a PDE4 species, and the
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'dense-vesicle' PDE, presumed to be a PDE3 species. These researchers were 
able to demonstrate that glucagon increased cAMP could be subsequently 
decreased by the addition of insulin, however, the action of insulin was 
inhibited by addition of IB MX, a known PDE inhibitor, to the reaction 
(Heyworth et al. 1983). Pyne et al (Pyne et al. 1987) in 1987 subsequently 
purified the 'dense-vesicle' PDE and showed that it could be activated by both 
glucagon and insulin whereas the plasma membrane PDE was activated by 
insulin in a fashion which could be blocked by glucagon. The 'dense-vesicle' 
PDE enzyme also observed to be inhibited by cGMP as well as milrinone, a 
specific inhibitor of cGI-PDEs (Pyne et al. 1987).
The observation that cilostamide acted as a specific inhibitor of the cGI- 
PDEs was exploited by Degerman and co-workers to purify to homogeneity a 
cGI-PDE from the particulate fraction of rat adipose tissue. This displayed an 
80% increase in cAMP hydrolytic activity upon incubation in the presence of 
nanomolar concentrations of insulin (Degerman et al. 1987). Degerman et al 
(Degerman et al. 1990) have since shown that the cGI-PDE from rat adipose 
tissue can be activated by both insulin and the catecholamine isoprenaline. 
These processes involve covalent modification, mainly phosphorylation. It has 
been postulated that thes effects may occur through the action of an insulin- 
activated serine protein kinase and cAMP-dependent protein kinase at two 
distinct sites (Degerman et al. 1990).
Insulin-stimulation of the human platelet cGI-PDE has also been 
reported by Lopez-Aparacio et al (Lopez-Aparicio et al. 1992) who have 
observed that patients with diabetes mellitus display an increased sensitivity to 
platelet aggregating agents due to the action of cAMP as an inhibitory second 
messenger in these cells. Experiments carried out by these investigators 
demonstrated that incubation of the purified platelet cGI-PDE with insulin was 
accompanied by a 300-400% increase in phosphorylation of the enzyme. That 
this covalent modification was responsible for the observed increase in cAMP
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hydrolysis was confirmed by a reduction of cGI-PDE activity after inclusion of 
the serine/threonine protein kinase inhibitor H7 in the reaction (Lopez-Aparicio 
et al. 1992). Since this study Lopez-Aparacioand colleagues (Lopez-Aparicio et 
al. 1993) have detected , partially purified and characterised an insulin- 
stimulated cGI-PDE serine kinase in human platelets. Previous studies have 
also demonstrated that agents such as prostaglandinds Ei and I2 mediate the 
activity of the human platelet cGI-PDE by a direct cAMP-dependent catalysed 
phosphorylation (Macphee et al. 1988).
The activation of cGI-PDEs by phosphorylation has been well 
documented in the literature since the first evidence that the rat adipocyte 
particulate cGI-PDE was specifically phosphorylated by the catalytic subunit of 
cAMP-dependent protein kinase (Gettys et al. 1988; Leroy et al. 1996; Lopez- 
Aparicio et al. 1993; Rahn et al. 1996; Rascon et al. 1994; Taira et al. 1993). 
Based on the observation that limited proteolysis released an active PDE into the 
cytosolic fraction which showed no measurable increase in activity upon 
incubation with the catalytic subunit of cAMP-dependent protein kinase, Gettys 
and co-workers postulated that the site of phosphorylation was located within 
the N-terminus of the enzyme (Gettys et al. 1988).
Degerman et al (Degerman et al. 1990) through radiolabelling and 
phosphopeptide mapping were able to show that insulin and isoprenaline 
induced serine phosphorylation. However, identification of several cAMP- 
dependent phosphorylation sites was only achieved upon isolation and 
characterization of the enzyme, suggesting that serine 427 was the specific 
residue phosphorylated (Leroy et al. 1996; Lopez-Aparicio et al. 1993; Rahn et 
al. 1996; Rascon et al. 1994; Taira et al. 1993). Interestingly, Leroy and co­
workers (Leroy et al. 1996) have recently demonstrated that although serine 427 
was the major site of in vitro phosphorylation found using solubilized 
adipocyte cGI-PDE, the major site of phosphorylation in intact cells treated with 
insulin, or other agents known to elevate cAMP, was in fact serine 302. This
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observation has since been confirmed by the experiments of Rahn etal (Rahn et 
al. 1996). It has been suggested that the reason for this difference may reflect a 
difference in structure of the enzyme upon membrane insertion (Leroy et al.
1996).
In addition to the wealth of information regarding hormonal activation of 
the cGI-PDEs, Brechler and co-workers have presented evidence for the 
inhibition of cGI-PDE by glucagon (Brechler et al. 1992). Brechler et al 
(Brechler et al. 1992) observed that, upon addition of glucagon to the particulate 
fraction of frog ventricle, approximately 40% inhibition of PDE activity was 
observed in the presence of micromolar concentrations of GTP. No effect was 
observed for the cytosolic PDE activity. Furthermore, it was noted that 
treatment of the particulate fraction with pertussis toxin (PTX) resulted in the 
complete abolition of the inhibitory effect of glucagon. Since no effect was 
observed upon treatment with cholera toxin, Brechler and colleagues (Brechler 
et al. 1992) suggested that the inhibition of the cardiac cGI-PDE by glucagon 
was mediated by membrane receptors via a PTX sensitive G-protein possibly 
Gi or G0- Further evidence in support of this theory was provided by the 
observation that mastoparan, a wasp venom peptide known to activate Gi /G0 
directly, mimicked the effect of glucagon.
In summary, cGMP-inhibited phosphodiesterases are 'low Xm' PDEs 
which specifically hydrolyse cAMP, are inhibited by cGMP and are stimulated 
by hormones and agents which raise intracellular cAMP and are known to be 
activated/deactivated by phosphorylation/dephosphorylation. Cyclic GI-PDEs 
have been identified, and in some cases isolated, from both cytosolic and 
particulate fractions of adipocytes, hepatocytes, cardiac tissue, smooth vascular 
muscle and platelets where they have been implicated in lipolysis 
glycogenolysis and gluconeogenesis, myocardial contractility, blood pressure 
and clotting respectively. Two distinct genes have been identified for the cGI- 
PDEs and there is evidence for the existence of alternative transcripts.
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Structurally, they show the same domain organisation as other PDE families, 
with membrane association and regulatory elements contained within the N- 
terminus and a C-terminal catalytic domain which contains a 44 amino acid 
insert unique to the cGI-PDE isozyme family.
1.5.6 PDE4, Cyclic AMP-Specific Phosphodiesterases
The PDE4 cyclic AMP-specific PDEs are, to date, the largest and most 
extensively studied of the seven PDE isozyme families (Beavo 1995; Beavo et 
al. 1994). At least four separate genes have been identified most of which, to 
add a further level of complexity, have been shown to possess two or more 
alternative splice variants (Beavo 1995; Beavo et al. 1994; Bolger et al. 1993; 
Colicelli et al. 1989; Davis et al. 1989; Engels et al. 1995; Horton et al. 1995; 
Livi et al. 1990; McLaughlin et al. 1993; Michaeli et al. 1993; Sullivan et al.
1994). This isozyme family specifically hydrolyses cAMP and can be further 
characterized by the observation that they are uniquely sensitive to inhibition by 
rolipram (Beavo 1995; Beavo et al. 1994; Beavo and Houslay 1990).
PDE4 was originally classified after the initial observations of Reeves et 
al (Reeves et al. 1987b) that four distinct PDE activities present in guinea-pig 
cardiac ventricle could be eluted by increasing salt concentration following 
separation by DEAE-ion exchange chromatography. Moreover, Reeves and 
collegues (Reeves et al. 1987a) observed that the compounds rolipram and RO- 
12-2074 were selective and potent inhibitors of PDE4 activity. However,it 
should be noted that some years prior to this work, Marchmont and Houslay 
(Marchmont and Houslay 1981) purified a 52kDa protein which specifically 
hydrolysed cAMP from rat liver. Subsequent studies by Pyne et al (Pyne et al. 
1987) identified this enzyme isolated from rat hepatocytes as the peripheral 
plasma membrane PDE (PPM.PDE) and showed that, similarily to the guinea- 
pig PDE4, it could be specifically inhibited by both rolipram and RO-17-2074.
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1.5.6.1 Molecular Cloning of PDE4 Isoenzymes
Undoubtedly a major insight in PDE understanding was obtained from 
early studies done on the fruit fly Drosophila melanogaster. Dudai et al (Dudai 
et al. 1976) had shown as early as 1976 that, unlike normal flies which can 
learn to avoid an odorant associated with an electric shock, an X-linked mutant 
failed to display this learning despite being able to sense both the odorant and 
the electric shock and so named the mutation dunce . Subsequent biochemical 
characterization of flies containing the dunce mutation revealed that the defect 
lay in a gene which encoded a cAMP phosphodiesterase (Byers et al. 1981; 
Davis and Kiger 1981) and therefore provided the first tangible evidence that 
memory and learning could have a genetic basis. Chen et al (Chen et al. 1986) 
have since isolated the gene by means of chromosome walking and identified 
various associated RNA transcripts. Upon sequencing several cDNA clones 
originating from the various transcripts, these investigators ascertained that the 
dunce gene product possessed striking amino acid sequence similarity to the 
amino acid sequence of the Ca2+/CaM PDE enzyme. That researchers have 
observed such high degrees between primary amino acid seqeuences has led to 
the postulation that dunce is most likely the probable ancestor of the 
mammalian cAMP PDEs (Chen et al. 1986; Qui et al. 1991). Qui et al (Qui et 
al. 1991) have provided a further valuable insight into the complex nature of the 
dunce gene by demonstrating that it spans a region of approximately 148 kb of 
genomic DNA whilst six different mRNA species can be generated by three 
alternative transcription initiation sites in conjunction with alternative splicing.
The first PDE genes to be cloned from mammalian species were 
obtained by two different experimental approaches. By exploiting the amino 
acid similarities observed between the bovine Ca2+/CaM PDE and the dunce 
PDE, Davis et al (Davis 1990; Davis et al. 1989) used a probe derived from the 
dunce gene to screen a rat brain cDNA library. They subsequently cloned a
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cDNA, now known as RD1 (RNPDE4A1), which encoded a 610 amino acid 
open reading frame. This displays significant homology to a conserved domain 
of approximately 275 amino acids found in most other PDEs . Interestingly, 
Davis and collegues (Davis 1990; Davis et al. 1989) also isolated a series of 
other cDNAs with divergent N-terminal regions, RD2 and RD3, (RNPDE4A2 
and RNPDE4A3 respectively). Furthermore, RD3 has a 99 bp deletion 
suggesting the possibility of the existence of alternative transcripts.
The second molecular approach to cloning mammalian cDNA was 
adopted by Colicelli et al (Colicelli et al. 1989). The yeast Saccaromyces 
cerevisiae contains genes which encode RAS 1 and RAS 2. When the activated 
form of RAS 2 is present yeast, cells display a loss of growth control and an 
increased sensitivity to heat shock as a result of the accumulation of cAMP by 
the uncontrolled activation of adenylyl cyclase (Colicelli et al. 1989). By 
constructing a rat brain cDNA library in a yeast expression vector, Colicelli et al 
(Colicelli et al. 1989) were able to isolate and clone and characterize the DPD 
(Dunce-like Phosphodiesterase) PDE cDNA clone that was able to complement 
the loss of growth control associated with RAS 2 activation in yeast. 
Biochemical characterization of DPD showed it to be a high-affinity cAMP PDE 
with approximately 80% amino acid similarity to the dunce gene of Drosophila 
melanogaster (Colicelli et al. 1989). This same approach has also been 
employed by other researchers to clone cDNAs for PDE4s from humans 
(Bolger et al. 1993; Michaeli et al. 1993; Sullivan et al. 1994).
The first definitive evidence for the existence of multiple genes encoding 
PDE4s was presented by Swinnen et al (Swinnen et al. 1989a; Swinnen et al. 
1989b). By adopting a similar strategy to that described by Davis et al (Davis et 
al. 1989) Swinnen and co-workers used a dunce derived probe to identify two 
cDNAs in a rat testis cDNA library which they named ratPDEl (RNPDE4C) 
and ratPDE2 (RNPDE4A). By using a probe derived from ratPDE2 a further 
two clones were isolated from a Sertoli cDNA library, ratPDE3 (RNPDE4D)
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and ratPDE4 (RNPDE4B). Sequence analysis of these four clones revealed that 
although they possessed similar but not identical sequences over a region of 
approximately 1080 bases they, more importantly, displayed considerable 
sequence heterogeneity outwith this region. Comparison of the deduced amino 
acid sequences for each of the four clones demonstrated that each contained the 
highly conserved region of approximately 270 residues observed in all 
previously published PDE sequences whilst a great degree of diversity was 
observed in the sequences corresponding to the amino and carboxy termini 
(Swinnen et al. 1989a). Bolger et al (Bolger et al. 1993) has independently 
established the presence of four distinct PDE4 genes homologous to the dunce 
gene product of Drosophila melanogaster, in human brain.
Clones corresponding to human PDE4 isoenzymes have also been 
isolated from human tissues by exploiting the same methodology employed 
above. Livi et al (Livi et al. 1990) cloned a PDE4A gene (HSPDE4A4) from a 
human monocyte cDNA library whilst Bolger and colleagues have isolated the 
cDNA for PDE46 (HSPDE4A5) from a human foetal brain cDNA library.
Since these initial studies several other researchers have cloned and 
characterized cDNAs representing each of the four PDE4 genes. Sullivan et al 
(Sullivan et al. 1994) reported the cloning of the PDE4A gene product h6.1 
(HSPDE4A7) from a human T-cell Jurkat cDNA library by a combination of 
PCR screening and reversal of heatshock in yeast and Horton and colleagues 
(Horton et al. 1995) have isolated the cDNA for 2EL (HSPDE4A8), a novel 
PDE4A splice variant, from the same Jurkat T-cell library. Interestingly, 2EL 
whilst possessing sequences in common with h6.1, differs from this gene 
product by virtue of a distinct 5'-end. It also contains a 34 base insert within 
the region thought to encode the catalytic domain which effectively renders this 
PDE inactive presumably by orchestrating a frameshift and thus causing the 
premature termination of the open reading frame. It has, to date not been 
possible to prove conclusively that 2EL exists in a physiological context, nor to
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assign a role to this splice variant. Curiously, in an earlier study Bolger et al 
(Bolger et al. 1993) reported a similar observation with the identification of 
TM3. Horton et al (Horton et al. 1995) have tentatively suggested that such 
non-functional splice variants may represent an intracellular mechanism for the 
control of PDE gene expression at the mRNA level.
As mentioned previously, a mutation in the Drosophila dunce gene 
leads to behavioral and learning difficulties (Byers et al. 1981; Davis and Kiger 
1981). Interestingly, Horton et al (Horton et al. 1995) by means of in situ 
fluorescence chromosomal hybridization have mapped the human PDE4A gene 
to the pl3.1-ql2 region of chromosome 19. Chromosome 19 has also been 
implicated in susceptibility to late-onset Alzheimers syndrome. It is intriguing, 
therefore, to consider the possibility that changes in the concentration of 
intracellular cAMP by this PDE may somehow be implicated in the 
manifestation of this disease state.
Several studies have established the existence of a second PDE4 gene 
designated PDE4B (Bolger et al. 1993; Bolger et al. 1994; Colicelli et al. 1989; 
Monaco et al. 1994; Obernolte et al. 1993; Swinnen et al. 1989a). The first 
reported cloning of a PDE4B gene was obtained by the studies of Colicelli et al 
(Colicelli et al. 1989) who isolated and characterized the DPD (RNPDE4B1) 
gene from rat brain, and Swinnen and colleagues (Swinnen et al. 1989a) who 
screened a Sertoli cell cDNA library with a probe derived from a rat PDE4A 
clone and isolated the cDNA for RNPDE4B2A. Comparison of the primary 
amino acids sequences for these two clones revealed that RNPDE4B2A differed 
from RNPDE4B1 by the addition of an extra 41 amino acids at the N-terminus 
thus suggesting that, like the PDE4A isozymes, PDE4B also demonstrated 
alternative transcripts. Subsequently, several researchers have reported the 
cloning of cDNA corresponding to PDE4Bs from both rat and humans. 
Obernolte et al (Obernolte et al. 1993) have cloned a 3.8kb cDNA from a human 
lymphocyte B-cell line by low stringency screening with a rat PDE4B probe.
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This clone exhibited -86% and -93% sequence similarity at the DNA and 
protein levels respectively to the rat PDE4B. Expression of this clone in 
bacteria revealed a 7.5-13-fold increase of cAMP hydrolysis which was shown 
to be inhibitable by rolipram, thus confirming its status as a PDE4 isozyme.
Whilst investigating the possibility of developing PDE4 inhibitors as 
anti-depressant and anti-inflammatory drugs, McLaughlin et al (McLaughlin et 
al. 1993) have presented evidence for the expression of a second PDE4B gene 
in human brain. A cDNA for HSPDE4B2A was isolated and characterized 
from a human frontal cortex cDNA library. Independent confirmation for the 
existence of this PDE4B gene has also been presented by Bolger and colleagues 
(Bolger et al. 1993) by utilizing a combination of PCR, hybridization screening 
and yeast complementation. Moreover, Bolger et al (Bolger et al. 1993) have 
provided evidence for the existence of a further human PDE4B splice variant 
TM72 (HSPDE4B1).
Further evidence for the existence of multiple PDE4B splice variants has 
been presented by Monaco et al (Monaco et al. 1994). Isolation of a genomic 
rat PDE4B clone from a cosmid library has shown that it is derived from the 
assembly of 11 exons and 10 introns distributed over -25 kb. Moreover, the 
5'-untranslated region contains the potential to encode multiple short open 
reading frames which may reduce translation of the full-length PDE4B mRNA 
in a manner analogous to that suggested previously for the PDE4A splice 
variant 2EL (Horton et al. 1995) and TM3 (Bolger et al. 1993).
By comparison with the information obtained for PDE4A and PDE4B 
gene products, relatively little is known about PDE4C. Early reports were 
successful in identifying and isolating cDNAs for both rat (Swinnen et al. 
1989a) and human (Bolger et al. 1993; Bolger et al. 1994). Moreover, since 
only partial cDNAs which do not encode functional isozymes have been 
identified, further characterization has not been possible. Engels et al (Engels et 
al. 1995) have reported the cloning of a putative full-length human PDE4C.
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However, it would appear that the approach used to generate this clone resulted 
in the generation of a composite cDNA from two different mRNA sources, thus 
any inferences made regarding this clone must necessarily be treated with a 
certain amount of caution. More recently, Owens and colleagues (Owens et al. 
1997) have reported the isolation of a cDNA for a PDE4C gene from the human 
glioblastoma cell line U87 by means of RT-PCR and 5' RACE. Interestingly, 
this approach has yielded two alternative 5' end sequences suggesting that 
PDE4C, like the PDE4A and PDE4B genes, encodes for alternative splice 
variants. Sequence comparison suggests that, as for the other PDE4s, the 
human PDE4C is more homologous to the rat PDE4C than it is to other human 
PDE4s thus implying some conservation of functional significance.
Next to the PDE4A isozyme family the PDE4D gene demonstrates the 
most heterogeneity with evidence to support the existence of multiple splice 
variants having been reported in the literature (Baecker et al. 1994; Beavo 1995; 
Beavo et al. 1994; Bolger et al. 1993; Bolger 1994; Bolger et al. 1994; Jin et al. 
1992; Monaco et al. 1994; Nemoz et al. 1996; Sette et al. 1994b; Swinnen et al. 
1989a). Swinnen et al (Swinnen et al. 1989b) reported the first cloning of a 
PDE4D cDNA from a Sertoli cell cDNA library whilst Bolger and co-workers 
(Bolger et al. 1994) have shown the existence in rat brain of two PDE4D splice 
variants, RPDE13 and RPDE3 (RNPDE4D1B and RNPDE4D3A respectively). 
These, while displaying a large degree of sequence similarity in the catalytic 
region, possess divergent 5'- ends. Evidence has also been obtained for the 
existence of distinct PDE4D splice variants from a variety of human sources 
including brain (Bolger et al. 1993), heart (Baecker et al. 1994) and, more 
recently, peripheral blood mononuclear cells (Nemoz et al. 1996). This 
suggests the possibility of the involvement of PDE4 isozymes in physiological 
proccesses as diverse as memory and learning, congestive heart failure and anti- 
i n f l a m m a t o r y  c o n d i t i o n s .
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1.5.6.2 Structure of PDE4s
Like most other PDE isozymes studied to date, PDE4s can be regarded 
as multi-domain proteins composed of a highly conserved core containing the 
catalytic domain linked to variant N- and C-terminal fragments (Charbonneau 
1990). Many groups have subsequently cloned cDNAs for a variety of PDE4 
isozymes (Bolger et al. 1996; Bolger et al. 1993; Bolger et al. 1997; Chen et al. 
1986; Colicelli et al. 1989; Davis et al. 1989; Engels et al. 1995; Jin et al. 1992; 
Livi et al. 1990; McLaughlin et al. 1993; Obernolte et al. 1993; Owens et al. 
1997; Sullivan et al. 1994) which are consistent with Charbonneau's proposal. 
Furthermore, such studies have demonstrated that considerable structural 
similarities exist throughout this region of approximately 270 amino acids.
More interestingly, studies carried out on human homologues of each of 
the four PDE4 genes by Bolger et al (Bolger et al. 1993) have ascertained the 
existence of two further regions of amino acid sequence homology. These are 
known as UCR1 and UCR2 (Upstream Conserved Regions) and have been 
demonstrated to be unique to the PDE4 gene family (Fig. 1.3). Thus, the PDE 
enzyme can be classified as either 'long form' PDE4s containing the catalytic 
domain along with UCR1 and UCR2, or 'short form' PDE4s consisting of the 
catalytic domain and UCR2 only. Furthermore, it has been observed that all 
catalytically active PDE4s transcribed from a specific gene have identical C- 
terminal regions. Each of these are distinct from the C-termini of isozymes 
transcribed from other PDE4 genes (Erdogan and Houslay 1997; Huston et al. 
1996; Lobban et al. 1994; Shakur et al. 1995)
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Figure 1.3: Splice Variants Arising from PDE4 Genes
PDE4 splice variants are shown with an open box representing the highly 
conserved putative catalytic region. Long form splice variants are denoted 
by closed circles ( • )  and short form splice variants by open circles (O). 
Three splice variants of the rat PDE4A gene are shown, the short isoform 
RNPDE4A1 and the long isoforms RNPDE4A5 and RNPDE4A8. The 
human long isoform splice variant HSPDE4A5B is also represented. 
HSPDE4A4C represents the N-terminally truncated clone known as h6.1 
(Sullivan et al 1994). In addition an inactive human splice variant 
HSPDE4A8 also known as 2EL (Sullivan et al 1994) which has short novel 
sequences (grey lines) spliced onto an N- and C- terminally truncated 
catalytic region is shown. Met26RDl denotes the active 'core' PDE4A gene 
product. Long and short isoform splice variants are also shown for PDE4B 
and PDE4D genes. PDE4D2 is related to PDE4D1 except for a deletion in 
the N-terminal splice region.
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1.5.6.2.1 The Catalytic Site
Evidence that the 270 amino acid region (Fig. 1.2) found to be highly 
conserved amongst PDE4 isozymes corresponded to the catalytic domain was 
provided by the studies of Jin et al (Jin et al. 1992). These researchers 
demonstrated that it was possible to remove a carboxy terminal 99 amino acid 
region flanking the conserved domain from RNPDE4D2A and still observe 
cAMP hydrolytic activity in both bacterial and eukaryotic expression systems. 
By employing the same strategy to engineer deletion of the N-terminal 97 amino 
acids of RNPDE4D2A, Jin and co-workers also demonstrated that the N- 
terminus does not form part of the catalytic domain whereas a larger deletion of 
131 amino acids at the N-terminus leads to abolition of cAMP hydrolysis. 
Interestingly, Swinnen et al (Swinnen et al. 1989a) had previously reported the 
cloning of RNPDE4D3 which was identical to RNPDE4D2A with the exception 
that it lacked 78 amino acids at the N-terminus and have shown that this 
isozyme possesses catalytic activity. More recently, Jacobitz et al (Jacobitz et 
al. 1996a) provided further confirmation that the highly conserved region 
common to all PDEs contained the catalytic domain by demonstrating that a 
truncated PDE4A encompassing only the conserved domain was capable of 
hydrolysing cAMP and that this activity could be inhibited by the selective 
PDE4 inhibitor rolipram.
Analysis of the amino acid sequences of all mammalian PDEs revealed 
the presence of several highly conserved serine, threonine and histidine residues 
thus implying a possible conservation of function. By means of site specific 
mutagenesis Jin et al (Jin et al. 1992) have determined that some of these amino 
acid residues are necessary for cAMP hydrolysis. Substitution of the invariant 
threonine 349 (numbered for RNPDE4D2A) by either alanine or proline 
abolished catalytic activity whereas substitution by serine resulted in catalytic 
activity but with a reduced VWMJC • Conversely, substitutions of serines 305 and 
398 had no effect upon cAMP hydrolysis but mutation of histidines 278 and
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311, which lie in close proximity to threonine 349, also prevented cAMP 
hydrolysis. More recently, Jacobitz and co-workers (Jacobitz et al. 1996b) 
working on a human PDE4A (HSPDE4A4) have shown that not only are 
histidine residues at positions 433, 437 and 473 necessary for substrate 
binding, but that, in addition to eliciting a substantial decrease in cAMP 
hydrolytic activity, mutation of these amino acids resulted in a marked reduction 
of this enzymes ability to bind the prototypical PDE4 inhibitors [3H](R)- 
rolipram or [3H]PR 73401.
1.5.6.2.2 UCR1 and UCR2
Cloning of the first human homologues to the dunce PDE and 
alignment of their sequences by Bolger et al (Bolger et al. 1993; Torphy et al. 
1992b) revealed the presence of two regions of high homology which were 
unique to the PDE4 gene family. These were subsquently named UCR1 and 
UCR2. Analysis of the amino acid sequence of UCR1 revealed a region of 
approximately 55 amino acid residues divided into a polar N-terminal region 
and an apolar predominatly hydrophobic C-terminal region which may 
demonstrate the ability to adopt an amphipathic a  helix. Interestingly, the polar 
region in PDE4D3 contains a PKA consensus phosphorylation site RRES 
situated within a region composed predominantly of positively charged amino 
acids. Phosphorylation of this serine may thus elicit a conformational change in 
the region which may have functional implications. UCR2 consists of 
approximately 76 amino acids and is, in contrast to UCR1, a very hydrophilic 
structure. Secondary structural predictions suggest that UCR2 is composed of 
three a  helices the first and last of which display strong negative charges whilst 
the middle helix is slightly positively charged and thus UCR2 may exist as an 
amphipatic helix (Torphy et al. 1992b).
UCR1 and UCR2 are separated from each other by the so called Linker 
Region 1, LR1 (Houslay et al. 1997b), a short region which exhibits very little 
primary amino acid sequence homology between individual members of the
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PDE4 isozyme family but which do appear to display some gene specific 
similarity. While LR1 of the PDE4A genes products consists of alternating 
hydrophobic and hydrophilic regions, LR1 of PDE4B is exclusively 
hydrophilic. The LR1 of PDE4C although predominantly hydrophilic 
possesses a hydrophobic N-terminal region while the LR1 region in PDE4D is 
located at its C-terminus. UCR2 is in turn separated from the catalytic domain 
by the so called Linker Region 2 (LR2) (Houslay et al. 1997b) which varies in 
size from 10 to 28 amino acids all of which are hydrophobic, although whilst 
the LR2 of PDE4C contains some negatively charged residues the others consist 
only of positively charged amino acids. Moreover, it would seem that LR2 may 
form a predominantly random coil structure.
Whilst specific functional significance has yet to be attributed to the 
predicted structures within URC1 and UCR2, Bolger (unpublished data) has 
observed that UCR1 can associate with UCR2 in a yeast two-hybrid assay 
designed to detect protein-protein interactions. It may be then, that association 
of these two distinct regions serves in some regulatory manner specific to the 
PDE4 isozyme family. It should be noted however, that this observation was 
based upon studies using isolated UCR1 and UCR2 regions and it remains to 
be seen whether this can be replicated by the full-length PDE4 gene products.
1.5.6.3 Tissue Distribution of PDE4 Isozymes
Members of the PDE4 gene family have been identified in a wide variety 
of cell and tissue types by a variety of experimental approaches. Marchmont 
and Houslay (Marchmont and Houslay 1980) have demonstrated the presence 
of PDE4 activity in rat liver plasma membranes and later in hepatocytes 
(Houslay et al. 1992). Meanwhile, Swinnen and colleagues (Swinnen et al. 
1989a; Swinnen et al. 1989b) isolated cDNA clones for the first mammalian 
homologues of the Drosophila dunce PDE from rat testis. Such data implies 
that the action of PDE4 species may be initmately involved in the regulation of 
cAMP levels in cells implicated in cellular development and differentiation. It
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has also been shown (Swinnen et al. 1989b) that whilst RNA transcripts for all 
four PDE4 genes are present in germ cells, Sertoli cells appear to contain only 
RNA corresponding to PDE4D. which, it was observed, increased by more 
than 100-fold upon stimulation of the cells by FSH. More recently,
Bolger et al (Bolger et al. 1996) demonstrated the specific expression of a 
PDE4A splice variant RPDE39 (RNPDE4A8) in testis by RNase protection 
assay and immunoblotting with a specific PDE4A polyclonal antibody. 
Evidence has also been presented for the existence of PDE4 isozymes in 
mammalian heart (Baecker et al. 1994; Reeves et al. 1987a). Furthermore, the 
numerous reports of PDE4 in lymphocytes (Erdogan and Houslay 1997; 
Obernolte et al. 1993; Sullivan et al. 1994), monocytes (Livi et al. 1990; Nemoz 
et al. 1996; Verghese et al. 1995) and thymocytes (Michie et al. 1996) suggests 
that regulation of cAMP levels by PDE4 may be important in a variety of 
inflammatory diseases and conditions.
Selective inhibition by the anti-depressant drug rolipram has implicated 
the PDE4 isozyme family in mood regulation, memory and learning. As such, 
many studies have described the specific expression of PDE4 gene products and 
splice variants in brain. Following the initial isolation of the cDNA from RD1 
(RNPDE4A1A) Shakur and co-workers (Shakur et al. 1995) have demonstrated 
by immunoblotting with a PDE4A specific antiserum, that RD1 is expressed 
predominantly in the cerebellum in rat brain. McPhee and co-workers (McPhee 
et al. 1995) have since shown that RD1 is widely expressed in other regions of 
rat brain as well as cerebellum, namely cortex, hypothalamus and striatum and 
to a lesser extent, hippocampus. Furthermore, this study has confirmed that the 
PDE4A splice variant RPDE6 (RNDPE4A5), which was previously identified 
by Northern blotting and RNase protection assay (Bolger et al. 1994), is also 
differentially expresssed in rat brain. However, unlike RD1, it appears to be 
absent from cerebellum and brain stem.
45
Several other studies have suggested the expression of other PDE4 
genes in brain. Colicelli (Colicelli et al. 1989) described the first cloning of a 
PDE4B gene from a rat brain cDNA library and Lobban et al (Lobban et al.
1994) have subsequently confirmed the existence of two PDE4B splice variants 
in rat brain by immunoblotting with specific antisera. Other researchers have 
also demonstrated the expression of PDE4B genes in human (McLaughlin et al. 
1993) and rat (Monaco et al. 1994) brain respectively. More recently, Engels 
and colleagues (Engels et al. 1995) reported the cloning of a PDE4C cDNA 
from human substantia nigra, while Owens et al (Owens et al. 1997) have 
identified the existence of PDE4C in the glioblastoma U87 cell line.
1.5.6.4 Regulation of PDE4
Analysis of the available literature reveals that PDE4 isozymes can be 
regulated in a number of ways by hormones and growth factor action. These 
include phosphatidic acid (Disanto et al. 1995; Disanto and Heaslip 1995; 
Nemoz et al. 1997; Savany et al. 1996) and phosphorylation (Alvarez et al. 
1995; Lenhard et al. 1996; Pyne et al. 1989; Sette and Conti 1996; Sette et al. 
1994a; Sette et al. 1994b; Swinnen et al. 1991a; Swinnen et al. 1989b) as well 
as at the level of mRNA transcription (Manning et al. 1996; Sette et al. 1994a; 
Sette et al. 1994b; Verghese et al. 1995).
1.5.6.4.1 Regulation of PDE4 by Phosphatidic Acid
Several studies have reported that elevated levels of phosphatidic acid 
(PA) can be observed in a range of cells associated with inflammatory 
responses (Disanto et al. 1995; Disanto and Heaslip 1995; Nemoz et al. 1997; 
Savany et al. 1996). As it is well known that cell cycle progression and 
proliferation of T-lymphocytes can be influenced by changes in cAMP then PA 
action on PDE4 activity may play a regulatory role (Michie et al. 1996; Savany 
et al. 1996). Indeed, as lymphocytes lack an adenylyl cyclase coupled 
inhibitory receptor (Savany et al. 1996) then it would seem reasonable to 
suggest that control of intracellular cAMP levels and hence lymphocyte function
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may be modulated by cAMP phosphodiesterase activity. Savany and co­
workers (Savany et al. 1996), by means of anion exchange chromatography, 
were able to resolve the cyclic nucleotide PDE activity in rat thymocytes into 
five peaks and demonstrated that 50-60% of the total PDE activity was found in 
peaks 2 and 3 which were inhibited by rolipram with IC50 values of 0.35 JJ.M 
and 0.60 fim respectively. Upon addition of physiological concentrations of 
various phospholipids Savany et al observed that peak 3 PDE activity was 
activated by approximately 50% above basal by anionic phospholipids whilst 
peak 2 PDE activity was inhibited by phospholipids possessing saturated fatty 
acid side chains. More recently, Nemoz et al (Nemoz et al. 1997) studied the 
effect of PA upon various recombinant PDE4 isoform expressed in Sf9 and 
MA10 cells. These researchers showed that PA could activate PDE4 activity in 
a splice variant specific fashion where the long form splice variants PDE4A5, 
PDE4B1 and PDE4D3 were activiated by anionic phospholipids whereas the 
short forms PDE4A1, PDE4B2 and PDE4D1 and 4D2 were not affected. 
Moreover, Nemoz et al observed that PA increased the Vmax of PDE4D3 whilst 
leaving the Km of the enzyme for cAMP unchanged. Why various isoforms of 
PDE4 should be differentially activated by PA remains unclear. However, one 
possible explanation that is suggested by the above observations refers to the 
fact that the long form PDE4s are known to contain the highly conserved region 
known as UCR1 (Bolger et al. 1993) which is absent in the short forms. The 
splice variant PDE4D3 has been shown to be phosphorylated on serine 54 
within UCR1 by cAMP-dependent protein kinase A (Sette and Conti 1996) and 
Nemoz et al have shown that PDE4D3 can be activated by both cAMP-PKA and 
PA to the same extent. Moreover, the observation that activation of PDE4D3 by 
both PA and PKA mediated phosphorylation is not additive (Nemoz et al. 1997) 
suggests that both may interact at a similar site on the enzyme. This argument is 
further strengthened by the observation that only anionic phospholipids, which 
possess a free phosphate group, are capable of activating PDE4 isozymes.
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While the exact nature of the mechanism of action of PA in activating PDE4 
remains a matter of speculation, experiments carried out by DiSanto et al 
(Disanto et al. 1995) showed that an antibody raised against a highly conserved 
peptide sequence near the catalytic region of PDE4 was able to inhibit PA- 
stimulated PDE4 activity whilst making no difference to basal PDE4 activity 
expressed in the monocyte cell line U937. Why this should be the case remains 
to be ascertained.
1.5.6.4.2 Regulation of PDE4 by Phosphorylation
As early as 1989, Pyne et al (Pyne et al. 1989) observed that the 
hepatocyte peripheral plasma membrane PDE (PPM.PDE) could be 
phosphorylated as a result of challenge of cells by insulin and that this 
phosphorylation event could be inhibited by glucagon. Moreover, by a 
combination of phosphoamino acid analysis and immunoblotting with specific 
anti-phosphotyrosine antibodies these workers were able to determine that the 
site of phosphorylation was tyrosine specific.
More recently, Sette et al (Sette et al. 1994a) observed that incubation of 
the rat thyroid cell line FRTL-5 with thyroid stimulating hormone (TSH) caused 
a rapid, albeit transient, increase in intracellular cAMP levels. The transient 
nature of this elevation in cAMP was explained by the concomitant increase in 
PDE4 activity observed 3 minutes post hormonal stimulation which reached a 
maximal level after 15 minutes. Immunoblotting studies with specific antisera 
showed the presence of an immunoreactive protein species of approximately 
lOOkDa in the TSH stimulated cells, in addition to the 93kDa species observed 
in both hormone stimulated and control cells. Inclusion of cyclohexamide in the 
reaction, and the lack of increase in mRNA levels suggested that the larger band 
was not due to ongoing protein synthesis. Moreover, radiolabelling of 
quiescent FRTL-5 cells showed that 32P was incorporated into a polypeptide of 
approximately 90-99kDa which co-purified with the cAMP-PDE acitvity upon 
hormonal stimulation. Sette and colleagues were then able to demonstrate that
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the catalytic subunit of cAMP-dependent protein kinase could phosphorylate the 
purified PDE4 component from FRTL-5 cells in a cell-free system (Sette et al. 
1994a; Sette et al. 1994b). This suggested that the larger immunoreactive band 
previously observed may represent a phosphorylation mediated conformational 
change of the enzyme thus altering its rate of migration in SDS acrylamide gels. 
Furthermore, Sette et al (Sette et al. 1994a) observed that okadaic acid, a potent 
phosphatase inhibitor, was able to potentiate the effect of TSH. It has 
subsequently been shown that the PDE4 component activated by cAMP- 
dependent protein kinase mediated phosphorylation in FRTL-5 cells is the long 
form splice variant PDE4D3 (Sette et al. 1994b). More recently, Alvarez et al 
(Alvarez et al. 1995) have demonstrated that the human PDE4D3, expressed in 
the monocyte cell line U937, can be phosphorylated by cAMP-dependent 
protein kinase. This occurred upon stimulation of the cells with PGE2, an agent 
which increases intracellular levels of cAMP. Moreover, these workers have 
shown that phosphorylation altered the response of human PDE4D3 to the 
divalent cation Mg2+, where the normally biphasic response became 
monophasic upon phosphorylation. Cyclic AMP-dependent protein kinase 
mediated phosphorylation of PDE4 has also been recently described in bovine 
vascular smooth muscle cells, although the specific isozyme involved remains 
to be identified (Ekholm et al. 1997).
Cyclic AMP-dependent protein kinase is known to specifically 
phosphorylate serine residues contained within the consensus sequence RRXS 
(Bramson et al. 1984; Hausken et al. 1996). Analysis of the amino acid 
sequence of PDE4D3 shows that it contains two putative PKA consensus 
phosphorylation sites around serines 13 and 54 which are contained with 
UCR1, the structural element identified by Bolger and colleagues (Bolger et al. 
1993) as being unique to the long-form PDE4 splice variants. By means of 
site-specific mutagenesis of serines 13 and 54, Sette et al (Sette and Conti 1996) 
have identified serine 54 as the site of PKA-dependent phosphorylation which
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leads to the activation of PDE4D3. This has been demonstrated by the 
expression of wild type and mutant proteins in both a cell-free system and in 
MA-10 cells.
In addition to PKA mediated phosphorylation, Lenhard and colleagues 
(Lenhard et al. 1996) have recently shown by means of mass spectrometry that 
the human PDE4B2B splice variant is phosphorylated in both Sf9 cells and 
yeast. Experiments using bacterially expressed peptide fragments of 
HSPDE4B2B have identified the phosphorylation site as serine 487 which lies 
within a serine-proline rich sequence SMIPQSPSPP which corresponds to the 
PXSP consensus sequence recognised by MAP kinase. Moreover, these 
researchers were able to demonstrate a certain degree of specificity of 
phosphorylation by MAP kinase compared to various other serine-proline 
kinases such as casein kinase and cdc2 kinase. Despite demonstrating that 
MAP kinase could specifically phosphorylate HSPDE4B2B peptide fragments it 
remains unclear as to the physiological significance of this modification since it 
was observed that phosphorylation did not alter either the Vmax or Km for 
cAMP. It should be pointed out, however, that this experiment was carried out 
on a peptide due to technical difficulties in expressing full-length HSPDE4B2B 
and therefore may not reflect the the true state of affairs in vivo.
1.5.6.4.3 Transcriptional Regulation of PDE4
Interestingly PDE4D3 appears to be the only PDE4D seen expressed in 
quiescent FRTL-5 cells. However, prolonged exposure of these cells to TSH 
results in the production of mRNAs for the two short form PDE4D1 splice 
variants in addition to PDE4D2. This is indicative of regulation at the level of 
transcription. Indeed transcriptional regulation of PDE4s has subsequently 
been reported in a number of instances Thus Verghese et al (Verghese et al.
1995) have recently shown that treatment of Mono Mac 6 cells with dibutyryl 
cAMP causes a transient increase in mRNA levels corresponding to PDE4A, 4B 
and 4D gene products in a concentration-dependent fashion. Furthermore, this
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rise in mRNA levels was accompanied by a concommitant rise in protein levels. 
In addition to this study, Manning et al (Manning et al. 1996) have 
demonstrated that treatment of isolated peripheral blood monoctyes with a 
mixture of salbutamol and rolipram to elicit an increase in intracellular cAMP, is 
followed by a selective increase in mRNA and protein levels corresponding to 
PDE4A and PDE4B. However, they also noted that the mRNA for PDE4D, 
which was detected in untreated control cells, appeared to be down regulated in 
the treated cells. Similarly, Torphy et al (Torphy et al. 1995) demonstrated that 
steady-state mRNA levels for PDE4A and PDE4B were elevated in the human 
monocyte U937 cell line upon treatment with the P-adrenoreceptor agonist 
salbutamol. This has led these investigators to speculate that increasing PDE4 
activity by such a method may exacerbate inflammatory processes.
More recently, the studies of Erdogan et al (Erdogan and Houslay
1997) have shown that PDE4 activity in Jurkat T-cells was increased by 
treatment of the cells with the adenylyl cyclase activator forskolin, in a manner 
which could be inhibited by the application of actinomycin D thus implying 
transcriptional regulation. Moreover, by means of RT-PCR these investigators 
showed that forskolin had the effect of decreasing mRNA levels corresponding 
to a novel PDE4A species identified as the sole PDE4 responsible for cAMP 
hydrolysis in untreated cells whilst increasing transcripts corresponding to 
PDE4D1 and PDE4D2 splice variants. Thus it may be speculated that dual 
regulation of PDE activity through transcription as described by the 
observations of Manning (Manning et al. 1996) and Erdogan (Erdogan and 
Houslay 1997) may be a mechanism whereby cells can fine tune the hydrolysis 
of cAMP in a time dependent fashion.
1.5.6.4.4 Regulation of PDE4 by Rolipram
In addition to regulation by phosphatidic acid, phosphorylation and 
mRNA transcription the type 4 PDE enzymes are unique in that they can be 
specifically inhibited by the anti-depressant rolipram (Baecker et al. 1994;
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Disanto and Heaslip 1995; Houslay et al. 1997a; Huston et al. 1996; Jin et al. 
1992; Kelly et al. 1996; Livi et al. 1990; McLaughlin et al. 1993; Nemoz et al. 
1997; Sette et al. 1994a; Verghese et al. 1995; Wilson et al. 1994). However, it 
should be mentioned here that the Dunce PDE isolated from Drosophila is 
unusual in that it is the only type 4 PDE enzyme which is not inhibited by 
rolipram. Whilst the reason for this apparent anomaly remains to clarified it has 
been suggested that it may be as a result of species-related codon bias in or 
around the region of the enzyme involved in interacting with rolipram (Heery et 
al. 1997; Jacobitz et al. 1996b). Moreover, the ability of rolipram to inhibit 
PDE4 isozymes appears to vary according to the expression system studied, the 
intracellular location as well as the conditions used to purify the enzyme 
(Houslay 1996; Houslay et al. 1997a; Muller et al. 1996; Schneider et al. 
1986). The studies of Wilson et al (Wilson et al. 1994) have shown that the 
human PDE4 splice variant h6.1 can be found in both particulate and cytosolic 
fractions when expressed in yeast and while the particulate fraction displayed a 
Ki of 0.7 |iM, in keeping with the value of 0.6 |iM reported for a similar 
isozyme by Livi et al (Livi et al. 1990) the soluble enzyme had a Ki of 0.4 |iM. 
A similar situation has also been observed in rat where the IC50 for rolipram 
was greater for the membrane bound form of RPDE6 (RNPDE4A5A) than the 
cytosolic form (McPhee et al. 1995). More recently, Bolger and collegues 
(Bolger et al. 1996) made a similar observation for another PDE4A splice 
variant, PRDE39 (RNPDE4A8) demonstrating an IC50 value of 0.5 |J.M for 
rolipram for the particulate enzyme and 1.0 jiM for the soluble fraction. The 
recent study carried out by Huston and colleagues (Huston et al. 1996) showed 
that when the human PDE4 splice variant h46 (HSPDE4A4B) was transiently 
transfected into COS cells the vast majority of the enzyme was cytosolic with an 
IC50 value for rolipram of 1.6 JiM but there was also a small but significant 
amount of PDE activity associated with the particulate fraction which gave an 
IC50 value of 0.195 [lM. These results have been explained by suggesting that
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the soluble enzyme exhibited simple competitive inhibition kinetics, whilst the 
particulate enzyme displayed partial competitive inhibition (Huston et al. 1996).
As mentioned above the cell system used to study and characterise PDE 
enzymes can have marked effects upon the results. For example Owens and 
collegues (Owens et al. 1997) recently demonstrated that a PDE4C splice 
variant gave markedly different inhibition characteristics depending on whether 
the PDE gene was expressed in COS cells or yeast. A Ki of 0.6 |iM for 
rolipram was observed upon expression of the gene in COS cells whereas this 
was noted to be 2.6 |iM if the same gene was expressed in yeast. Earlier results 
obtained by Torphy et al (Torphy et al. 1992a) have demonstrated that PDE4 
expressed in rat brain, heart and human monocytes was inhibited by rolipram 
with a Ki of 1 JiM whereas in yeast this was approximately 0.06 jiM. These 
workers have speculated that this may reflect a conformational change in the 
protein dependent upon the expression system studied.
In addition to the above mentioned differences in the inhibition of PDE4 
mediated cAMP hydrolysis other factors have been observed to affect the 
efficacy of rolipram. DiSanto and Heaslip (Disanto and Heaslip 1995) have 
observed that the phosphatidic acid (PA)-stimulated PDE4 activity in U937 cells 
could be inhibited by nanomolar concentrations of rolipram in a PA dependent 
fashion. This, however, could be reversed by increasing the PA concentration 
whereas inhibition by micromolar rolipram concentrations proceeded in a PA 
independent manner. Moreover, such observation were apparent regardless of 
whether intact cells, cell homogenates or purified PDE4 was used. More 
recently, Sette and Conti (Sette and Conti 1996) demonstrated that inhibition of 
PDE4D3 in FRTL-5 cells by rolipram was altered by phosphorylation. In the 
absence of hormone stimulation, rolipram exhibited a biphasic inhibition with a 
low affinity and high affinity component in the micromolar and nanomolar 
range respectively but TSH-mediated phosphorylation of PDE4D3 
demonstrated only the high affinity inhibition. The fact that these findings
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could be replicated using purified recombinant PDE4D3 ruled out the possibility 
that this was caused by the presence of a mixture of different PDE4 isoforms. 
All these data might then imply that rolipram inhibition is highly sensitive to a 
conformational state of the PDE4 isoform. Thus changes in phosphorylation 
or, for example, interaction with intracellular components may be expected to 
elicit changes in rolipram sensitivity.
The contention that rolipram may bind to more than one site on PDE4 
has been suggested by the observations of several investigators (Disanto and 
Heaslip 1995; Jacobitz et al. 1996a; Jacobitz et al. 1996b; Kelly et al. 1996; 
Souness et al. 1992; Torphy et al. 1992a). The results of Schneider et al 
(Schneider et al. 1986) suggested that rolipram bound with high affinity and in 
a saturable manner to sites in rat brain although the identity of this binding site 
has not been demonstrated. The studies of Souness et al (Souness et al. 1992), 
on guinea-pig eosinophil PDE4 activity, showed that incubation with 
vanadate/glutathione (V/GSH) was accompanied by an increase in cAMP 
hydrolysis which could be potently inhibited by rolipram. Moreover rolipram 
was 10-fold more potent on solubilized than on membrane-bound PDE4 
activity, which led these workers to postulate that V/GSH caused a 
conformational change in the enzyme which exposed a high affinity rolipram 
binding site. Evidence for the existence of such a site has been presented by the 
work of Torphy and colleagues (Torphy et al. 1992a) who observed that a 
human monocyte PDE4 bound rolipram in the nanomolar range but that 
inhibition only occurred when rolipram was present in micromolar 
concentrations. This apparent lack of correlation between high affinity binding 
and inhibition of cAMP hydrolysis has since been noted by several investigators 
(Barnette et al. 1995b; Disanto and Heaslip 1995; Kelly et al. 1996). New 
evidence for the existence of two rolipram binding sites has been demonstrated 
by the studies of Jacobitz et al (Jacobitz et al. 1996a) who demonstrated that a 
recombinant human PDE4A, which had been N- and C-terminal truncated,
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could be inhibited by rolipram at micromolar concentrations, but that it could 
not bind [3H]-rolipram with the same high affinity observed for the non­
truncated form. Furthermore, these workers were able to narrow down the 
location of the high affinity binding site to a region encompassing amino acids 
265-332 and demonstrated that binding to this site was not a pre-requisite for 
inhibition. In addition, there is some evidence to suggest that high affinity 
rolipram binding may contribute to some of the side effects such as nausea, 
observed upon administration of rolipram as an anti-depressant. Barnette and 
co-workers (Barnette et al. 1995a) have observed that in isolated rabbit gastric 
glands, increased acid secretion was a function of high affinity rolipram binding 
in the presence of histamine. Although a satisfactory explanation for the 
phenomenon of high affinity rolipram binding remains elusive, some 
researchers (Souness et al. 1992; Souness and Scott 1993) have tentatively 
suggested that high affinity rolipram binding may act as an allosteric regulator 
in a manner similar to that observed for cGMP on PDE2 isozymes (Beavo 
1995; Rybalkin and Beavo 1996). However, other investigators consider this 
to be unlikely (Kelly et al. 1996).
A further level of confusion surrounding the subject of rolipram binding 
and inhibition has been provided by the observation that, in some systems at 
least, there is a marked stereoselectivity for the different enantiomers of 
rolipram whilst in others no such selectivity has been observed. Since the 
original observation by Schneider et al (Schneider et al. 1986) that R-rolipram 
was more potent for binding than S-rolipram in rat brain, Torphy and co­
workers (Torphy et al. 1992a) have reported a similar result for the human 
monocyte PDE4 although this observation could not be repeated with the 
purified enzyme. When this isozyme was expressed in yeast, R-rolipram 
inhibited cAMP hydrolysis with an apparent Ki of 61 nM in contrast to 390 nM 
as noted for the S-enantiomer. In contrast, Owens et al (Owens et al. 1997) 
have shown that the PDE4C gene product expressed in yeast displayed no
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stereoselectivity for either enantiomer but that there was a marked selectivity for 
R-rolipram when this isozyme was expressed in COS cells.
Clearly, the binding and inhibition of PDE4 by rolipram is a complex 
subject which is complicated by the diverse results observed by a number of 
investigators studying a wide range of PDE4 splice variants in a variety of cell 
systems. Whether some PDE isoforms exist in two conformational states as 
suggested by some researchers (Huston et al. 1996; Kelly et al. 1996; Owens et 
al. 1997; Sette and Conti 1996; Souness et al. 1992; Souness and Scott 1993) 
remains to be further elucidated, as does the contention that only the long-form 
PDE4 splice variants display high affinity rolipram binding (Disanto and 
Heaslip 1995; Sette and Conti 1996).
1.5.7 PDE5, Cyclic GMP-Specific Phosphodiesterases
The PDE5 phosphodiesterases are a group of enzyme which are 
characterised by their ability to bind and hydrolyse cGMP (Beavo 1995; 
Beltman et al. 1995; Burns and Pyne 1992; Burns et al. 1992; Francis 1990; 
Francis et al. 1994; Ito et al. 1996; McAllister-Lucas et al. 1993; Miyahara et al. 
1995; Saeki et al. 1995; Thomas et al. 1990).
To date only one gene for PDE5 has been identified. McAllister-Lucas 
et al (McAllister-Lucas et al. 1993) used a PCR generated probe to screen a 
bovine lung cDNA library and isolated and subsequently cloned a cDNA 
encoding a 99.5kDa protein. This, upon transfection into COS7 cells, was 
observed to produce a protein able to bind and hydrolyse cGMP. More recently 
it has been suggested that at least two alternative splice variants may exist in 
bovine lung (Beavo 1995). Comparison of the sequence of the cloned gene 
suggested that, in addition to the highly conserved core of approximately 250 
amino acids common to all known mammalian PDEs, PDE5 enzymes also 
contained a second region. This region showed most similarity to the cGMP- 
binding region found in the PDE2 and PDE6 PDE gene families. Furthermore, 
this region was also observed to contain two internal repeats and has been
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speculated as representing an allosteric site (McAllister-Lucas et al. 1993). It 
has also been suggested that in its native conformation, PDE5 is a homodimer 
(Francis 1990; McAllister-Lucas et al. 1993).
Whilst no detailed studies have been carried out on tissue distribution of 
PDE5, it has been shown to exist in rat and human platelets, rat spleen, guinea- 
pig and bovine lung, vascular smooth muscle, sea urchin sperm (Beavo 1995; 
Ito et al. 1996; McAllister-Lucas et al. 1993) and, more recently, porcine and 
human aortic smooth muscle (Miyahara et al. 1995; Saeki et al. 1995). 
Moreover, PDE5 has been implicated in ANP-mediated Na2+ loss and diuresis 
observed in kidney (Beavo 1995).
Kinetic studies have determined that the PDE5 enzyme from bovine lung 
has a Km for cGMP of 5 JiM while half-maximal binding occurs at 0.2 |iM 
(McAllister-Lucas et al. 1993) and that Mg2+ or Mn2+ is required for catalysis 
(Francis 1990). There is also some evidence that the bovine lung PDE5 has a 
requirement for Zn2+. Francis et al (Francis et al. 1994) have identified two 
tandem amino acid sequences which contain some similarity to the Zn2+ binding 
motif in the catalytc site of thermolysin, a known Zn2+ hydrolase. Moreover, 
these investigators have determined that Zn2+ in the range 0.05-1 fiM, supports 
cGMP catalysis. As mentioned above, the cGMP-specific PDEs contain a high- 
affinity non-catalytic cGMP binding site (Beavo 1995; Bums and Pyne 1992; 
Bums et al. 1992; McAllister-Lucas et al. 1993; Thomas et al. 1990). As yet no 
function has been attributed to this site although a possible function as an 
allosteric site has been suggested. However, it has been observed that upon 
binding of cGMP to this site, the bovine lung PDE5 becomes a substrate for 
phosphorylation by cGMP-dependent protein kinase (Beavo 1995; Thomas et 
al. 1990). Thomas et al (Thomas et al. 1990) have identified serine at position 
92 as the site of phosphorylation, while other investigators have observed that 
guinea-pig lung PDE5 can be phosphorylated on the same serine by the catalytic 
subunit of cAMP-dependent protein kinase (Bums and Pyne 1992; Bums et al.
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1992). These observations are somewhat surprising since the consensus 
phosphorylation sites differ for each kinase. One possible explanation may lie 
in the fact that these studies were carried out on a partially purified enzyme 
which may have co-purified some factor which allowed activation by PKA 
whereas this factor would be absent in the pure enzyme preparation (Beavo
1995).
1.5.8 PDE6, Photoreceptor Phosphodiesterases
The photoreceptor PDE6 enzymes are involve in attenuation of light 
activated visual transduction. Upon excitation of rhodopsin by light, the G- 
protein transducin undergoes an exchange of GDP for GTP followed by 
dissociation of the Ta subunit from Tpy subunits (Beavo 1995; Gillespie
1990). Ta in turn, activates a membrane associated PDE through dissociation 
of its inhibitory subunits from the cataltyic core causing cGMP hydrolysis 
which affects a cGMP dependent ion channel thus mediating Na2+ influx. 
Photoreceptor PDEs specifically hydrolyse cGMP and Km values of 20-150 
|iM have been reported in the literature (Baehr et al. 1979; Gillespie 1990) 
although, more recently, a Km for cGMP in the range of 17-80 JiM has been 
suggested (Granovsky et al. 1997). Multiple genes have been isolated for the 
PDE found in rod and, in addition, a gene has been identified for a cone PDE 
which shows that these isozymes are distinct but highly related (Beavo 1995).
Whilst most PDEs are thought to exist in vivo as homodimers, the 
photoreceptor PDEs are unusual in that they are heterotetramers composed of 
one of each of two catalytic subunits (a and p) of approximately 90kDa and 
two inhibitory y subunits of lOkDa (Deterre et al. 1988; Ovchinnikov et al. 
1986). Recently it has been discovered that a a j2 and PPY2 species can exist in 
addition to the more common aPy 2 species (Granovsky et al. 1997). 
Comparison of the primary amino acid sequence for the catalytic a  and P 
subunits has revealed that they are highly related (72%) products of separate 
genes with the a ' subunit sharing >60% similarity with the a  and p subunits
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(Artemyev et al. 1996). Both rod and cone PDE catalytic subunits contain a 
highly conserved region of approximately 250 amino acids conserved in all 
mammalian PDEs. In addition they contain a high affinity non-catalytic cGMP 
binding site common to the other cGMP hydrolysing PDEs (Artemyev et al. 
1996; Beavo 1995; Charbonneau et al. 1990; Cote et al. 1994; Gillespie 1990; 
Gillespie and Beavo 1988; Lipkin et al. 1988). The a  and p subunits contain 
C-terminal CAAX sequences which are modified by famesylation and geranyl- 
geranylation respectively. This may play a role in determining the membrane 
localization of the photoreceptor PDEs (Artemyev et al. 1996; Catty and Deterre
1991).
Some investigators have reported that the photoreceptor PDEs can be 
activated by limited proteolytic digestion by trypsin and suggested that this 
treatment removed the inhibitory y subunits (Gillespie and Beavo 1988; 
Gillespie and Beavo 1989). However, it has since been demonstrated that 
trypsin treatment caused release of the PDE from the membrane by degradation 
of the p subunit C-terminus while the y aubunits remained bound to the catalytic 
core (Catty and Deterre 1991). Since the early work of Ovchinnikov and 
colleagues (Ovchinnikov et al. 1986) first determined the primary structure of 
the y subunit. Lipkin et al (Lipkin et al. 1988) observed that the inhibitory 
subunit contained a polycationic sequence of amino acids (residues 24-45) 
which were essential for interaction with transducin and that inhibition of the 
catalytic core was via the C-terminus. Brown et al (Brown and Stryer 1989) 
later extended this observation to implicate the C-terminus in the interaction of 
the y subunit with the catalytic subunits as well as transducin. More recently, 
by means of photolabelling, it has been demonstrated that Cys68 is critical in 
this interaction and, furthermore, that it accelerated the rate of GTP hydrolysis 
by the T a subunit (Granovsky et al. 1997; Liu et al. 1996). Moreover, these 
investigators have shown that inhibition of the a  subunit by the y subunit is by
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binding to the catalytic site at a region which contains the NKXD guanine ring 
binding motif found in G-proteins (Granovsky et al. 1997).
There is some evidence to suggest that the photoreceptor PDEs can be 
regulated by a negative feedback mechanism involving the noncatalytic cGMP 
binding site. Cote et al (Cote et al. 1994) have shown that binding of cGMP to 
this site slows the rate of PDE activation and that activation by transducin 
decreases cGMP binding to the noncatalytic site in addition to increasing its rate 
of dissociation by approximately 10-fold. Following removal of the inhibitory 
y subunits the rate of disociation was observed to increase >50-fold which has 
led these investigators to suggest that this may constitute a mechanism for 
generating faster but smaller photoresponses which are characterisic of light- 
adapted photoreceptors.
It would appear that the phosphoinositol signal transduction pathway 
may also be involved in mediating visual transduction. Udovichenko et al 
(Udovichenko et al. 1994) have reported that protein kinase C purified from 
bovine rod outer segments (ROS-PKC) can phosphorylate the inhibitory y 
subunit on a specific threonine residue (thre35) and thus increase its ability to 
inhibit the catalytic subunit which may, in turn, play a role in desensitization of 
the photoreceptor PDEs.
1.5.9 PDE7, Cyclic AMP-Specific Phosphodiesterase
The first evidence for the existence of a PDE7 gene family was 
inadvertantly obtained by Michaeli et al (Michaeli et al. 1993) who isolated a 
cDNA, which they referred to as HCP1 (HSPDE7A1). This was derived from 
a human glioblastoma cDNA library by means of a sensitive yeast 
complementation assay. Comparison of the amino acid sequence revealed 
significant homology to the cAMP-specific PDE, with approximately 50% 
similarity including a core region of -300 amino acids found to be conserved in 
all mammalian PDEs. Upon characterisation of the pharmacological properties 
of HCP1 these investigators observed that while HCP1 displayed a high affinity
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for cAMP, with a Km of 0.2 |iM there was no detectable cGMP hydrolytic 
activity. This was unlike the cAMP-specific PDE4 isozymes. Indeed HCP1 
was insensitive to inhibition by the archetypal PDE4 specific inhibitors rolipram 
and RO20-1724. Independently, Ichimura and Kase (Ichimura and Kase 1993) 
reported expression of an unknown cAMP-specific PDE which accounted for 
~35% of the total activity in certain T-lymphocyte cell lines which shared the 
same inhibition profile as HCP1, although it should be noted that their findings 
were based on kinetic studies rather than immunological methods. Interestingly 
some years earlier, Lavan et al (Lavan et al. 1989) reported that rat liver 
contained an IBMX-insensitive cAMP hydrolysing PDE component which 
accounted for approximately 30% of the total cAMP hydrolysing PDE activity. 
This species may represent a liver PDE7. However, it should be noted that in 
addition to exhibiting a Km for cAMP of 25 JiM, this PDE also hydrolysed 
cGMP with a Km of 237 (iM. Based on Northern blot analysis of various 
human tissues Michaeli et al (Michaeli et al. 1993) demonstrated that HCP1 
mRNA was abundant in skeletal muscle and also detectable in heart and kidney.
In a more recent study, Bloom and Beavo (Bloom and Beavo 1996) 
have reported the isolation of a novel alternative splice variant of PDE7 from a 
murine skeletal muscle cDNA library (MMPDE7A2). Comparison of this clone 
with HSPDE7A1 revealed that while the two shared >90% amino acid 
similarity, the human splice variant contained a longer N-terminus which was 
considerably more hydrophilic than the mouse PDE. Moreover, RNAse 
protection showed the mRNA for this clone to be most abundant in skeletal 
muscle. Interestingly, the sequence analysis of HSPDE7A1 was thought to 
suggest originally that this clone was truncated at the 5' end. However, 
Western blot data obtained with an antibody raised against a C-terminal 
antibody of HSPDE7A1 by these investigators appeared to confirm that the 
clone is indeed full-length. This antibody was also used to probe the human T- 
cell line Hut78 which previously was suggested to express PDE7 activity
(Ichimura and Kase 1993). Indeed these investigators identified an 
immunoreactive protein species of approximately 55kDa in both the soluble and 
particulate fractions. This antibody could also detecte HSPDE7A1 in 
transfected Sf9 cells, where it exhibited a Km for cAMP in the submicromolar 
range, which was absent in mock transfected cells.
Based on the above studies it is evident that PDE7 splice variants are 
expressed in a cellular and tissue specific manner. However, there appears to 
be some difficulty in correlating the presence of mRNA with detectable levels of 
protein in some cases. What the physiological role of PDE7 is remains, as yet, 
to be elucidated but it has been suggested that such PDEs may be involved in 
immune response. This is clearly an area requiring much further study.
1.6 Coinpartinentalization of Cyclic AMP Response Elements
As a second mesenger, cAMP has been implicated in a diverse range of 
physiological and metabolic processes including synaptic transmission, ion 
channel and transporter activities, gluconeogenesis, glycogenolysis, cell growth 
and differentiation, gene transcription, learning and apoptosis (Beavo 1995; 
Houslay and Milligan 1997; Rubin 1994). The mechanism by which cAMP is 
involved in so many intracellular activities has intrigued many investigstors for 
many years due to the fact that the sole role of this molecule is to cause the 
activation of cAMP-dependent protein kinase (PKA). This has led to the 
hypothesis (Houslay and Milligan 1997; Scott 1991) that cAMP signalling is 
restricted to specific intracellular compartments within a given cell type due to 
localized expression of adenylyl cyclase, PKA and PDE enzymes. Such an 
inference has been strengthened by the discovery (Houslay and Milligan 1997) 
that at least nine isoforms of adenylyl cyclase and over thirty isoforms of PDE 
can be expressed within a cell due to the existence of multiple genes and 
alternate splicing of individual genes.
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The basal level of cAMP in a cell is ~ 1 |iM but activation of cAMP- 
dependent protein kinase will not occur until this is increased to approximately 
10 |iM (Houslay and Milligan 1997). This can be brought about by either 
increased production of cAMP by adenylyl cyclase, inhibition of 
phosphodiesterase mediated cAMP degradation or a combination of both. 
Thus, in a situation where two different receptors can elicit entirely different 
responses through PKA mediated phosphorylation, it would seem likely that a 
non-uniform concentration of cAMP would be established within any given cell 
rather than a uniform increase in the concentration of cAMP which, having 
occurred, would result in the activation of the entire PKA pool. Indeed, there 
are a number of pieces of evidence to support such a contention. For example, 
Hem pel and colleagues (Hempel et al. 1996) have analysed the spatio-temporal 
distribution of cAMP in intact neurons of the lobster stomatogastric network 
(STG) by means of indicator dyes and confocal microscopy. By doing this 
these investigators obtained evidence for specific localized increases in cAMP 
concentration mediated by a variety of neruomodulators. Prior to this study, 
Barsony and Marx (Barsony and Marx 1990) observed that for epithelial cells 
and fibroblasts localized fluctuations in cAMP concentrations occurred in 
specific subcellular compartments which was hormonally mediated. Whereas 
isoproternol and PGE2 increased cAMP at the plasma membrane, calcitonin 
resulted in a perinuclear localization.
In order that a non uniform gradient of cAMP be generated and 
maintained in a compartmentlised manner within a given cell, the various 
components of the cAMP signalling pathway, namely adenylyl cyclase, cAMP- 
dependent protein kinase and cAMP-specific PDE4, would have to be targeted 
to specific intracellular locations. It has been well established that adenylyl 
cyclase is located in the plasma membrane by virtue of its hydrophobic 
transmembrane spanning Mi and M2 domains and this has been discussed at 
length in a previous section (Section 1.3.1). The remainder of this chapter will
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be devoted to a review of the mechanism of membrane localization of cAMP- 
dependent protein kinase and PDE4 isoforms as well as attempting to provide 
an overview of the subject of subcellular localization/targeting.
1.6.1 Intracellular Targeting of cAMP-Dependent Protein Kinase 
Protein kinases represent a large and diverse group of enzymes of which 
to date approximately 300 members have been identified (Faux and Scott 1996). 
The activity of these enzymes is tightly regulated and demonstrates a restricted 
substrate availability. Clearly conformational constraints provide the major 
means of achieving substrate selectivity. However, it has been postulated that 
one additional mechanism for selective activation of kinases may involve their 
compartmentalization to specific subcellular localizations (Faux and Scott 
1996). As mentioned previously (Section 1.4), PKA is a hetrotetrameric 
molecule composed of two catalytic (C) and two regulatory subunits (R) 
(Bramson et al. 1984; Taylor 1989). Moreover, the R subunits can be further 
characterised into RI and RII and it is these which confer selective tissue 
distribution upon the different PKA isoforms (Rubin 1994; Scott and Carr
1992). In mammalian brain at least 70% of PKA catalytic subunits are found 
associated with the particulate fraction via interaction with the RIip subunit. 
However, analysis of their amino acid sequence initially revealed the absence of 
any obvious classical targeting signal. Subseqeuently, Sarkar et al (Sarkar et al. 
1984), whilst purifying RIip co-purified a contaminating 75kDa protein from 
bovine brain which displayed a high affinity for RIip (P75). The subsequent 
isolation of a cDNA corresponding to P75 by Hirsch et al (Hirsch et al. 1992) 
resulted in this protein being renamed AKAP75 (A Kinase Anchoring Protein 
75). Since these initial studies several investigators have reported the isolation 
of a number of AKAPs from a variety of tissues and cell types, thus suggesting 
the existence of a large and diverse family of proteins which bind not only RJIb 
subunits but also PKAII holoenzymes (Bregman et al. 1989; Coghlan et al. 
1994; Lester et al. 1996; Lin et al. 1995a; McCartney et al. 1995).
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There now appears to be a wealth of evidence implicating AKAPs in 
compartmentalization of PKAII to specific subcellular localizations (Faux and 
Scott 1996; Hausken and Scott 1996; Rubin 1994; Scott and Carr 1992). For 
example, Coghan et al (Coghlan et al. 1994) have isolated and characterised 
AKAP95 from rat pituitary gland and observed its localization to the nuclear 
matrix, McCartney and colleagues (McCartney et al. 1995) have identified 
AKAPIOO in the sacroplasmic reticulum of human cardiac and sketetal muscle 
and, more recently, Lester et al (Lester et al. 1996) have isolated AKAP220 
from rat pituitary gland. They have observed the association of AKAP220 with 
the peroxisomal fraction where it may be involved in controlling cAMP- 
mediated androgen biosynthesis. Lin and co-workers (Lin et al. 1995a) have 
characterized S-AKAP84 , a novel AKAP from mammalian sperm which 
appears to be developmentally regulated. Moreover, immunofluorescence 
analysis demonstrated that S-AKAP84 is co-localized with mitochondria in the 
flagellum possibly by means of a putative mitochondrial targeting signal located 
within its N-terminal 30 amino acids.
As the same function is shared by AKAPs, namely the ability to bind 
RII, it is reasonable to expect that they may share other features in common. 
However, analysis of several AKAPs cloned in recent years has revealed a 
distinct lack of homology at the primary amino acid level (Hausken and Scott 
1996). There is, however, a certain degree of conservation at the secondary 
structural level. All AKAPs studied to date appear to contain a C-terminal RII 
binding site which some investigators believe can adopt an amphipatic a  helical 
conformation (Carr et al. 1993; Coghlan et al. 1994; Faux and Scott 1996; 
Hausken et al. 1996; Hausken and Scott 1996; McCartney et al. 1995; Scott and 
Carr 1992). However, this view is not shared by all investigators. Rubin 
(Rubin 1994) has suggested that such studies based solely upon computer 
predictions require more detailed experimental confirmation.
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In addition to binding RII subunits or PKAII holoenzymes, AKAPs 
must also contain information which dictates targeting to specific intracellular 
locations (Hausken and Scott 1996). Glantz et al (Glantz et al. 1993) have 
provided evidence that AKAP75 contains two non-contiguous domains, Ti and 
T2, located at its N-terminus and which are responsible for conferrment of 
cytoskeletal asociation in HEK293 cells. Subsequent research has shown that 
deletion or replacement of key amino acids within Ti or T2 caused a 
translocation of AKAP75 to the cytoplasm (Li et al. 1996). It has also been 
reported that AKAP95 contains two zinc finger motifs similar to the zinc 
binding regions of the transcription factor TFIIIA (Coghlan et al. 1994; Rubin
1994). When considered in conjunction with the fact that AKAP95 is localized 
to the nuclear matrix it is reasonable to speculate that PKAII mediated 
phosphorylation may be involved in activation of cAMP-mediated transcription 
through elements such as CREB (Rubin 1994).
Until recently it has been thought that AKAPs were responsible for 
targeting of individual kinases to specific subcellular locations however, there is 
evidence to suggest that AKAP79 binds Ca2+/CaM-dependent phosphatase 2B, 
calceneurin and the a  and p isoforms of PKC and targets these enzymes to the 
postsynaptic densities in neurons (Hausken and Scott 1996). This has led to 
the suggestion that reversible phosphorylation may be involved in cAMP- 
mediated synaptic receptor/channel transmission (Hausken and Scott 1996).
In addition to studying the RII/PKAII binding site of various AKAPs, 
some researchers have investigated the self-interaction of the RII subunit. It has 
thus been shown that dimerization of the RII subunit is a prerequisite for 
anchoring (Hausken and Scott 1996; Scott and Carr 1992) and studies using 
truncation mutations of RIip have narrowed down the site of interaction to a 
region within the N-terminal 1-50 amino acids (Luo et al. 1990). More 
recently, Li et al (Li and Rubin 1995) ascertained that large bulky side chains 
which are a feature of amino acid residues Leu13 and Phe36 play pivotal roles in
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both dimerization and tethering of RIip dimers to AKAP75. Hausken et al 
(Hausken et al. 1996) have recently extended this observation to include the 
R lla subunit of PKAII. In this instance substitution of isoleucines at positions 
3 and 5 for either leucine of phenylalanine caused a 24-fold decrease in AKAP 
binding whilst replacement with serine of asparginine resulted in a complete 
abolition of AKAP binding.
In summary, cAMP-dependent protein kinases are a group of enzymes 
characterised by their widespread distribution and substrate specificity. 
Intracellular expression of PKAs is restricted by means of protein-protein 
interactions with members of a family of anchor proteins known as AKAPs by 
virtue of intracellular localization to various subcellular compartments.
1.6.2 Compartmentaliztion of cAMP-hydroIysing 
phosphodiesterases
In addition to targeting of PKA, maintenance of specific intracellular 
pools of cAMP may be influenced by the intracellular localization of cAMP 
hydrolysing PDEs. In total, five of the seven PDE isoenzyme families are 
responsible for cAMP degradation. Thus members of the PDE 1,2 and 3 
families can hydrolyse both cAMP and cGMP whereas PDE4 and 7 enzymes 
are specific for cAMP (Beavo 1995). There is evidence to suggest that at least 
some of the cAMP PDEs expressed in a variety of cells and tissues are localized 
in specific subcellular compartments (Pyne et al. 1987; Pyne et al. 1986; Pyne 
et al. 1989). Examples of this will be described in more detail below.
Yang et al (Yang et al. 1994) have shown that cGS-PDE clones from 
bovine adrenal gland and rat brain are splice variants of the same gene which 
display divergent 5' ends with the N-terminal 37 amino acids of the rat enzyme 
demonstrating no homology to the bovine isozyme. Moreover, analysis has 
shown that this region is extremely hydrophobic. Since more than 75% of the 
cGS-PDE activity in both rabbit and bovine brain is associated with the 
particulate fraction it has been postulated that the hydrophobic amino terminal
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may confer membrane targeting upon cGS-PDEs in a tissue specific manner 
(Yang et al. 1994).
Members of the cGMP-inhibited PDE3 family have been isolated from 
both cytosolic and particulate fractions from several tissues (Degerman et al. 
1996; Manganiello et al. 1995). Early studies by Gettys et al (Gettys et al. 
1988) on rat adipocytes demonstrated that cGI-PDE activity was associated with 
the particulate fraction of microsomes, moreover, incubation with trypsin 
resulted in a transfer of cAMP hydrolytic activity from the particulate to the 
soluble fraction. Interestingly, these investigators also observed that the soluble 
PDE3 activity exhibited minimal activation by the catalytic subunit of PKA 
suggesting the possibility that membrane association was required for regulation 
of cGI-PDE. Since this initial reseach, cGI-PDE activity has been isolated from 
mammalian myocardial sarcoplasmic reticulum (Meacci et al. 1992; Movsesian 
et al. 1991; Smith et al. 1993). Although the elements responsible for 
conferment of membrane association of the cGI-PDEs have not been 
conclusively identified, analysis of the primary amino acid sequences has 
revealed that the N-termini of these enzymes contain several stretches of 
hydrophobic residues (Degerman et al. 1996; Leroy et al. 1996; Manganiello et 
al. 1995; Meacci et al. 1992; Smith et al. 1993; Taira et al. 1993). Meacci et al 
have suggested that these hydrophobic regions may constitute a series of 
transmembrane a  helices. Interestingly, recent studies have shown soluble 
cGI-PDEs to be N-terminally truncated thus implying that membrane 
association is determined by information contained within this region. (Leroy et 
al. 1996; Manganiello et al. 1995).
Early indications that cAMP-specific PDE4 activity localizes to distinct 
subcellular membrane fractions was obtained from studies on rat liver. 
Marchmont and Houslay (Marchmont and Houslay 1980) first demonstrated 
that insulin could stimulate cAMP hydrolytic activity associated with the plasma 
membrane fraction in a broken cell system. Later, Heyworth et al (Heyworth et
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al. 1983) extended this observation to intact hepatocytes where cAMP PDE 
activity was identified in two separate fractions, referred to as the peripheral 
plasma membrane PDE (PPM.PDE), a PDE4 isoform, and the 'dense-vesicle' 
PDE, a PDE3 species, associated with microsomes. In recent years a great deal 
of interest has been shown in compartmentalization of PDE4 isoforms (Bolger 
et al. 1996; Houslay 1995; Houslay 1996; Houslay et al. 1992; Houslay et al. 
1997a; Houslay et al. 1995; Houslay and Tipton 1973; Huston et al. 1996; 
Lobban et al. 1994; McPhee et al. 1995; Nemoz et al. 1996; O'Connell et al. 
1996; Pooley et al. 1997; Shakur et al. 1993; Shakur et al. 1995; Souness et al. 
1992; Wilson et al. 1994). What has become apparent is that this area has been 
made more complicated by the existence of multiple genes and alternative splice 
variants for PDE4 (Bolger et al. 1993; Bushnik and Conti 1996).
Of all the PDE4 isozymes studied to date, the most significant advances 
in understanding of subcellular compartmentalization relate to members of the 
PDE4A gene family. As mentioned earlier cAMP-specific PDEs are transcribed 
from four separate genes (Section 1.5.6.1) all of which share a conserved 
catalytic core and C-terminal region but which possess distinct N-terminal 
domains (Beavo 1995; Bolger 1994; Houslay 1995). Moreover, individual 
splice variants can be further characterised as either 'long-form', containing 
UCR1 and UCR2 in addition to the catalytic core, or 'short-form' containing 
UCR2 only (Beavo 1995). Initial studies carried out by Shakur et al (Shakur et 
al. 1993) focussed on the rat brain PDE4 isoform called RD1 (RNPDE4A1) 
(Davis et al. 1989). When a cDNA clone for RD1 was transiently transfected 
into COS cells approximately 85% of the PDE4 activity was found in the high­
speed particulate fraction. In contrast to this and N-terminally truncated species 
called Met26RDl was exclusively cytosolic. As Met26RDl was missing the 
first 25 amino acids it was suggested that this region may contain the 
information required for compartmentalization of RD1. Subsequent studies 
confirmed the existence of RD1 as being solely in the membrane fraction of rat
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brain cerebellum (McPhee et al. 1995; Shakur et al. 1995). In addition these 
studies also showed that in COS cells transfected with a plasmid encoding RD1 
all of the enzyme was in fact membrane associated and that the small cytosolic 
activity detected was due to co-expression of Met26RDl (McPhee et al. 1995; 
Shakur et al. 1995). More recently, Pooley et al (Pooley et al. 1997) 
demonstrated that human thyroid carcinoma FTC cells stably transfected with 
cDNA for RD1 showed the entire pool of RD1 to be not only membrane 
associated but sequestered specifically to the Golgi apparatus.
Specific intracellular targeting of PDE4A isozymes is not restricted 
solely to RD1. The long-form splice varant RPDE6 (RNPDE4A5) has been 
identified as partitioning between the particulate and soluble fractions both in 
transfected COS cells and also expressed natively in brain (McPhee et al. 1995). 
Bolger et al (Bolger et al. 1996) have also reported recently the identification of 
a testis specific PDE4A splice variant pRPDE39 (RNPDE4A8) which, upon 
expression in COS cells, is distributed between the high speed P2 pellet fraction 
and the supernatant. Huston and colleagues (Huston et al. 1996) have also 
reported that the human PDE4A splice variant PDE46 (HSPDE4A4B), when 
expressed in COS cells, was associated with both the soluble and particulate 
fractions. Moreover, they observed that the particulate enzyme could not be 
solubilized by either the non-ionic detergent Triton X-100 nor high salt 
concentrations. This might indicate cytoskeletal association. That particulate 
association of PDE46 was a function of its N-terminus was confirmed by the 
observation that h6.1 (Sullivan et al. 1994), which lacks the N-terminal 
extension of PDE46, was exclusively soluble when expressed in COS cells 
(Huston et al. 1996).
One valuable insight into targeting of PDE4A has been gained from the 
work of O'Connell et al (O'Connell et al. 1996). These investigators observed 
that RPDE6 (RNPDE4A5) was able to interact with the Src homology (SH3) 
domain of the tyrosyl kinase Src. In addition it also displayed varying affinities
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for the SH3 domains of other tyrosyl kinases, namely c-Abl, Crk, Csk, Lck, 
Lyn and Fyn. This interaction is thought to have been mediated through a 
proline-rich motif contained within the N-terminus of RPDE6. It has been 
postulated that such an interaction between Src and a PDE may serve to prevent 
inhibition of the kinase by cAMP-mediated phosphorylation (Houslay and 
Milligan 1997; Houslay et al. 1997a). The PDE4B gene product PDE4 
(RNPDE4B2A) has also been suggested to occur exclusively associated with 
selective membrane compartments in brain (Lobban et al. 1994). This is 
thought to occur by virtue of its alternatively spliced N-terminal region. In 
contrast, the splice variant DPD, which lacks this region was completely 
cytosolic.
While there is a growing body of evidence that PDE4 isozymes are 
located within specific subcellular compartments the mechanism involved in 
each case remains to be elucidated as does the biolological function. It does 
appear, however, that such interactions are mediated through information 
contained within the splice variant specific N-terminal regions of the individual 
PDE isozymes (O'Connell et al. 1996; Shakur et al. 1993).
It is known that proteins can be targeted to various intracellular locations 
by a number of different mechanisms. Outlined below are some of the methods 
involved in targeting of proteins to such subcellular compartments as the plasma 
membrane, endoplasmic reticulum, Golgi apparatus, peroxisomes and 
lysosomes.
1.7 Protein Targeting Signals
Signals required for the intracellular targeting of cytoplasmic proteins 
are often found at their amino or carboxy termini. Moreover, these signals may 
or may not be removed following the initial targeting of the protein (Boyd and 
Beckwith 1990; Szczesna-Skorupa et al. 1988). In contrast, nuclear targeting 
signals may be internally located and not removed upon achieving correct
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targeting. Targeting signals involved in directing proteins to the peroxisomes 
tend to be either internal or carboxy terminally located and remain uncleaved. 
An additional feature of protein targeting signals is based upon the observation 
that they can, in some instances, act in an independent context to their protein of 
origin by targeting otherwise normally soluble foreign proteins to specific 
intracellular locations (von Heijne 1996).
1.7.1 The Signal Peptide
The signal peptide (SP) mediates the entry of proteins into the secretory 
pathway (Andrews et al. 1992; Green et al. 1989; Kaiser and Botstein 1990; 
Lyko et al. 1995; Milstein et al. 1972; Szczesna-Skorupa et al. 1988; von 
Heijne 1990; von Heijne 1996). Analysis of the amino acid sequence of 
various signal peptides has failed to reveal any conservation of sequence. 
However, such sequences usually possess a characteristic tripartite structure 
consisting of a basic amino terminus, known as the n-region, and invariantly 
contains lysine and arginine residues, followed by a central hydrophobic core 
and, finally, a C-terminal polar region consisting of small uncharged amino 
acids which constitute the site of cleavage by signal peptidase (Lyko et al. 1995; 
von Heijne 1990; von Heijne 1996). The n- and h-regions are responsible for 
membrane targeting, however, the n-region is also thought to mediate surface 
binding through interactions between the basic amino acids and anionic 
phospholipids in the lipid bilayer. The h-region would appear to adopt an a  
helical conformation which may or may nor span the lipid bilayer (von Heijne
1996). Following translocation and cleavage of the signal peptide by signal 
peptidase, both the signal peptide and the protein are released into the lumen of 
the endoplasmic reticulum (ER) (Andrews et al. 1992).
In addition to the cleaved signal peptide, a second class of translocation 
signal has been identified. Known as a signal anchor, this sequence shares 
some of the features of the signal peptide in that they initiate translocation but 
unlike signal peptides, they are not cleaved from the protein (Andrews et al.
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1992; Sakaguchi et al. 1987; Szczesna-Skorupa et al. 1988; von Heijne 1990). 
The signal anchor can also be found in tandem with a third class of topogenic 
elements known as a stop transfer signal. This functions to halt translocation 
of the polypeptide into the ER lumen and thus establishes it as an integral ER 
membrane protein (Andrews et al. 1992; Davis and Model 1985; Sakaguchi et 
al. 1987; Szczesna-Skorupa et al. 1988).
1.7.2 Endoplasmic Reticulum Retention/Retrieval Signals
Many of the proteins found in the ER lumen are in transit to various 
regions within the cell. However, some proteins are permanent residents in the 
ER itself and as such, must somehow be distinguished from proteins which will 
be secreted. This may happen by one of two mechanisms either by direct 
retention or by retrieval of the protein from distal compartments of the secretory 
pathway, these proteins must possess an endoplasmic reticulum retention signal 
(Pfeffer and Rothman 1987). In the first instance this function has been 
identified for many proteins as the carboxy terminally located tetrapeptide 
sequence KDEL, originally identified by Munro and Pelham (Munro and 
Pelham 1987) and Warren (Warren 1987). The KDEL sequence has now been 
shown to occur in several mammalian proteins (Andres et al. 1991; Hsu et al. 
1992; Lewis and Pelham 1992b; Mazzarella et al. 1990; Tang et al. 1993; Yun 
and Eipper 1995). Furthermore, a variant, HDEL, is known to determine ER 
retention in yeast (Hsu et al. 1992; Lewis and Pelham 1990). Moreover it has 
been suggested that proteins with a KDEL sequence are retrieved from the 
Golgi complex to the ER by a mechanism involving a KDEL receptor which 
cycles between the Golgi complex and the ER (Lewis and Pelham 1992b; 
Pelham 1988; Warren 1987). To this effect, several researchers have isolated 
and characterised cDNAs for these receptors in both humans and yeast (Lewis 
and Pelham 1990; Lewis and Pelham 1992a; Lewis and Pelham 1992b; 
Semenza et al. 1990). Furthermore, it has been shown in at least one instance 
that human KDEL receptor resides in the Golgi complex until challenged by
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high concentrations of KDEL-bearing ligand whereupon it redistributes to the 
ER (Lewis and Pelham 1992a). While the sequence KDEL is highly conserved 
amongst mammalian proteins, there is some degeneracy allowed. For example, 
it has been shown (Andres et al. 1991) that mutagenesis of KDEL to QDEL, 
KEDL and KDEI prevented secretion of human prepro-neuropeptide Y whereas 
substitution of the leucine for valine, to generate KDEV, prevented ER retention 
of this protein.
The second mechanism whereby proteins are localized to the ER is less 
well understood. While soluble proteins are retrieved from the Golgi complex 
and retained in the ER by means of the KDEL tetrapeptide, integral membrane 
proteins have been observed to employ a dibasic motif (Calakos et al. 1994; 
Cosson and Letourneur 1994; Jackson et al. 1990; Szczesna-Skorupa et al. 
1995; Vincent et al. 1998). Nilsson and colleagues (Nilsson et al. 1989) have 
demonstrated that the adenoviral E3/19K gene product, a type 1 transmembrane 
protein, is retained in the ER by virtue of information contained within its C- 
terminal 15 amino acid residues. Deletion of the extreme C-terminal 6 amino 
acids revealed that the ER localization signal was contained within the sequence 
DEKKMP (Nilsson et al. 1989). Moreover, addition of this sequence to the C- 
terminii of CD4 and CD8, two T lymphocyte expressed type 1 cell surface 
localized proteins, resulted in their retention in the ER (Nilsson et al. 1989). 
Subsequent to these initial observations Jackson et al (Jackson et al. 1990) have 
identified by site-specific mutagenesis two consensus motifs KKXX and 
KXKXX in which an invariant lysine at position -3 from the C-terminus are 
sufficient for ER localization. Furthermore, these researchers were able to 
demonstrate that the di-lysine motif functioned independently of the 
surrounding amino acid composition. Moreover, the ability of this motif to 
direct ER retrieval is not simply a feature of charge as substitution of either 
lysine residue by arginine or histidine causes translocation to the cell surface 
(Jackson et al. 1990). While the mechanism by which di-lysine motifs direct
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retrograde transport to the ER remains to be elucidated, there has been a 
suggestion that coatomer interaction may be involved (Cosson and Letoumeur 
1994; Vincent et al. 1998).
A similar strategy to that outlined above was employed by Schutze et al 
(Schutze et al. 1994) in demonstrating that a double-arginine motif located at the 
N-terminus of the human invariant chain lip33, a type II transmembrane 
protein, was involved in its retrieval to the ER. Moreover, the position of the 
double-arginine motif within the N-terminus was shown to be essential for its 
function with positions 2 and 3, 4 and 5, 2 and 4 or 3 and 5 the only 
combinations being tolerated.
While the examples outlined above represent some of the ways in which 
proteins can be retrieved by the ER these are by no means the only mechanisms 
which are exploited for this function. For example, influenza virus 
haemagglutinin, which is normally excluded from coated pits at the cell 
surface, was internalized to the perinuclear region upon mutation of a specific 
cysteine located within its cytoplasmic domain to tyrosine in a manner which 
did not involve phosphorylation of the tyrosine (Lazarovits and Roth 1988).
Interestingly, it would appear that in addition to its involvement with the 
secretory pathway the ER also functions as site for the retention and subsquent 
degradation of misfolded and mutated proteins (Klausner and Sitia 1990). The 
plasma membrane Ca2+ ATPase has an acidic region in its cytoplasmically 
exposed C-terminus (Zvaritch et al. 1995). A truncated protein terminating with 
this sequence is retained in the ER, moreover, mutation of the acidic amino 
acids in this region to basic reidues resulted in its expression at the cell surface 
thus suggesting that the Ca2+ ATPase has a masked ER retention signal in its C- 
terminus (Zvaritch et al. 1995)
Moreover, it has also been shown that proteins which do not themselves 
contain ER retention signals can be localised within the lumen of the 
endoplasmic reticulum by associating with a protein which does possess such a
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signal. An example of this (Zhen et al. 1995; Zhen et al. 1993) is given by p- 
glucuronidase where a significant fraction can be sequestered to the ER lumen 
by virtue of the interaction of this protein with egasyn.
1.7.3 Golgi Retention Signals
Upon leaving the endoplasmic reticulum, proteins are transported to the 
Golgi complex where they undergo a variety of modifications such as addition 
of carbohydrate structures, tyrosine sulphation and O-linked sugars (Munro 
1991; Pfeffer and Rothman 1987). Such modified proteins then progress 
through the trans-golgi network (TGN) prior to export to various intracellular 
locations (Munro 1991; Pfeffer and Rothman 1987). Several modifying 
enzymes such as asialoglycoprotein receptor subunit HI (Wahlberg et al.
1995), GnTl (Burke et al. 1994; Burke et al. 1992), a-2,6-sialyltransfrerase 
(Munro 1991) and p-1,4-galactosyltransferase (Yamaguchi and Fukuda 1995) 
are retained by the Golgi complex in addition to the viral glycoproteins E2 and 
G1 of Rubella virus and Punta Tora virus respectively (Hobman et al. 1995; 
Matsuoka et al. 1994; Matsuoka et al. 1996).
The mechanism of Golgi retention remains poorly understood in 
comparison to other retention signals such as the carboxy terminal KDEL motif 
of the endoplasmic reticulum. However, there is a growing body of evidence 
which suggests the involvement of a single amino terminal transmembrane 
(TM) domain (Burke et al. 1994; Burke et al. 1992; Matsuoka et al. 1996; 
Munro 1991; Nilsson et al. 1991; Pearce et al. 1991; Pelham and Munro 1993; 
Youakim et al. 1994). Analysis of the primary amino acid sequences of various 
transmembrane domains reveals a distinct lack of homology. However, they all 
appear to be approximately 17 residues long and composed predominantly of 
hydrophobic amino acids (Hobman et al. 1995; Pelham and Munro 1993; 
Wahlberg et al. 1995; Yamaguchi and Fukuda 1995; Youakim et al. 1994). 
Munro (Munro 1991) has demonstrated that increasing the length of the 
transmembrane domain to 23 amino acid residues results in export of the
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peptide to the cell surface. It has been suggested that 17 amino acids would be 
more suited to traversing the thinner Golgi membrane than longer sequences 
(Pelham and Munro 1993). More recently, some investigators have reported 
results which implicate the cytoplasmic domain of Golgi retained proteins as 
being important for retention. Matsuoka et al (Matsuoka et al. 1996) have 
shown that mutation of a proline within the first 10 amino acids of the 
cytoplasmic domain of the Punta Tora virus G1 glycoprotein causes its 
translocation to the cell surface. Prior to this Munro (Munro 1991) suggested 
that three lysine residues immediately downstream of a-2,6-sialyltransferase 
may function as a stop-transfer signal in a fashion similar to that observed in 
the endoplasmic reticulum (See section 1.7.2).
It has previously been suggested that oligomerization may also be an 
important factor in Golgi retention by generating large protein complexes which 
may be difficult to export (Nilsson et al. 1994; Pelham and Munro 1993). 
Whether this proves to be the case remains to be seen. However, some recent 
research has identified that at least some Golgi proteins form dimers in vivo. 
Yamaguchi and colleagues (Yamaguchi and Fukuda 1995) have demonstrated 
that p-l,4-galactosyltransferase forms a homodimer mediated by the interaction 
of specific cysteine and histidine residues located in its transmembrane domain, 
while Hobman et al (Hobman et al. 1995) have shown that Rubella virus 
glycoproteins El and E2 form a heterodimer. Interestingly, these investigators 
have also shown that the transmembrane and cytoplasmic domains of El are not 
required for Golgi retention. Such studies demonstrate that two integral 
membrane proteins can be retained by a single signal (Hobman et al. 1995).
1.7.4 Endosomal/Lysosomal Targeting Signals
It has been shown that the major histocompatability class II molecules 
associate with Iip31, a type II transmembrane protein found in the endoplasmic 
reticulum, prior to translocation to a specialized endosomal compartment. 
When the complex reaches this compartment, Iip31 is released prior to MHCII
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appearing at the cell surface (Pond et al. 1995). Endosomal targeting of Iip31 is 
mediated by virtue of information contained within the first 16 amino acids of 
its cytoplasmic tail (Lotteau et al. 1990). Site specific mutagenesis has identifed 
this signal as a di-leucine motif which also requires the presence of an acidic 
amino acid approximately 4-5 residues N-terminal to the di-leucine motif (Pond 
et al. 1995). Di-leucine related motifs have also been identified in a variety of 
receptors and other proteins which are targeted to lysosomes including T-cell 
antigen receptor CD3 chains (Leteourneur and Klausner 1992), lysosomal 
integral membrane protein (LIMP) II (Ogata and Fukuda 1994), interleukin-6 
(IL-6) signal transducer gpl30 (Dittrich et al. 1996), macrophage IgG Fc 
receptors (Hunziker and Fumey 1994) and the insulin receptor (Haft et al. 
1994). In addition, a di-leucine motif has been implicated in internalization and 
lysosomal targeting of the T lymphocyte integral cell surface glycoprotein CD4 
mediated by the human immunodeficiency virus (HIV) Nef gene product (Aiken 
et al. 1994).
1.7.5 Peroxisomal Targeting Signals
Peroxisomes are small organelles comprised of a single membrane that 
are found in most eukaryotic cells and which are involved in a variety of 
processes (Glover et al. 1994). Peroxisomal proteins are synthesised in the 
cytosol on membrane-free polysome prior to translocation to pre-existing 
peroxisomes (Fransen et al. 1995; Miyazawa et al. 1989; Tsukamoto et al.
1994). Early studies by Gould et al (Gould et al. 1989) revealed that firefly 
luciferase was targeted to peroxisomes by information contained within its 
carboxy terminus. This was identified as the tripeptide sequence serine-lysine- 
leucine (S-K-L). In addition, these investigators observed that fusion of the 
SKL tripeptide to the carboxy terminus of chloramphenicol acetyl transferase 
(CAT) directed this normally cytosolic protein to the peroxisomal fraction of 
transfected mammalian cells (Gould et al. 1989; Gould et al. 1990). Moreover, 
Gould and colleagues (Gould et al. 1989) have shown that serine (S) can be
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replaced by alanine (A) or cysteine (C) and lysine may be substituted for by 
histidine (H) or arginine (R) without loss of targeting. Since these intial studies 
several peroxisomally targeted proteins have been identified that contain 
carboxy terminal tripeptide targeting signals, such as rat liver alcohol oxidase 
(AOX) (Miyazawa et al. 1989), insulin degrading enzyme (IDE) (Eitzen et al.
1995) and 3-hydroxy-3-methylglutaryl-CoA lyase (HL) (Authier et al. 1994). 
While the mechanism for the peroxisomal retention of these proteins has not 
been elucidated, there is evidence to suggest that it may involve a protein- 
protein interaction. Fransen et al (Glover et al. 1994) have recently isolated a 
cDNA clone from a rat liver cDNA library which binds to the SKL peroxisomal 
targeting signal by using this peptide as bait in a yeast two hybrid assay.
Peroxisomal targeting and retention has also been reported for proteins 
that lack the C-terminal tripeptide SKL signal. For example, peroxisomal 3- 
ketoacyl-CoA thiolase (PT) has been shown to possess an amino terminal 
peroxisomal targeting signal peptide which is cleaved upon successful targeting 
(Swinkels et al. 1991; Tsukamoto et al. 1994). Moreover, the analogous 
enzyme in yeast is targeted by information within its amino terminal 16 amino 
acids. This is in contrast, to the rat enzyme, where such a region is not cleaved 
following peroxisomal translocation (Glover et al. 1994). More recently, Eitzen 
et al (Fransen et al. 1995) have isolated the cDNA for the yeast gene Pay2p 
which encodes a peroxisomal integral membrane protein that may be targeted by 
virtue of a hydrophobic N-terminal transmembrane domain.
1.7.6 Mitochondrial Targeting Signals
Greater than 90 % of the proteins found in the mitochondria are encoded 
by nuclear DNA and synthesised in the cytoplasm whereupon, following 
import, they are sorted to one of four distinct compartments; the outer or inner 
membranes, the intermembrane space or the matrix (Glaser et al. 1990; Hahne 
et al. 1994; Kaput et al. 1982; Shore et al. 1995; Steenaart and Shore 1997; van 
Loon et al. 1986). As import of these proteins is mediated in most instances by
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the same mechanism, then specificity of sorting must be encoded by different 
topogenic domains contained within the precursor protein (Steenaart and Shore
1997). Indeed, it would appear that many mitochondrial proteins are 
synthesised with a presequence which directs the peptide into the mitochondrion 
whereupon the presequence is cleaved, prior to translocation to a specific site 
within the mitochondrion (Glaser et al. 1990; Kaput et al. 1982; van Loon et al. 
1986).
The matrix targeting signal (MTS) is the most well studied of the 
mitochondrial targeting signals having been characterised for a variety of 
proteins including yeast alcohol dehydrogenase (ADH) III and cytochrome ci 
(van Loon et al. 1986), NADH-cytochrome b5 reductase (Hahne et al. 1994) 
and pre-ornithine carbamoyl transferase (Steenaart and Shore 1997). Matrix 
targeting signals are typically rich in basic and hydroxylated amino acid residues 
and have been postulated to form amphiphilic helices (Hahne et al. 1994; 
Steenaart and Shore 1997). In contrast, targeting of proteins to the 
mitochondrial outer, inner and intramembrane compartments is less well 
understood, although it is thought to involve stretches of hydrophobic amino 
acids which may act as transmembrane domains (Shore et al. 1995). Steenaart 
et al (Steenaart and Shore 1997) have shown that the yeast protein Tom70p is 
targeted and inserted into the mitochondrial outer membrane with its N-terminal 
located in the intermembrane space while its C-terminus is exposed to the 
cytoplasm. This orientation is achieved by means of an N-terminal anchoring 
sequence comprised of two domains, an N-terminal hydrophilic domain and a 
transmembrane domain. Moreover, it has been shown that increasing the 
hydrophobicity of the transmembrane caused the Tom70p localization signal to 
target dihydofolate reductase (DHFR) to the mitochondrial inner membrane 
(McBride et al. 1992; Steenaart and Shore 1997). Further confirmation of the 
importance of hydrophobic domains in mitochondrial inner membrane targeting 
has been presented by Glaser et al (Glaser et al. 1990) who found that deletion
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of a C-terminal hydrophobic transmembrane domain of yeast cytochrome c 
oxidase subunit Va resulted in its translocation to the matrix. It has also been 
demonstrated (van Loon et al. 1986) that the presequence of yeast cytochrome c 
can target DHFR to the inner membrane, where it is anchored by a 19 amino 
acid hydrophobic transmembrane domain. The presence of two basic amino 
acid residues following the hydrophobic domain has been suggested by these 
investigators as fulfilling the function of a stop-transfer sequence.
More recently, Lin et al (Lin et al. 1995a) have identified a putative 
transmembrane domain in the protein kinase A anchoring protein S-AKAP84 
which may serve as a mitochondrial targeting signal. In addition, 
immunofluorescence studies have shown (Lin et al. 1995a) that S-AKAP84 co- 
localizes with flagellar mitochondria where it may be involved in PKA 
mediated activation of flagellar movement in mature spermatozoa.
Targeting of proteins to the intermembrane space is thought to involve a 
two-step process whereby proteins are first targeted to the mitochondrial inner 
membrane and subsequently released into the intermembrane space (Gasser et 
al. 1982; Kaput et al. 1982). Kaput and colleagues (Kaput et al. 1982) have 
shown that yeast cytochrome c oxidase (CCP) is synthesised with an amino 
terminal 68 amino acid presequence (preCCP) which would appear to anchor 
the peptide in the inner membrane, exposing only the extreme N-terminus to the 
matrix. Mature, soluble CCP is then generated from this transmembrane 
intermediate upon cleavage of the presequence thus releasing the protein into the 
intermembrane space.
Thus is would seem that targeting of proteins to specific mitochondrial 
compartments, while not as clearly defined as targeting to other intracellular 
locations, is mediated by a variety of factors including hydrophobicity and the 
presence of charged amino acid residues. Moreover, it has become apparent 
that several proteins contain targeting signals for more than one mitochondrial
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location (Steenaart and Shore 1997) and that their position within the peptide 
relative to each other can determine the final submitochondrial localization.
1.7.7 Nuclear Localization Signals
Signals responsible for targeting of proteins to intracellular locations 
such as peroxisomes, the Golgi apparatus and the endoplasmic reticulum are 
characteristically located at either the amino or carboxy terminus of a protein. In 
marked contrast, nuclear localization signals (NLS) may be present at any point 
along the polypeptide chain and, unlike for example signal peptides, are not 
removed by cleavage following targeting (von Heijne 1996).
While no consensus sequence exists for nuclear localization signals, it 
has been observed that they are short (4-21 residues) amino acid sequences 
dominated by the presence of the basic amino acids lysine and arginine 
(Kalderon et al. 1984; Smith et al. 1985; von Heijne 1996). One such example 
is characterized by the sequence PKKKRKV found in the nuclear localization 
signal of SV 40 large T antigen (Smith et al. 1985). Variations upon such 
signals have been identified in a variety of proteins including nucleoplasmin 
(Dingwall et al. 1987), the transcription factors NGF1-A (Matheny et al. 1994), 
NF-kB (Lin et al. 1995b), SW15 (Jans et al. 1995), the DNA binding protein 
human lymphoid enhancer factor-1 (hLEF-1) (Prieve et al. 1996), C-193, a 
novel cytokine induced nuclear protein (Chu et al. 1995) and ubiquitin- 
activating enzyme of yeast (Dohmen et al. 1995). Interestingly, Ono et al (Ono 
et al. 1994) have recently a identified a nuclear localization signal, KKRKK, 
close to the amino terminus of the actin- modulating protein cofilin. This is 
responsible for causing the translocation of this protein to the nucleus upon 
exposure to metabolic insults such as heat shock or dimethyl sulphoxide. It has 
been suggested (Ono et al. 1994) that such treatments may alter the structural 
conformation of the protein thus exposing the nuclear localization signal which 
would normally remain buried.
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A second type of nuclear localization signal demonstrating a bipartite 
motif composed, usually of two regions of basic amino acids separated by a 
short spacer region, has also been identified (Matheny et al. 1994). This type 
of nuclear localization signal has been identified in proteins as diverse as the 
plant transcription factor Opaque2 (Hicks and Raikhel 1995) and the 
mammalian zinc-binding protein parathymosin-a which contains the sequences 
RKR and PKRQKT separated by a 9 amino acid spacer (Trompeter et al.
1996). Zhu et al (Zhu et al. 1995) have shown that the nuclear phosphoprotein 
mitosin contains a rather unusually spaced bipartite nuclear localization signal 
consisting of the sequences KRQKX(20)KKSKK. Interestingly, it should be 
noted that bipartite nuclear localization signals show a greater degree of 
variation in their amino acid sequence than the more familiar linear nuclear 
localization signals. It may be in these instances that a bipartite signal is 
required bring together sufficient positively charged amino acids to allow 
nuclear import, although it is emphasised that this is pure speculation and would 
require experimental investigation.
1.7.8 Membrane Association of Proteins by Post-translational 
Modification
One method of targeting of proteins to the plasma membrane involves 
acylation which involves the covalent attachment of one or more fatty acid 
molecules at sites located within either the N- or C- terminus of the protein. 
The addition of lipids to proteins has been well documented (Chapman et al. 
1992; Gaudin et al. 1991; Grand 1989; O'Brien and Zatz 1984; Okubo et al. 
1991; Perez et al. 1991; Schlesinger et al. 1980; Soly and Meighen 1991; 
Spiegel et al. 1991b) and normally occurs through one of two mutually 
exclusive pathways involving palmitic acid or myristic acid. Myristoylation 
has been observed for numerous proteins including G protein a  subunits 
(Linder et al. 1991; Spiegel et al. 1991a; Wildman et al. 1993) and ADP- 
ribosylation factor (Haun et al. 1993; Kahn et al. 1992) where it is linked
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through an amide bond to a highly conserved amino terminal glycine residue 
(Han and Martinage 1992; Linder et al. 1991; Spiegel et al. 1991a). Analysis of 
the amino acid sequence of RD1 revealed the presence of a proline at position 2 
rather than the required glycine so it was therefore deemed unlikely that 
myristoylation was the mechanism by which the subcellular localization of RD1 
was determined. Palmitoylation is a modification which has also been observed 
for many proteins (Beranger et al. 1991; Glomset et al. 1990; Hancock et al. 
1989; Kloc et al. 1991; Leevers et al. 1994; O'Dowd et al. 1989; Okubo et al. 
1991). Such modified proteins containing covalently bound palmitate are 
strongly anchored in the plasma membrane (Grand 1989). In most examples 
the palmitate moiety is attached via a thioester bond to a cysteine which is 
located within the consensus sequence CAAX found only at the carboxy 
terminus (Beranger et al. 1991; Cox and Der 1992; Glomset et al. 1990; Grand 
1989; Hancock et al. 1989; Kloc et al. 1991; Leevers et al. 1994). However, in 
recent years proteins have been identified which are palmitoylated on cysteine 
located close to their amino terminus (Parenti et al. 1993; Sudo et al. 1992; 
Widmer and Caroni 1993). Indeed it has been reported that the neuronal 
protein GAP-43, which is palmitoylated on two N-terminal cysteines, becomes 
only partially membrane-associated upon prevention of acylation of either 
cysteine (Zuber et al. 1989).
1.8 Intracellular Localization of the cAMP-Specific 
Phosphodiesterase RD1 (RNPDE4A1)
Nuclear encoded proteins synthesised in the cytoplasm are transported 
to various intracellular locations through the secretory pathway via the 
endoplasmic reticulum (ER) and Golgi apparatus/trans Golgi network (TGN) 
(Pfeffer and Rothman 1987). In the absence of specific retention signals for
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these organelles, proteins are transported by default to the cell surface (Pfeffer 
and Rothman 1987).
Previous studies have shown that when the cDNA for the cAMP- 
specific phosphodiesterase splice variant RD1 (RNPDE4A1) is transiently 
expressed in COS cells, the resultant gene product is predominantly associated 
with the plasma membrane (McPhee et al. 1995; Shakur et al. 1993). Plasma 
membrane association of RD1 has also been demonstrated in the synaptosomes 
of rat brain cerebellum (Shakur et al. 1995). Studies carried out by Shakur et al 
(Shakur et al. 1993) have shown that deletion of the extreme amino terminal 25 
amino acids of RD1 results in translocation of the enzyme from the plasma 
membrane to the cytosol thus suggesting plasma membrane association of RD1 
is mediated by information contained within this region. Extensive database 
searches have failed to reveal any significant homology between the N-terminus 
of RD1 and the targeting signals of various plasma membrane associated 
proteins thus suggesting that this region may contain a novel, previously 
unidentified, membrane targeting signal. The aim of this thesis was to 
determine whether the extreme amino terminus of RD1 did indeed, contain a 
targeting signal or whether this region formed part of a larger structural element 
r e q u i r e d  for  p l a s m a  m e m b r a n e  l o c a l i z a t i o n .
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CHAPTER 2 
Methods and Materials
2.1 CHEMICALS AND SUPPLIERS
Supplier
Promega U.K., 
Southampton, U.K.
Sigma Chemical Co., 
Pool, Dorset, U.K.
Life Technologies Ltd., 
Renfrew, U.K.
Reagent 
dNTP mix
Wizard Miniprep Kits 
Wizard PCR Prep Kits 
Wizard Maxiprep Kits 
Taq DNA Polymerase 
Xbal (10 units/|il) 
Xhol (10 units/|il) 
Narl (10 units/jil)
Clal (10 units/|il) 
BamHl (lOunits/jil) 
T4 DNA Ligase 
SP6 TnT ™ System
Ampicillin
Ethidium Bromide
Chloramphenicol
TMPD
AMP
BSA
DMEM
Pen/Strep soln.
L-Glutamine
F.C.S.
pSV.SPORTl
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Bio-Rad Laboratories Ltd 
Herts, U.K.
Bradford Protein 
Assay Reagent
Pharmacia Biotech 
Milton Keynes, U.K.
Perkin-Elmer U.K 
Warrington, U.K.
Cambridge Bioscience 
Cambridge, U.K.
Amersham International 
Amersham, U.K.
All other reagents were
pSVL
Taq Dye Deoxy™ Terminator 
Kits
Phenol/H20/CHCL3
Anti-CAT Antibody
ECL Detection Kits 
Hyperpaper-ECL 
[2-3H] AMP (2 ICi/mmol) 
[14C] Chloramphenicol 
(54Ci/mmol)
L-[35S] Methionine 
(>1000Ci/mmol) 
purchased from B.D.H. Ltd., Poole Dorset, U.K.
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2.2 CONSTRUCTION OF RECOMBTNANT PLASMIDS
2.2.1 Generation of PCR Fragments
The following reagents were assembled in a sterile 0.5 ml Eppendorf 
tube, lpg template DNA, 25pmol each primer, 0.2mM each dNTP, 50mM 
KC1, lOmM Tris-HCl (pH9.0), 0.1% Triton X-100 (v/v), 1.5mM MgCl2 and 
2.5units of Taq polymerase 1 in a final volume of 50pl. reactions were 
overlayed with 40 pi mineral oil and subjected to the following conditions in a 
Techne PHC-3 thermocycler; denaturation for 1' at 94DC, annealing for 2' at 
37°C, extension for 3' at 72"C for one cycle followed by denaturation for 1' at 
94"C, annealing for 2' at 60 'C, extension for 3' at 72°C for 30 cycles. Upon 
completion, the reaction was extracted with an equal volume of chloroform to 
remove residual mineral oil and the reaction product precipitated by incubation 
at -70"C for 15 minutes upon addition of 1/10th volume (v/v) of 3M sodium 
acetate (pH 5.2) and 3 volumes (v/v) absolute ethanol. Finally the PCR 
fragment was centrifuged at 12,000 g for 15 minutes at 4°C in a Jouan 
MR 18.12 bench-top microcentrifuge, the pellet washed with 1 ml 70% ethanol 
and centrifuged as above before air drying at room temperature for 15 minutes.
2.2.2 Restriction Digestion of DNA and PCR Fragments
Fragments were digested by the restriction enzymes either for 2 hours or
overnight at 37"C according to the manufacturers instructions for the specific 
enzyme; Xbal and Xhol in 6mM Tris-HCl (final pH7.9), 150mM NaCl, 6mM 
MgCl2 and ImM DTT , Clal in lOmM Tris-HCl (final pH7.9), 50mM NaCl, 
lOmM MgCl2 and ImM DTT and Narl in 50mM Tris-HCl (final pH8.2), 5mM 
MgCl2, BamHl in 6mM Tris-HCl (final pH7.5), lOOmM NaCl, 6mM MgCl2 and 
ImM DTT. Final volumes were either 50 pi or 100 pi.
88
2.2.3 Ligation of PCR Products and DNA Fragments
All ligations were carried out according to Sambrook et al (Sambrook et al. 
1989). Essentially, insert and vector DNA at a molar ratio of 1:1 was incubated at 
14°C for 16 hours in a final volume of 10 |il containing 3 Wiess units T4 DNA 
ligase 30mM Tris-HCl (final pH7.8), lOmM MgCl2, 10mM DTT and 5mM ATP. 
Ligation reactions were then directly transformed into competent bacteria for 
propagation and selection.
2.3 BACTERIAL EXPRESSION OF PLASMIDS
2.3.1 Preparation of Competent Bacteria
The Escherichia coli strains JM109 (recA 1 supE 44 endA 1 hsdR  17 gyr 
A 96 rel A 1 thi A (lac-proAb)) and HB101 (sup E 44 hsd S 20 (r b m  b ) rec A 13 
ara -14 pro A 2 lac Y 1 gal K 2 rps L 20 xyl -5 mtl -1) used for propagation of 
recombinant and stock plasmids, were made competent by a modification of the 
calcium chloride method (Sambrook et al. 1989). Essentially, 5ml of 2TY broth 
was inoculated with 10 |il of a glycerol stock solution and incubated at 37°C while 
shaking. After 18 hours, 1 ml of this seed culture was used to inoculate 100 ml 
2TY broth in a 500 ml conical flask which was incubated at 37 °C as before. 
Bacterial growth was assayed by removal of 1 ml of culture at 30 minute intervals 
and measuring absorbance at 600nM in a visible wavelength spectrophotometer. 
The bacteria were grown until the cells were in mid log phase (A600 of 0.3-0.4 ) 
then placed immediately at 0°C for 30 minutes to arrest metabolic activity. Cells 
were harvested by spinning in a bench top centrifuge (Jouan Instruments C3.12) at 
3,500 g for 5 minutes at ambient temperature. The cells were washed to remove 
any residual growth medium by re suspending the pellets in 15 ml ice cold 0.1M 
CaCl2 and centrifugation as above. The washed cell pellets were then re suspended 
in 50 ml 0.1M CaCl2 and incubated at 0°C for 30 minutes followed by 
centrifugation as before and finally re suspended in 4 ml 0.1M CaCl2.
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2.3.2 Transformation of Competent Bacteria
Plasmid DNA was introduced into competent E.coli by a modification of 
the method of Sambrook et al (Sambrook et al. 1989). Essentially, 10 fil of TE 
(lOmM Tris-HCL, ImM EDTA pH8.0) containing 500 ng of plasmid DNA or 10(il 
ligation reactions were added to 0.2 ml aliquots of competent cells in a pre-chilled 
5ml tube (Falcon no.2059) and incubated at 0°C for 30 minutes. Following a heat 
shock at 37°C for 2 minutes, 2 ml 2TY broth pre-warmed to 37°C was added each 
tube which was then incubated at 37 °C for 1 hour whilst shaking to allow for 
expression of antibiotic resistance. 0.1 ml aliquots of cells were then spread onto 
2TY agar plates (Appendix) containing 50|ig/ml ampicillin (final concentration) and 
incubated at 37"C for 16 hours to facilitate selection of antibiotic resistant plasmid 
containing colonies. Samples of competent cells incubated in the absence and 
presence of the plasmid pSVL were plated out as negative and positive 
transformation controls respectively. All procedures were carried out under 
asceptic conditions.
2.3.3 Screening of Bacterial colonies for Recombinant Plasmids
Antibiotic resistant colonies were picked from 2TY agar plates by sterile 
toothpicks and inoculated asceptically into 5 ml cultures of 2TY broth containing 50 
pg/ml (final concentration) ampicillin (2TYamp) and the cultures were shaken at 
37°C. After an overnight incubation plasmid DNA was isolated from each culture 
by a modification of the alkaline lysis procedure of Bimboim and Doly (Bimboim 
and Doly 1979). Essentially, bacterial cells were pelleted from 3 ml of overnight 
culture by centrifugation at 2500 g in a bench-top microcentrifuge for 5 minutes at 
room temperature. The supernatant was removed by aspiration and the pellets were 
re suspended in 0.2 ml 50mM Tris-HCl (pH7.5), lOmM EDTA, 100 |ig/ml RNase 
A. The cells were lysed by the addition of 0.2 ml 0.2M NaOH, 1% SDS with 
gentle agitation. The lysate was neutralised upon the addition of 0.2 ml 1.32M 
potassium acetate (pH4.8). Cleared cell lysates were obtained by centrifugation of 
the samples at 16,000 g for 5 minutes at room temperature. Plasmid DNA was
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isolated from the cleared cell lysate by the Wizard Miniprep system (Promega 
U.K.) which routinely yielded 3-10 jig of supercoiled plasmid DNA. Duplicate 
samples of putative recombinant plasmid DNA were incubated with and without the 
restriction enzymes Xbal and Xhol as mentioned above. Digested and non 
digested samples were analysed by electrophorisis through a 1% agarose gel in 
89mM Tris-Borate, 89mM boric acid, 2mM EDTA (pH8.0), 0.2 |ig/ml ethidium 
bromide. (Brondyk et al. 1993)
2.4 LARGE SCALE PURIFICATION OF PLASMID DNA
2.4.1 Preparation of a Cleared cell Lysate
For large scale plasmid isolation bacterial glycerol stocks containing the 
plasmid of interest were streaked onto 2TY agar plates containing 50 |ig/ml (final 
concentration) and grown for 16-18 hours at 37°C. The following day 100 ml 
2TYamp was inoculated with a single colony isolate (SCI) from the overnight plate 
and grown to saturation by incubation at 37°C for 16 hours whilst shaking. Post 
incubation, cells were pelleted from the overnight culture by centrifugation at 
8,000g for 10 minutes at room temperature in Beckman JA2-21 high-speed 
centrifuge equipped with a JA-14 rotor . After discarding the supernatant the cell 
pellet was re suspended in 15 ml 50mM Tris-HCl (pH7.5), lOmM EDTA, 100 
jig/ml RNase A. Cell lysis was achieved by the addition of 15 ml 0.2M NaOH, 
1% SDS followed by inversion of the container until the suspension cleared 
whereupon neutralisation was effected by the addition of 15 ml 1.32M potassium 
acetate (pH4.8). The cell lysate was centrifuged at 14,000 g for 15 minutes at room 
temperature and the supernatant filtered through four layers of muslin to remove 
denatured protein, chromosomal DNA and other cellular debris.
2.4.2 Purification of Plasmid DNA
Plasmid DNA was precipitated from the cleared cell lysate by the addition of 
0.5 volumes of iso-propyl alcohol followed by centrifugation as above. The 
supernatant was decanted and the pellet re-suspended in 2ml lOmM Tris-HCl
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(pH8.0), ImM EDTA (pH8.0) and purified by Wizard Maxiprep system (Promega 
U.K.) according to the manufacturers instructions.
2.4.3 Quantification of Plasmid DNA
Plasmid DNA concentrations were determined in each instance from the 
absorbance reading of a l/100th dilution made in d.H20 at 260 nm in a Shimadzu 
UV-1201 spectrophotometer zeroed against a d.H20 blank and calculated according 
to the following formula where an absorbance of 1 OD unit at A260 is equivalent to
50.0 |ig/ml of double stranded DNA Sambrook et al (Sam brook et al. 
1989 ).
2.5 PREPARATION OF OLIGONUCLEOTIDES
2.5.1 Purification of Oligonucleotides
Synthetic oligonucleotide primers were synthesised on an Applied 
Biosystems model 381A synthesiser using standard phosphoramidite chemistry. 
Following synthesis and deprotection, the primers were precipitated from solution 
by the addition of l/10th volume (v/v) of 3M sodium acetate (pH 5.2), 3 volumes 
(v/v) absolute ethanol, incubation at -70°C in a dry ice/methanol bath and 
centrifugation in a Jouan MR18.12 bench-top microcentrifuge at 12,000 g for 15 
minutes at 4"C. The pellet was washed by the addition of 1 ml 70% ethanol, 
centrifuged as above and air dried for 15 minutes at room temperature before re 
suspension in 30 |il d.H20
2.5.2 Quantification of Oligonucleotides
Oligonucleotide concentrations were determined from the absorbance 
reading of a l/100th dilution at 260 nm in a Shimadzu UV-1201 spectrophotometer 
and calculated according to the following formula where at an absorbance of A260, 
1 OD unit of single stranded oligonucleotide = 33.0 |ig/ml Sambrook et al 
( S a m b r o o k  e t  a l .  1 9 8 9 ) .
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2.6 SITE -SPECIFIC MUTAGENESIS
Mutagenesis was carried out by a modification of the method described by 
Ho et al (Ho et al. 1989) which is outlined in Figure 3 and Chapter 4. PCR 
conditions were as follows; in a sterile 0.5 ml Eppendorf tube was added l|ig 
template DNA, 25pmol each primer (A+C or B+D), 0.2mM each dNTP, 50mM 
KC1, lOmM Tris-HCl (pH9.0), 0.1% Triton X-100 (v/v), 1.5mM MgCl2 and 
2.5units of Taq polymerase 1 in a final volume of 50|il with a mineral oil overlay 
and subjected to the following PCR conditions; denaturation for 1' at 94°C, 
annealing for 2' at 37"C, extension for 3' at 72°C for one cycle followed by 
denaturation for 1' at 94°C, annealing for 2' at 60°C, extension for 3' at 72°C for 
30 cycles in a Techne PHC-3 thermal cycler. Following completion, reactions were 
extracted once with an equal volume chloroform to remove residual mineral oil 
before loading onto a 1.75% low melting point agarose gel and electrophoresis at 
100V constant voltage for 75 minutes in 89mM Tris-Borate, 89mM boric acid, 
2mM EDTA (pH8.0), 0.2 qg/ml ethidium bromide at 4°C. PCR products were 
visualised by ultra-violet transilluminator at 312 nm and excised with a sharp 
scapel. Small fragments (approximately 2-3 mm3) of each gel slice were combined 
in a fresh sterile 0.5 ml Eppendorf tube but in this instance the complementary 
mutagenic primers Band C were omitted in favour of the sense and anti-sense 
primers A and D only, in a final reaction volume of 100 |il before being subjected to 
the same thermal cycling conditions as described above. Upon completion of 
thermal cycling, the mutagenic PCR product was purified directly from the reaction 
by W izard  PCR P rep  sy stem  (P ro m eg a  U .K .).
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2.7 SEQUENCING OF PCR PRODUCTS AND MUTATIONS
2.7.1 Taq Cycle Sequencing Reactions
Sequencing reactions were carried out essentially by di-deoxy chain 
termination according to the method of Sanger et al (Sanger et al. 1977) 
using a Taq DyeDeoxy™ Terminator Cycle Sequencing Kit (Applied Biosystems) 
according to the manufacturers instructions. Reaction conditions were as follows; 
to a sterile 0.5 ml Eppendorf tube was added 1 pg template DNA, 3.2 pmol 
sequencing primer (SP6), 8.5 ml reaction mixture in a final volume of 20 pi. The 
samples were subjected to the following conditions in a Techne PHC-3 thermal 
cycler; denaturation for 30 seconds at 96UC, annealing for 50 seconds at 45°C, 
extension for 4' at 60°C for 30 cycles. Upon completion of thermal cycling, 
reaction volumes were increased to 100 jil by the addition of 80 pi d.H2 0  and 
extracted twice with an equal volume of phenol/FUO/chloroform (68:18:14) before 
precipitation by the addition of 1/10th volume (v/v) of 3M sodium acetate (pH 5.2), 
3 volumes (v/v) absolute ethanol and incubation at 0°C for 15 minutes, 
centrifugation at 12,000 g for 15 minutes at 4°C in a Jouan MR18.12 bench-top 
microcentrifuge. The pellets were washed by the addition of 1 ml 70% ethanol and 
centrfuged as above before drying by incubation at 85°C for 2 minutes.
2.7.2 Gel Electrophoresis of Sequencing Reactions
Pellets were re suspended in 4 pi de-ionised formamide and heated at 90°C 
for 2 minutes followd by incubation at 0°C. Samples were resolved by 
electrophoresis on a 6% acrylamide gel containing 8.3M urea run for 14 hours on 
an Applied Biosystems model 373A automated sequencer. Sequences obtained 
were analysed directly by Gene Jockey II software (Biosoft).
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2.8 COS CELL EXPRESSION OF RECOMBINANT PLASMIDS
2.8.1 Propagation and Transfection of COS cells
The SV40 transformed monkey kidney cell line COS-7 (G luzm an 
1981) was propagated in an atmosphere of 5% CO2 at 37°C in DMEM containing 
10% v/v penicillin/streptomycin (lOOunits/ml), 20mM L-glutamine and 10% v/v 
FCS. Cells were plated on 10cm plates and grown to 75% confluency before 
transfection. DNA (7|ig) was added to the cells in serum- free DMEM containing 
50mM Tris/HCl (pH 7.3), 20mM HEPES (pH7.2) and 750pg/ml DEAE-dextran. 
The plates were incubated at 37"C for 4h. After aspiration of the transfection 
medium the cells were incubated in 25% glycerol/serum free DMEM for 1' min at 
25°C. After rinsing the plates with serum-free DMEM, the cells were then cultured 
at 37°C for 48h. Cells were also subjected to the same transfection protocol but in 
the absence of DNA in order to provide a negative control.
2.8.2 Preparation of COS Cell Membrane Fractions
Transfected COS cells were grown as above. After aspiration of the growth 
medium, the plates were washed with 5 ml sterile PBS before incubation in 1.5ml 
40mM Tris/HCl (pH7.8), lOmM EDTA (pH8.0), 120mM NaCl at 25°C for 5min. 
The cells were scraped from the plate and harvested in an Eppendorf tube by 
centrifugation at 6000g for 5min at 4°C. The pellets were resuspended in 100pl 
lOmM Tris/HCl (pH7.8), 0.2mM MgCl2 (TEN) and lysed by 3 cycles of liquid 
nitrogen, 2min/37’C, 2min. The lysate was centrifuged at 350g for 5min at 4°C to 
give a PI pellet fraction and the supernatants aspirated to fresh tubes. The PI 
pellets were washed by resuspending in lOOpl 40mM Tris/HCl (pH7.8), lOmM 
EDTA (pH8.0), 120mM NaCl and centrifuging as above. Supernatants were 
pooled and re-centrifuged at 150,000g in a Beckman Airfuge for 20min to give a P2 
pellet fraction with the supernatants designated as S2. Both the low speed (PI) and
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the high speed (P2) pellets were resuspended in 25mM Tris/HCl (pH7.8), 5mM 
EDTA (pH8.0), O.lmM MgCl2, 60mM NaCl.
2.8.3 Triton X-100 Solubilization
A post nuclear supernatant of transfected COS cells was incubated at 0°C 
for 30 minutes in the presence of various concentrations of the non-ionic detergent 
Triton™ X-100. Post incubation, P2 pellet and S2 supernatant fractions were 
prepared by centrifugation at 150,000g in a Beckman Airfuge for 20 minutes and 
assayed for CAT activity. The results were plotted as percentage solubilized 
activity against total activity.
2.9 CHLORAMPHENICOL ACETYLTRANSFERASE (CAT) ASSAY
Chloramphenicol acetyl transferase (CAT) activity was monitored 
essentially by the method of Seed and Sheen (Seed and Sheen 1988). Duplicate 
samples of each fraction were assayed in O.lmM Tris/HCl (pH7.8), 0.25mM 
butyryl CoA and 0.2|iCi [14C] chloramphenicol in a final volume of 100|il by 
incubating at 37‘C for lhr. Reactions were stopped by addition of 200|il 
tetramethylpentadecaneixylene (TMPD) (2:1, v/v) and vortexing for 15secs. The 
organic and aqueous phases were separated by centrifugation at 13,000g in a 
microfuge before the upper organic phase was transferred to scintillation vials. 
After addition of scintillation fluid, the samples were then counted for 60secs in a 
LKB Wallac model 1409 liquid scintillation counter.
2.10 SUBCELLULAR FRACTIONATION
2.10.1 Sucrose Gradients
This was done by a modification of the procedure described previously 
(Shakur et al. 1993). Forty eight hours post transfection the COS-7 cells were 
harvested, resuspended in a final volume of TEN buffer and disrupted by forty
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strokes of the pestle in a Dounce homogeniser. A post nuclear supernatant was 
prepared by harvesting transfected COS cells by centrifugation at 6000g for 5 min 
at 4°C. The pellets were resuspended in 100|il lOmM Tris/HCl (pH7.8), 0.2mM 
MgCl2 and lysed by 3 cycles of liquid nitrogen, 2min/37°C, 2min. The lysate was 
centrifuged at 350g for 5min at 4°C to remove cell debris and give a post nuclear 
supernatant. This was layered on top of a non-linear 0.5 M/1.6 M sucrose step 
gradient and centrifuged at 50,000 g for 1 hr in a Beckman L8-70M ultracentrifuge 
equipped with a SW50.1 swing-out rotor. Membranes were harvested from the 
interface and solid sucrose added to yield a concentration of 1.6M. These were 
layered under a 0.6-1.6 M continuous sucrose gradient prior to centrifugation at
50,000 g for 18 hr in a Beckman L8-70M ultracentrifuge equipped with a SW50.1 
swing-out rotor. After this the gradient was separated into fractions of 180|il which 
were taken for immediate analysis of CAT and 5'- nucleotidase activity.
2.10.2 Assay for 5'-NucIeotidase Activity
This was carried out essentially according to the method of Newby et al 
(Newby et al. 1975). 5'-nucleotidase activity was determined by measuring the 
release of pH] adenosine from pH]-AMP. Essentially, 10 fil of particulate fraction 
were added to a 1.5 ml Eppendorf tube containing 200 jiM AMP previously spiked 
with 3 jiCi tritiated AMP in a final reaction volume of 1.0 ml. Samples were 
incubated at 37 "C for 15 minutes before termination by the addition of 100 }il of 
0.15M ZnSC>4 and 100 |il of 0.15M Ba (OH)2- Following centrifugation at 
12,000g for 5 minutes in a Jouan MR 18.12 bench-top microcentrifuge at room 
temperature, 500 fil of supernatant was transferred to a scintillation vial containing 
5 ml scintillation fluid. Samples were then counted on an LKB Wallac 1409 
s c i n t i l l a t i o n  c o u n t e r .
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2.11 WESTERN-BLOT ANALYSTS OF TRANSFECTED COS
CELLS
2.11.3 Assay for Protein Concentration
Protein concentration of the various cell fractions was assayed essentially by 
the method of Bradford (Bradford 1976). Briefly, protein samples were added to 
800 pi of d.H20 in a 1 ml semi-micro cuvette. 200 pi of Protein Assay Reagent 
(Bio-Rad) was added to the cuvette which was mixed by inversion. Samples were 
read at 595 nm in a Shimadzu UV1201 UV/visible spectrophotometer. Protein 
concentrations were determined by reading absorbance values against a standard 
curve of known concentrations of BSA
2.11.2 SDS-Polyacrylamide Gel Electrophoresis
Separation of proteins was carried out essentially by the method of Laemmli 
(Laemmli 1970). Briefly, 50-100 pi of sample containing 100 pg of protein was 
dissolved in an equal volume of 5M urea, 0.18M SDS, 0.38M DTT, 0.05M Tris- 
HC1 (pH8.0) containing bromophenol blue as a tracking dye. Samples were 
incubated at 100"C for 3 minutes before separation of proteins by electrophoresis 
through a 10% polyacrylamide slab gel run in 0.025M Tris-HCl, 0.19M glycine 
and 0.0035M SDS at a constant current of 45mA until the dye front reached the 
bottom of the gel.
2.11.3 Immunoblotting Analysis
Proteins were transferred to nitrocellulose membrane by incubation in 
25mM tris, 192mM glycine, 0.05% SDS, 20% methanol at 1A for 2h in a Hoeffer 
Transphor blotting system. After blocking the membrane by incubation for 2 hours 
at room temperature for 45 minutes with 5% dried skimmed milk reconstituted in 
PBS, the membrane was incubated overnight with a 1:500 dilution of a 
commercially available anti-CAT polyclonal antibody (5 Prime-3 Prime inc.) in 
PBS containing 1% dried skimmed milk, 0.2% Nonidet P40, 0.05% thimerosal.
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Proteins were detected by subsequent incubation of the blot with a 1: 200 dilution 
of a horseradish peroxidase conjugated secondary IgG antibody (SAPU) and 
visualisation by incubation in ECL reagents (Amersham) for lmin. at room 
temperature followed by exposure to either or both Hyperpaper-ECL (Amersham) 
and X-ray film.
2.12 MEMBRANE ASSOCIATION OF RD1-CAT CHIMERAS IN A 
CELL-FREE EXPRESSION SYSTEM
2.12.1 Cell-Free Expression of Recombinant plasmids in a Coupled 
Transcription/Translation System
Mature native and chimeric proteins were synthesised in an SP6 TnT ™ 
coupled transcription/translation system (Promega U.K.) according to the 
manufacturers instructions. Briefly, 1 pg of plasmid DNA was added to a sterile 
0.5 ml Eppendorf tube containing 25 pi lysate, 2 pi TnT ™ buffer, 1 pi SP6 
polymerase, 1 pi amino acid mixture minus methionine and 4 pi [35S] methionine 
(>1000Ci/mmoll) in a final volume of 50 pi. Protein synthesis was initiated by 
incubation at 30 "C for 90 minutes.
2.12.2 Membrane Association of Proteins Generated in a Cell-Free 
System
This was carried out essentially according to the method of Scotland and 
Houslay (Scotland and Houslay 1997). Post translation, duplicate lOpl aliquots 
were treated by the addition of either lOpl of TEN buffer (no added membranes) or 
lOpl of TEN containing 0.27mg/ml COS cell membranes (added membranes). 
Membranes were prepared as described above for transfected COS cells. Samples 
were incubated at 37°C for 30 minutes and then centrifuged at 150,000g in a 
Beckman Airfuge for 20 minutes. Supernatants were removed to fresh tubes and 
pellets were washed by resuspension in 20pl TEN and re-centrifuged as above. The 
supernatants were removed and pooled with those from the first centrifugation 
whereupon the pellets were finally resuspended in TEN containing 0.5% Triton X-
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100. All samples were subsequently adjusted to give equal volumes, salt and 
detergent concentrations before running on a 10% SDS-polyacrylamide gel against 
[14C] labelled molecular weight markers. Gels were visualised on a Fuji Bas 1000 
p h o s p h o r i m a g e r w i t h  M a c B a s  s o f t w a r e .
100
CHAPTER 3
Construction and Expression of a Novel Eukaryotic 
Expression Vector Used in the Study of Membrane 
Association of the PDE4 RD1
3.1 Introduction
Transfection of COS cells with the eukaryotic expression vector pSVL 
containing full-length cDNA encoding the PDE4A species RD1 (rPDE-IVAl), 
led to around 85% of the novel PDE activity found to be associated with the 
plasma membrane fraction and required low concentrations of the non-ionic 
detergent Triton X-100 to effect its release (Shakur et al. 1993). In contrast, 
transfection with a plasmid encoding a truncated PDE4A species which lacked 
the N-terminal first 25 amino acids led to the expression of novel PDE activity 
which was exclusively cytosolic. It was therefore, suggested that membrane 
association of RD1 was determined by this unique 25 amino acid N-terminal 
domain (Shakur et al. 1993). Subsequent cloning of various splice variants of 
the PDE4A gene has demonstrated that the first 23 residues of RD1 is the 
alternatively spliced region. Thus it has been suggested that the PDE4A genes 
encodes a 'core' soluble PDE to which membrane targeting may be conferred 
by virtue of the N-terminal splice region.
In order to assess whether this N-terminal splice region was indeed 
responsible for the conferment of membrane association upon a core soluble 
PDE enzyme I set out to generate chimeric species formed between the N- 
terminal region of RD1 and the soluble bacterial enzyme chloramphenicol 
acetyltransferase (CAT) in order to determine if this species would be similarly 
targeted to the plasma membrane. A eukaryotic expression vector was thus 
engineered and used as the basis for the generation of a family of plasmids 
which contained in-frame fusions between various regions of the N-terminus of 
RD 1 and the gene encoding chloramphenicol acetyltransferase (CAT) derived 
from Transposon 9 (Alton and Vapnek 1979; Gorman et al. 1982; Murry et al. 
1988; Shaw et al. 1979). CAT, which was used to successfully determine the 
mechanism of membrane association of the neuronal protein GAP-43 (Zuber et 
al. 1989) was chosen as an ideal candidate for a reporter gene because this
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bacterial gene in its native form is exclusively soluble and very stable, 
furthermore, under normal circumstances, CAT is not expressed in mammalian 
cells. Also, it has been reported that some reporter genes, for example 
dihydrofolate reductase (DHFR) can encode passenger proteins which contain 
cryptic subcellular localisation signals (Hurt and Schatz 1987; Janiak et al. 
1994).
3.2 Generation of Recombinant Plasmids Containing In-Frame 
Fusions Between Various Amino Terminal Fragments of RD1 and 
CAT
3.2.1 Construction of pGS4
Generation of the plasmid pGS4 encoding an in-frame fusion between 
the CAT gene and the first 100 amino acids of RD1 is outlined in Figure 3.1. 
The plasmid pBLCAT2 (Luckow and Schutz 1987) is a pUC18 derived 
eukaryotic expression vector which contains the CAT gene from the bacterial 
transposon Tn9, as well as the SV40 polyadenylation site. Transient 
expression of this vector in Chinese Hamster Ovary (CHO) cells is facilitated by 
the presence of the tk promoter from Herpes simplex virus (Luckow and 
Schutz 1987). This vector was used as the precursor for the generation of an 
in-frame fusion between the CAT gene and a DNA fragment encoding the first 
100 amino acids of RD1. The first 100 amino acids were chosen for this 
preliminary construct on the grounds that the first 25 amino acids of RD1 may, 
in fact, constitute part of a larger structural element responsible for membrane 
targeting whose function was disrupted by the deletion of the extreme N- 
terminal 25 amino acids.
In order to create an in-frame fusion between the N-terminal 100 amino 
acid RD1 fragment and CAT, the synthetic oligonucleotide primers 
GSOL12, 5,-GCGAGGGAATTCTAGAATGCCTCTGGTT-3,and 
GSOL15, 5'-GGCTC£TCGAGCTTCCAGTGTGT-3'
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were used in a polymerase chain reaction (PCR) synthesis using full-length 
RD1 cDNA as the template. A DNA fragment with a predicted length of 321 bp 
was observed when, post synthesis, a fraction of the reaction mix was analysed 
by electrophoresis through a 1.75% agarose gel (Figure 3.2). The primers 
GSOL12 and GSOL15 were designed to include recognition sequences 
(underlined above) for the restriction enzymes Xbal and Xhol (underlined) 
respectively and following an overnight digestion in the presence of the two 
enzymes a 307 bp DNA fragment was electrophorised through a 1.75% low 
melting point (LMP) agarose gel and purified as detailed in Materials and 
Methods (Ch. 2, section 2.6).
The parent plasmid pBLCAT2 (Luckow and Schutz 1987) was digested 
with Xbal and Xhol to release the tk promoter region. The digestion products 
were separated by electrophoresis through a 1.75% LMP agarose gel and the 
large digestion product purified as described in Materials and Methods (Ch. 2, 
section 2.6) and subsequently incubated in a ligation reaction with the 
previously digested PCR product. It was predicted from analysis of the DNA 
sequence for pBLCAT2 that successful ligation of the RD1 specific fragment 
into the plasmid would result in the loss of the unique BamHl restriction site at 
position 429 (bp) and would thus prevent linearization upon digestion with 
BamHl. That this was indeed the case is shown in figure 3.3. Plasmid DNA 
was isolated from two ampicillin resistant colonies picked at random following 
transformation of ligations into E.coli . Duplicate samples of DNA were 
incubated in the absence (Figure 3.3, lanes 1 and 3) and presence (lanes 2 and 
4) of BamHl at 37°C for 3 hours followed by electrophoresis on a 1.0% 
agarose gel. Lane 1 (Fig. 3.3 shows the presence of two bands which 
correspond to supercoiled and open-circular forms of the plasmid (lower and 
upper bands respectively) commonly purified from bacteria after several rounds 
of replication. Incubation in the presence of the restriction enzyme BamHl of a 
duplicate sample of plasmid DNA isolated from the same colony revealed the
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presence of a single band which corresponds to linearized plasmid DNA (fig. 
3.3, lane 2). This shift from one molecular species to another is dependent on 
the presence of a BamHl site found only in the wild-type plasmid therefore 
indicating that this was pBLCAT2 and as such contained no insert DNA. 
Incubation of plasmid DNA isolated from the second colony revealed the 
presence of supercoiled and open-circular forms of the plasmid when incubation 
was carried out either in the absence (Fig. 3.3, lane 3) or presence of BamHl 
(Fig. 3.3, lane 4) which could only occur upon successful ligation of an insert 
between the Xbal and Xhol sites of the parent plasmid. Further confirmation 
of the presence of an insert and thus successful generation of an in-frame fusion 
between the first 100 amino acids of RD1 and CAT was obtained by Taq cycle 
sequencing. The construct was named pGS4.
3.2.2 Construction of the Eukaryotic Expression Vector pGS7
The plasmid vector pGS4 was generated to create an in-frame fusion 
between the first 100 amino acids of RD1 linked to the N-terminus of the 
bacterial enzyme CAT, in order to investigate the role of the N-terminal region 
of RD1 in determining membrane targeting. Previous work (Shakur et al. 
1993) analysing the expression of full-length RD in COS cells was done by 
transient transfection in a pSVL plasmid (Pharmacia Biotech) with expression 
under the control of an SV40 promoter. In order to achieve transient expression 
in COS cells a fragment of DNA containing the SV40 early promoter (Figure 
3.1) was incorporated into the plasmid pGS4 encoding the 1-100RD1-CAT 
chimera.
The plasmid pSV.SPORT used as a source of the SV40 early promoter 
is a eukaryotic expression vector capable of transiently expressing cloned genes 
in COS cells. Sequential digestion of pSV.SPORT by the restriction enzymes 
Xbal and Clal resulted in the release of a 433bp DNA fragment (Figure 3.4) 
which contained not only the SV40 early promoter but also the bacterial SP6 
promoter which was selected to allow expression of chimeric species in a cell-
104
free coupled transcription/translation system. In order to facilitate subcloning of 
this fragment into pGS4 the plasmid was first digested sequentially by the 
restriction enzymes Xbal and Narl (which generated a complementary sticky 
end to Clal) to release a 172bp 'stuffer' fragment under conditions described in 
materials and methods. The 4452bp digestion product of these reactions was 
gel purified to remove the 172bp fragment and thus prevent recircularization 
upon subsequent ligation. Both Clal and Narl sites were lost upon ligation of 
the two fragments to generate pGS7 (Fig. 3.1). The successful generation of 
this construct was confirmed by the release of a 500bp DNA fragment upon 
digestion the plasmid DNA with the restriction enzymes Ndel and Xbal 
(Figure 3.5, lane 4). By contrast, plasmids devoid of the SV40/SP6 promoter 
fragment release a 300 bp fragment upon incubation with Ndel and Xbal 
(Figure 3.5, lanes 2,6 and 10).
3.2.3 Generation of pGS8
In order to assess the effect of fusing N-terminal fragments of RD1 to 
CAT upon membrane localisation it was necessary to generate a control plasmid 
which expressed native CAT only. This was achieved by digestion of pGS7 
with the restriction enzymes Sail and Xhol to release a 330bp fragment 
containing the RD1 specific sequence. Following gel purification, the 4.54kb 
digestion product was recircularized by ligation due to the complementary 
nature of the sticky ends generated by S a il  and X h o l.  Following 
transformation and DNA purification the successful generation of pGS8 was 
confirmed by failure to linearise plasmid DNA by digestion with Xhol.
3.2.4 Generation of pG Sll
As had been previously demonstrated (Shakur et al. 1993) full-length 
RD 1 was observed to be predominantly membrane associated when expressed 
in COS cells. In contrast a construct where the extreme N-terminal 25 amino 
acids had been deleted (met26 RD1) was entirely cytosolic when expressed in 
COS cells (Shakur et al. 1993). The plasmid pGSll was designed to generate
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an RD1-CAT chimera which was analogous to met26RDl. A 241bp DNA 
fragment encoding amino acids 26-100RDlwas generated by PCR using the 
primer
GSOL24, 5'- GCTTATCTAGAATGCTGAACCGTGAGCTC-3' when paired 
with the primer GSOL15 used in the generation previously of pGS7. This 
fragment was digested with the restriction enzymes Xbal and X hol, gel 
purified (figure 3.6), and substituted for the 'wild-type' 1-100RD1 fragment in 
pGS7. Following purification of plasmid DNA from overnight cultures, Taq 
cycle sequencing confirmed the generation of the construct.
3.2.5 Generation of pGS13
Shakur et al (Shakur et al. 1993) have previously suggested that the 
membrane targeting of RD1 is a function of information contained within its 
extreme N-terminus. In order to test the hypothesis, primers 
GSOL12, 5'-GCGAGGGAATTCTAGAATGCCTCTGGTT-3' and 
GSOL13, GCATATCTCGAGCGCCTTTTGAACTGGT-3' 
were used to generate a 79bp DNA fragment encoding amino acid residues 1-25 
Of RD1 which used full-length RD1 as a template (Figure 3.7). Following 
digestion by the restriction enzymes Xbal and Xhol, the fragment was purified 
by electrophoresis through a 1.75% LMP agarose gel and substituted for the 1- 
100 amino acid RD1 fragment in the plasmid pGS7 to generate a 1-25 amino 
acid RD1-CAT fusion. Confirmation of the successful generation of this 
construct was obtained by sequencing miniprep DNA purified from overnight 
cultures.
3.3 Expression of pGS7. pGS8. pG Sll and pGS13 in COS Cells
3.3.1 Assay of CAT Activity
Plasmids pGS7, pGS8, pGSll and pGS13 encoding 1-100RD1-CAT, 
native CAT, 26-100RD1-CAT and 1-25RD1-CAT respectively were transiently 
expressed upon transfection in COS-7 cells by the DEAE-dextran method. 48
106
hours post transfection, cells were harvested and assayed for CAT activity as 
described in materials and methods. The results of these experiments are given 
in Table 3.1 .
In typical transfection experiments CAT activity of the order of 1-10U 
per pi cell homogenate (1.5-2.0 c.p.m.xlO-4; range n= 5 separate transfections) 
was observed. For native CAT, expressed using the plasmid pGS8, the 
majority of CAT activity was clearly found in the high speed supernatant, 
cytosol fraction (Table 3.1). This is consistent with data reported by Seed & 
Sheen (Seed and Sheen 1988) using a different CAT plasmid. In marked 
contrast to this, when COS cells were transfected with the plasmid pGS7, to 
produce the chimera 1-100RD1-CAT, then a profound shift in the distribution 
of activity was seen such that the major fraction of CAT activity now occurred 
in the membrane fraction (Table 3.1). This distribution reflects that of RD1 
where, in various transfection experiments, around 85% of this enzyme was 
found to be membrane associated (Shakur et al. 1993). However, transfection 
of COS cells with the plasmid pGSl 1, which encoded the chimera 26-100RD1- 
CAT, demonstrated that the distribution of CAT activity now paralleled that of 
native CAT itself with CAT activity now predominately in the cytosol fraction 
(table 3.1). Such data indicates that fusion of the N-terminal 100 amino acids 
of RD1 to CAT can confer membrane association on a normally soluble 
enzyme, in this instance the bacterial protein CAT. In marked contrast to this 
26-100RD1-CAT demonstrated an identical distribution to soluble native CAT. 
The chimeric species 1-25RD1-CAT was also expressed transiently in COS 
cells transfected with the plasmid pGS13. Analysis of CAT activity showed, as 
with 1-100RD1-CAT, a marked increase in membrane association when 
compared to experiments done using either native CAT or the 26-100RD1-CAT 
chimera (Table 3.1). However, from these analyses where distribution was 
assessed using CAT activity, this 25 amino acid segment of RD1 appeared to be 
less efficient in conferring membrane association on CAT than was seen for the
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longer extension found in the 1-100RD1-CAT chimera (Table 3.1).This is 
consistent with previous studies (Shakur et al. 1993) done on the analogous 
truncation for RD1 (met26RDl) and also shows that merely generating a 
chimeric CAT does not lead to membrane association. Such experiments are 
entirely consistent with the notion that the first 25 amino acids of RD1 appears 
to provide the information necessary for conferring membrane association on a 
soluble protein.
3.3.2 Triton X-100 Solubilization of pGS7 Transfected COS 
Cells
COS cells transfected with pGS7 expressing the 1-100RD1-CAT 
chimera were harvested and a high-speed pellet (P2) fraction isolated from the 
post nuclear supernatant as described previously Samples of the P2 pellet were 
incubated on ice in the presence of either 0.05%, 0.1%, 0.2%, 0.5% or 1.0% 
Triton X-100 for 30 minutes followed by centrifugation at 150,000g for 20 
minutes to separate membrane pellet and supernatant fractions. Duplicate 
samples of each fraction were assayed for CAT activity and compared to a 
sample incubated in the absence of Triton X-100. The results were plotted as 
the percentage of Triton solubilized CAT activity against [Triton X-100]. 
Figure 3.8 represents the data typical of experiments done three times using 
membranes from three separate transfections. The results of these experiments 
demonstrate that the 1-100RD1-CAT chimera can be stripped from COS cell 
membranes by incubation in the presence of the non-ionic detergent Triton X- 
100. Indeed, in this respect, the chimeric form appears to behave in an 
analogous fashion to full-length RD1 subjected to the same treatment with 
Triton X-100 (Shakur et al. 1993; Shakur et al. 1995). 1-100RD1-CAT 
demonstrated that a release of membrane associated CAT activity of -40% when 
incubated with 0.1% Triton X-100 and that increasing the detergent 
concentration to 1.0% resulted in a loss of >80% of the membrane associated 
CAT activity. The dose-dependent solubilization of this chimeric species by
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Triton X-100 closely followed the detergent release of native RD1 from 
cerebellum derived membranes (Shakur et al. 1995) and was similar to that seen 
for the solubilization of RD1 from transfected COS cells. Approximately 20% 
of CAT activity remained in the pellet fraction after incubation in the presence of 
2.0% detergent. This might indicate that a fraction of 1-100RD 1-CAT, like 
full-length RD1 observed in brain is associated with detergent-insoluble 
membrane remnants, which could include associated cytoskeletal components. 
Nevertheless, that the non-ionic detergent Triton-X-100 can release the majority 
from membranes suggests that the association is hydrophobic in nature.
This hypothesis was given further credence by the observation made 
previously my Shakur et al (Shakur et al. 1993) that 2M NaCl could not remove 
the 1-100RD1-CAT chimera from membranes thereby suggesting that 
electrostatic interactions were not important in localisation of this chimeric 
protein.
3.3.3 Subcellular Fractionation of COS Cells Expressing 
Chimeras
Experiments were done so as to assess whether RD1-CAT chimeras 
showed a similar subcellular distribution to full-length RD1 in transfected COS 
cells. To do this, COS cells were grown to -75% confluency on 24.5cm x 
24.5cm tissue culture plates and then transfected by essentially the same method 
as used for the 10cm plates as described previously. Forty eight hours post 
transfection the COS-7 cells were harvested, resuspended in a 1 ml final volume 
of TEN buffer and disrupted by forty strokes of the pestle in a Dounce 
homogeniser. A post nuclear supernatant was prepared as described previously 
(Shakur et al. 1993). This was layered on top of a non-linear 0.5 M/1.6 M 
sucrose step gradient and centrifuged at 50,000gav for 1 hr. Membranes were 
harvested from the interface and solid sucrose added to yield a concentration of 
1.6M. These were layered under a 0.6-1.6 M continuous sucrose gradient 
prior to centrifugation at 50,000g for 18 hr. After this the gradient was
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separated into fractions of 180|il which were taken for immediate analysis of 
CAT activity and the plasma membrane marker enzyme 5'- nucleotidase.
The result of such an experiment is shown in Figure 3.9. Two peaks of 
CAT activity were identified, a small peak was detected in the fractions 
corresponding to 0.6M-0.8M, sucrose and a larger peak of activity was 
observed in that fraction of the gradient corresponding to 1.06M sucrose 
(Figure 3.9). The small peak of CAT activity was located at the top of the 
gradient, whereas the larger peak was detected in an area of the gradient 
corresponding to the plasma membrane. That this fraction did indeed contain 
plasma membranes was confirmed by assaying for the presence of the plasma 
membrane marker enzyme 5'- nucleotidase. As can be seen from Figure 3.9, 
5'- nucleotidase activity was detected in the sucrose gradient, moreover, this 
activity was concentrated in a single peak which co-migrated through the 
gradient at the same position as the major peak of CAT activity. This 
demonstrates that the chimeric 1-100RD1-CAT was indeed associated with the 
plasma membrane when expressed in COS cells as found for native RD1 
(Shakur et al. 1993)
3.3.4 Western-Blot Analysis of Chimeras Expressed in COS Cells
In order to gain an independent assessment of the distribution of CAT 
and the various chimeras between the cytosol and membrane fractions, Western 
blotting experiments were carried out. COS cells were transfected with either 
pGS7, pGS8, pGSl 1 or pGS13 and then harvested 48 hours post-transfection. 
Pellet and high speed supernatant fractions were prepared and proteins were 
resolved by SDS-polyacrylamide gel electrophoresis. These were subsequently 
transferred to nitro-cellulose membrane by means of electrophoretic elution 
essentially according to the methodology of Harlow and Lane (Harlowe and 
Lane 1988). Following blocking, blots were then probed with a commercially 
available polyclonal rabbit anti-CAT first antibody (5-Prime 3-Prime). These 
were then challenged with an HRP conjugated goat anti-rabbit second antibody
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and developed by the ECL western blotting method (Amersham). The result of 
a typical experiment is shown in Figure 3.10. Lanes 1-2 represent cells 
transfected by pGS8, lanes 3-4 pGS7, lanes 5-6 pGSll and lanes 7-8 pGS13 
corresponding to cells expressing native CAT, 1-100RD-CAT, 26-100RD-CAT 
and 1-25RD-CAT respectively. Lanes 1,3,5 and 7 represent pellet fractions 
whereas lanes 2,4,6 and 8 contain the high-speed supernatants. In the cells 
transfected with pGS8 the presence of an immunoreactive species of ~26kDa 
was observed which corresponds to the size expected for native CAT. It was 
found predominantly, (85-91%, range; n=3 separate experiments) in the 
supernatant fraction. This indicated that CAT was expressed essentially as a 
soluble protein when transiently transfected into COS cells . Lanes 3 and 4 
(Fig. 3.10) correspond to the pellet and supernatant fractions of cells transfected 
with pGS7 encoding 1-100RD-CAT, however use of this antibody failed to 
detect any immunoreactive species despite the ability to detect CAT 
enzymatically. A similar observation was made on cells expressing the 26- 
100RD-CAT chimera where, again, no significant immunoreactive species was 
noted in either pellet or supernatant (Figure 3.10, lanes 5 &6). Failure to detect 
chimeras between CAT and either the 1-100 amino acid or the 26-100 amino 
acid RD1 fragments might occur as a result of a conformational change upon 
folding of the chimeric protein which prevented the antibody, which was raised 
against the N-terminus of CAT, recognising the CAT moeity. In marked 
contrast, using cells transfected so as to express the 1-25RD-CAT, two major 
protein species of ~30kDa and ~26kDa were detected. Whilst the ~30kDa 
component is of the size predicted for the chimera 1-25RD1-CAT, the species at 
~26kDa is as expected for native CAT. This suggests that both the 1-25RD1- 
CAT chimera and native CAT were simultaneously expressed in COS cells 
transfected with this plasmid. Consistent with the ~26kDa band being native 
CAT, it was observed that it migrated identically to the single species found in 
COS cells transfected with pGS8 and was primarily associated with the cytosol
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fraction (Figure 3.10, lane 8). In profound contrast to this, it was observed 
that the ~30kDa band (fig. 3.10; lane 7), corresponding to 1-25RD1-CAT, was 
exclusively associated with the membrane fraction. This is entirely consistent 
with fusion of the N-terminal 25 amino acid splice region of RD1 being able to 
confer membrane association on CAT and, therefore, by inference, upon the 
'core' PDE4A protein as observed with RD1.
3.3.5 Cell-Free Expression of RD1-CAT Chimeras
To determine whether chimeras of 1-100RD-CAT and 1-25RD-CAT 
would be capable of subsequently associating with membranes in the absence of 
any mechanism for post translational modification, a cell-free, coupled 
transcription/translation system was utilised to generate mature chimeric 
proteins. The advantage of using a coupled system lies in the fact that plasmid 
DNA is used as a template for protein production which circumvents the need to 
generate RNA transcripts to programme a separate translation reaction. 
Plasmids were subjected to the reaction conditions as described in materials and 
methods, protein products were resolved by SDS-PAGE and subsequently 
visualised by autoradiography.
Fig. 3.11 shows a typical experiment where, in lane 1, the plasmid 
pGS8 containing the native CAT gene was used. This produced a single 
species of ~26kDa, corresponding to that expected for native CAT (25.5kDa; 
(Seed and Sheen 1988)). Subsequent incubation of this product with COS cell 
membranes, followed by separation of pellet (Fig. 3.11; lane 2) and supernatant 
(Fig. 3.11; lane 3) fractions, failed to show any membrane association of native 
CAT. When the plasmid pGS7 was expressed in the in vitro system, then 
three predominant bands were observed of ~38kDa, ~35kDa and ~33kDa (Fig. 
3.11, lane 4). These are of the calculated sizes for initiation events occurring 
not only at the first Met start codon (38.6kDa) but also at M et26 (35.5kDa) and 
Met^7 (34.2kDa) which provide the next two available met residues. Initiation 
at these three sites would be expected to yield the full length 1-100RD1-CAT
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chimera together with 26-100RD1-CAT and 37-100RD-CAT. Additionally, 
several other minor bands were noted which might reflect other initiation events 
in the reaction (Fig. 3.11, lane 4). Using such a mixture of mature chimeric 
CAT species formed in this synthetic system, it was noted that only the largest 
chimera, presumably 1-100RD 1-CAT became membrane associated (Fig. 3.11, 
lane 5) and thus depleted from the soluble fraction (fig. 3.11, lane 6). In 
marked contrast to this, the intensity of the ~35kDa and ~33kDa bands (Fig.
3.11 lanes 4 and 6), due to 26-100RD1-CAT and 37-100RD 1-CAT, 
respectively, remained identical in both the initial synthesis mix and the 
supernatant fraction from membrane incubation. Thus these, presumably, N- 
terminally truncated species showed no evidence for membrane association. In 
confirmation that these two truncated species did not associate with membranes, 
the plasmid pG Sll was used, which not only produced in this system a 
~35kDa species reflecting 26-100RD-CAT but also a ~33kDa species that was 
presumed to be the chimera 37-100RD 1-CAT, and also native CAT itself at 
~26kDa (Fig. 3.11, lane 7). None of these species became associated with the 
membrane fraction (Fig. 3.11, lane 8) with both remaining exclusively in the 
supernatant fraction (Fig. 3.11; lane 9). The failure of both the 26-100RD1- 
CAT chimera and the 37-100RD1-CAT chimera to become membrane 
associated also indicates that merely adding additional amino acid residues to the 
N-terminus of CAT does not confer upon this protein the ability to become 
membrane associated. Such species also act as internal 'book-keeping' controls 
showing that these species are entirely recovered in cytosol whereas 1-100RD1- 
CAT associates with membranes.
Using the plasmid pGS13, which encodes a chimera formed from the first 25 
amino acids of RD1 fused to CAT, two major bands were observed. These 
were a species of ~30kDa, which would be predicted to reflect the chimera 1- 
25RD1-CAT, and a further band of ~26kDa, which would be predicted to be 
native CAT, as the next available Met codon would be expected to produce this
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(Fig.3.11, lane 10). Lane 11 (Fig. 3.11) shows that only the 1-25RD1-CAT 
chimera became associated with the membrane pellet fraction and depleted in the 
soluble fraction (Fig. 3.11, lane 12) whereas the presumed native CAT species 
remained exclusively in the soluble fraction (Fig. 3.11, lane 12).
Multiple translation can occur in the combined transcription/translation 
system (Kozak 1986; Promega 1993) and it is believed that such an event 
provides the most plausible explanation for the production of multiple products 
by this system. Certainly the species observed upon SDS-PAGE migrate with 
sizes consistent with the start of translation occurring at the indicated methionine 
residues. This is exemplified by, for example, the observed co-migration of the 
first product (Fig. 3.11; track 7) from the plasmid pGSl 1, namely 26-100RD1- 
CAT, with the second product (Fig. 3.11, track 4) from the 1-100RD1-CAT 
containing plasmid pGS7, which would be predicted to produce 26-100RD1- 
CAT due to a second start occurring at met26. Indeed, analysis of the 
nucleotide sequence surrounding these methionine residues indicates that they 
do in fact provide sub-optimal Kozak sequences (Kozak 1986). Thus, for the 
initiation of translation, Kozak (Kozak 1986) has identified an optimal sequence 
of ACCATGG, with sub optimal sequences being those with a purine at 
position -3 to the ATG codon. From inspection of the sequence of the RD1 
fragment in pGS7 it was noted that the initiating methionine was located within 
a region which obeys the consensus for a sub-optimal Kozak sequence 
AGAATGC (Kozak 1986). However, sub-optimal Kozak sequences (Kozak 
1986) are also evident at both Met26 (AGGATGC) and at Met37 
(GAAATGA)which would be expected to heighten the chances of occurrence of 
translation products occurring at these points in the in vitro 
transcription/translation system used here. Additionally, it may also explain 
why multiple species were seen in the COS cell expression studies using the 
RD1-CAT chimera (see Fig. 3.10). For example, analysis of the products of 
the plasmid pGS13, showed that in both COS cells (Fig. 3.10) and the in vitro
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transcription/translation system (Fig. 3.11, track 10), two products were 
observed, namely the 1-25RD1-CAT chimera and also native CAT.
It is thought extremely unlikely that the presence of multiple bands 
observed in this system are generated as a result of proteolysis. However, in 
order to try and address the question of possible proteolysis various strategies 
were employed. These included employing a cocktail of protease inhibitors, 
used routinely when isolating PDEs isoforms [see for example (Shakur et al. 
1993)] in the reaction using the plasmid pGS7. However, these compounds 
prevented product formation by the in vitro transcription/translation system 
(data not shown). In contrast, addition of soybean trypsin inhibitor, at 
concentrations of up to 1 mg/ml, allowed for a pattern of product formation (data 
not shown) which was identical to that seen in its absence (Fig. 3.11 track 4). 
However, as the targets for action of trypsin inhibitor are proscribed this 
observation cannot be used to eliminate protease action. If, however, the 
smaller species found using, for example, the plasmid pGS7 were due to 
proteolysis then a time course of the production of these species might be 
expected to follow a product precursor relationship, with 1-100RD1-CAT being 
produced initially. In contrast, it was observed (Fig. 3.12) that the time course 
of production of the three products examined showed great similarity in both the 
rate of production and the time at which a maximum yield was produced. 
Routinely, analyses were performed after reactions were incubated for 90min 
(see Methods). However, here it was noted (Fig. 3.12) that the absolute levels 
and the proportions of all three products reached maximal expression 70 
minutes after incubation and these levels remained stable even after some 
240min. Additionally, it is evident that the addition of the crude membrane 
fraction did not alter the relative proportions of the species produced in the in 
vitro transcription/translation system. For example, the relative amounts of 
three products of plasmid pG Sll, presumed to be 26-100RD1-CAT, 
37-100RD1-CAT and CAT itself appear identical upon analysis of both the
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products of the in vitro transcription/translation system (Fig. 3.11, track 7) and 
also in the supernatant fraction after incubation with membranes (Fig. 3.11, 
track 9).
It is believed that such time course data, together with the observations that 
met26 and met37 in RD1 provide sub-optimal Kozak sequences (Kozak 1986) 
and that the in vitro transcription/translation system is susceptible to multiple 
initiation events (Kozak 1986; Promega 1993), make multiple initiation the most 
probable explanation for the multiple products produced by the in vitro 
transcription/translation system in this study (Fig. 3.11). Moreover, it is 
possible to exploit this promiscuity to provide internal controls given that when 
presented with a mixture of protein products transcribed from the same gene, 
only those species possessing the unique N-terminal splice region will associate 
with membranes.
3.4 Conclusions
In summary, a eukaryotic expression vector was constructed to allow 
investigation of the role of the unique N-terminal splice domain of the PDE4A 
RD1 in determination of membrane association by creating in-frame fusions 
between various regions of RD1 and the N-terminus of the soluble bacterial 
enzyme chloramphenicol acetyltransferase (CAT). Expression of these 
plasmids in COS cells demonstrated chimeric proteins containing the unique N- 
terminal splice region of RD1 could be detected enzymatically and by 
immunoblotting in the membrane fraction whilst native CAT was exclusively 
cytosolic. Furthermore, expression of those same plasmids in a cell-free 
expression system demonstrated that it was possible to generate mature chimeric 
proteins which would associate with added membranes.
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Figure 3.2. Generation of a PCR Fragment encoding the 
N-terminal 1-100 Amino Acids of RD1.
A 321bp DNA fragment was successfully generated by PCR using 
synthetic oligonucleotide primers and the plasmid pSVL-RDl (Shakur et al. 
1993) as a template. pSVL-RDl contains a DNA insert encoding the open 
reading frame (ORF) corresponding to the PDE4A isoform RD1 (Davis et al. 
1989).
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Figure 3.3: Generation of the 1-100RD1-CAT Fusion Plasmid
pGS4.
Cloning of a PCR fragment encoding the N-terminal 100 amino acids of 
RD1 into the plasmid pBLCAT2 (Luckow and Schultz. 1987) resulted in the 
loss of the unique BamHl restriction enzyme recognition site. Lanes 1 & 2 
correspond to native pBLCAT2 digested in the absence (lane 1) and presence 
(lane 2) of B am H l. The appearance of a single band in lane 2 denotes the 
presence of the recognition site for this enzyme. In contrast, digestion of pGS4 
with BamHl (lanes 3 &4) shows no difference when the plasmid was incubated 
in the absence (lane 3) of presence (lane 4) of the enzyme thus indicating the loss 
of the BamHl site.
1 2  3 4
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Figure 3.4: Generation of a DNA Fragment Containing the SV40 
Early Promoter.
The plasmid pSV.SPORTl (Life Technologies Ltd, UK) was digested 
with the restriction enzymes Clal and Xbal according to the manufacturers 
instructions. The resultant 433bp DNA fragment, which contained the SV40 
early promoter and SP6 bacterial promoter, was isolated by agarose gel 
electrophoresis as described in Methods (section 2.6). A 564bp band generated 
by digestion of bacteriophage O XI74 DNA with the restriction enzyme Haelll 
is also shown.

Figure 3.5: Generation of the Eukaryotic Expression Vector 
pGS7.
Plasmid DNA was isolated from five colonies and incubated in the 
absence (lanes 1,3,5,7 & 9) and presence (lanes 2,4,6,8 & 10) of the restriction 
enzymes Ndel and Xbal. Lane 4 shows the presence of the 500bp DNA 
fragment predicted upon digestion of pGS7 with Ndel and Xbal. Lanes 2, 6 
and 10 show a 300bp fragment predicted to occur upon incubation of pGS4 with 
the same enzymes. The 2.3kb, 2.0kb and 0.5kb fragments of bacteriophage 
^DNA digested with the restriction enzyme Hindlll were used as molecular 
weight markers. This gel was overexposed to allow visualization of the 300bp 
and 500bp digestion products.
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Figure 3.6: Generation of a PCR Fragment Corresponding to 
Amino Acids 26-100 of RD1.
This figure shows the successful generation of a 241 bp PCR fragment 
generated when synthetic oligonucleotide primers designed to correspond to 
amino acids 26-100 of RD1 were used in a PCR reaction utilizing the plasmid 
pSVL-RDl (Shakur et al. 1993) as a template.
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Figure 3.7: Generation of a PCR Fragment Corresponding to 
Amino Acids 1-25 of RD1.
This figure shows the successful generation of a 79bp PCR fragment 
generated when synthetic oligonucleotide primers designed to correspond to 
amino acids 1-25 of RD1 were used in a PCR reaction utilizing the plasmid 
pSVL-RDl (Shakur et al. 1993) as a template. Haelll digested bacteriophage O 
X I74 DNA is shown as molecular standards.
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Table 3.1. Distribution of CAT activity in Native- and
Chimeric- CAT Transfected COS Cells.
COS cells were transfected with the indicated plasmid and then, after 48h, 
membrane and high speed supernatant fractions isolated as described in 
Methods. All CAT assays were performed in duplicate as described in the 
Methods section. The distribution between the membrane (pellet) and cytosol 
(high speed supernatant) fractions are given as percentages. This data provides 
the mean of three separate transfection experiments done on different occasions 
with errors as SEM. No CAT activity was evident in COS cells which were 
mock transfected with either the plasmids pSVL or pSPORT.
plasmid Construct Membrane (%) Cytosol(%)
pGS8 CAT 13 ± 2 87 ± 2
pGS7 1-100RD CAT 64 ± 3  36 ± 3
pG Sll 26-100RD CAT 17 ± 2 83 ± 2
pGS13 1-25RD CAT 51 ± 3  49 ± 3
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Figure 3.8: The Effect of Triton X-100 Concentration on 
Membrane Association of 1-100RD1-CAT
COS cells were transfected with pGS7 to express the chimera 1- 
100RD1-CAT. Following transfection, membranes were prepared and replicate 
samples incubated at 0°C for 30 minutes with varying concentrations of the 
non-ionic detergent Triton X-100 as indicated. High-speed pellet and 
supernatant fractions were prepared by centrifugation at 100,000g for 30 
minutes. CAT activity was determined as reported in Methods (section 2.9). 
Results are given as percentage CAT activity in the membrane fraction versus 
detergent concentration. The data shown are typical of one experiment done 
three times using membranes from separate transfection experiments.
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Figure 3.9: Subcellular Distribution of CAT Activity in COS cells
Transfected with pGS13
COS cells were transfected with pGS13 to express the chimera 1- 
25RD1-CAT as described in Methods (section 2.8.1). Following transfection, 
a post-nuclear membrane preparation was subjected to centrifugation on a 
continuous sucrose density gradient (0.5M-1.6M) as described in Methods 
(section 2.10.1). Fractions were taken and assayed for CAT activity and 5'- 
nucleotidase activity as described (Methods, sections 2.9 and 2.10.2 
respectively). Results are given as percentage enzyme activity versus sucrose 
concentration. These data are tyipical of one experiment done twice with 
membranes from separate transfections.
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Figure 3.10: Western Blot Analysis of COS Cells Transfected
with RD1-CAT Chimeric Plasmids.
COS cells were transfected with pGS8 (lanes 1 & 2), pGS7 (lanes 3 & 
4), pG Sll (lanes 5 &6) or pGS13 (lanes 7 &8) as described in Methods 
(section 2.8.1). High-speed supernatant and pellet fractions were 
electrophoresed on denaturing acrylamide gels (Methods, section 2.11.2) prior 
to transfer to nitrocellulose as described (Methods, section 2.11.3). 
Membranes were probed with an anti-CAT polyclonal antibody (5'-Prime 3'- 
Prime) before visualization by enhanced chemiluminescence. Lanes 1,3,5 and7 
represent pellet fractions whereas lanes 2,4,6 & 8 correspond to supernatant 
fractions. These results are typical of one experiment repeated three times.
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Figure 3.11: Cell-Free Expression of RD1-CAT Chimeras.
Plasmids encoding various RD1-CAT chimeras were used to prime a 
coupled transcription/translation system to produce mature chimeric CAT 
species in an in vitro system. This was done in the presence of 35S-methionine 
to produce radioactive products as described (Methods, section 2.12). 
Following transcription/translation duplicate samples were incubated in the 
absence and presence of COS membranes. After incubation a high speed 
supernatant (soluble) fraction and a membrane fraction were isolated. These 
two fractions, and that of the original product of the transcription/translation 
reaction, were subjected to SDS-PAGE. Identification of the radioactive 
species was done using a phosphorimager. All fractions were normalized for 
volume and concentration. Lanes 1-3 represent native CAT provided by the 
plasmid pGS8; lanes 4-6 represent 1-100RD1-CAT provided by the plasmid 
pGS7; lanes 7-9 represent 26-100RD1-CAT provided by the plasmid pGSll; 
lanes 10-12 represent 1-25RD1-CAT provided by the plasmid pGS13. The 
lanes are in sets of three, where the first track shows the original products of the 
transcription/translation reaction, the second the membrane (high speed pellet) 
fraction and the third the soluble (high speed supernatant) fraction. Thus lanes 
1, 4, 7 &10 show the original material emanating from the 
transcription/translation experiment; lanes 2, 5, 8 & 11 the high speed pellets 
after incubation in the presence of COS membranes and lanes 3, 6, 9 & 12 the 
high speed supernatants obtained after centrifugation of the incubation mixture 
done in the presence of COS membranes. The size of the chimeric proteins are 
indicated in kilodaltons These data are typical of an experiment done three 
times.
1 2 3 4 5 6 7 8 9 10 11 12
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Figure 3.12: Time Course of Cell-Free Expression of RD1-CAT
Chimeras.
Transcription/translation reactions were performed for the various 
indicated times using the plasmid pGS7 (1-100RD1-CAT) as a template. After 
the designated time, aliquots of the reaction mixture were immediately boiled in 
Laemmli sample buffer. These were then subjected to SDS-PAGE and the 
radioactive species identified using a phosphorimager. Gel lanes were loaded 
such that equal amounts of the transcription/translation reaction mixture were 
analysed. Shown are levels of radioactive associated with the three 
predominant bands which were observed (see fig. 3.11; lane 4). These species 
were at ~38kDa (B), presumed to be 1-100RD1-CAT, ~35kDa (E), presumed 
to be 26-100RD1-CAT and ~33kDa, presumed to be 37-100RD1-CAT (H). 
These data are typical of an experiment done twice.
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CHAPTER 4
Determination of the Role of N-Terminal Cysteine 
Residues in the Membrane Association of RD1
4.1 Introduction
Previous studies have shown that upon transient transfection of the 
cDNA encoding the type 4A cyclic AMP specific phosphodiesterase RD1 
(RNPDE4A1) in COS cells the major fraction of activity is found associated 
with the plasma membrane (Shakur et al. 1993). Furthermore, imunoblotting 
studies have detected that in vivo , RD1 is the only PDE4A species expressed 
in rat brain cerebellum (McPhee et al. 1995; Shakur et al. 1995) 
where it was found associated with synaptosomal membranes. In contrast 
met26RDl created by engineered deletion of the extreme N-terminal 25 amino 
acid splice region of RD1 and which forms a 'core' enzyme comon to all type 
4A PDEs was detected exclusively in the cytosolic fraction of transfected COS 
cells. Furthermore, met26RDl was also observed to display increased activity 
and decreased thermostablity when compared to full-length RD1. This has led 
to the suggestion that this unique N-terminal 25 amino acid region may be 
implicated in the subcellular localization of RD1 and play some role in 
regulation of the enzyme possibly through interaction with another protein or 
lipid membrane component (Shakur et al. 1993).
I have demonstrated that an in-frame fusion of the unique N-terminal 25 
amino acids of RD1 to the reporter gene CAT will result in targeting of this 
normally soluble enzyme to plasma membranes when expressed in COS cells 
(Scotland and Houslay 1995). However, the mechanism by which this 
interaction occurs remains to be determined. One method of targeting of 
proteins to the plasma membrane involves acylation which involves the covalent 
attachment of one or more fatty acid molecules at sites located within either the 
N- or C- terminus of the protein. The addition of lipids to proteins has been 
well documented (Chapman et al. 1992; Gaudin et al. 1991; Grand 1989; 
O'Brien and Zatz 1984; Okubo et al. 1991; Perez et al. 1991; Schlesinger et al. 
1980; Soly and Meighen 1991; Spiegel et al. 1991b) and normally occurs
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through one of two mutually exclusive pathways involving palmitic acid or 
myristic acid. Myristoylation which has been observed for numerous proteins 
including G protein a  subunits (Linder et al. 1991; Spiegel et al. 1991a; 
Wildman et al. 1993) and ADP-ribosylation factor (Haun et al. 1993; Kahn et 
al. 1992) where it is linked through an amide bond to a highly conserved amino 
terminal glycine residue (Han and Martinage 1992; Linder et al. 1991; Spiegel et 
al. 1991a). Analysis of the amino acid sequence of RD1 revealed the presence 
of a proline at position 2 rather than the required glycine so it was therefore 
deemed unlikely that myristoylation was the mechanism by which the 
subcellular localization of RD1 was determined. Palmitoylation is a 
modification which has also been observed for many proteins (Beranger et al. 
1991; Glomset et al. 1990; Hancock et al. 1989; Kloc et al. 1991; Leevers et al. 
1994; O'Dowd et al. 1989; Okubo et al. 1991). Such modified proteins 
containing covalently bound palmitate are strongly anchored in the plasma 
membrane (Grand 1989). In most examples the palmitate moiety is attached via 
a thioester bond to a cysteine which is located within the consensus sequence 
CAAX found only at the carboxy terminus (Beranger et al. 1991; Cox and Der 
1992; Glomset et al. 1990; Grand 1989; Hancock et al. 1989; Kloc et al. 1991; 
Leevers et al. 1994). However, in recent years proteins have been identified 
which are palmitoylated on cysteine located close to their amino terminus 
(Parenti et al. 1993; Sudo et al. 1992; Widmer and Caroni 1993). Indeed it has 
been reported that the neuronal protein GAP-43, which is palmitoylated on two 
N-terminal cysteines, becomes only partially membrane-associated upon 
prevention of acylation of either cysteine (Zuber et al. 1989).
Analysis of the amino acid sequence of RD1 revealed the presence of 
two cysteines at positions 8 and 11 within the N-terminal 25 amino acids 
(Figure 4.1). I have shown previously that mature chimeras containing the 
unique splice region of RD1 fused to the N-terminus of CAT generated in a cell- 
free expression system (ch. 3, section 3.2.5 and (Scotland and Houslay
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1995)Scotland and Houslay 1995) can associate with added membranes. Thus 
it seems unlikely that post-translational modification in the form of 
palmitoylation is the mechanism through which the chimera and, therefore by 
inference RD1, becomes membrane associated. Furthermore, it has been 
suggested that palmitoyl transferase itself is membrane associated (Degtyarev et 
al. 1994) and as such would be absent from the cell-free system. As well as 
serving as sites for the attachment of palmitc acid, cysteines are also important 
for the formation of di-sulphide bridges. It has been demonstrated that 
cathepsin E, an intracellular aspartic protease, is retained in the endoplasmic 
reticulum through a mechanism involving covalent dimer formation via a 
disulphide bridge (Finley and Kornfeld 1994). More recently Shimada etal 
(Shimada et al. 1996) demonstrated that rat endothelin-converting-enzyme 1 
(ECE1) exists as a plasma membrane associated disulphide linked dimer when 
expressed in COS cells. Mutation analysis revealed that dimer formation was 
disrupted by mutation of a specific cysteine residue and, although monomers 
showed no difference in subcellular localization, they demonstrated markedly 
different kinetic characteristics from the dimer form. Moreover, a disulphide 
bridge between the two SH2 domains of the signalling protein SH-PTP2 is 
thought to be critical for enzymatic activation (Eck et al. 1996). Such 
observations clearly demonstrate the importance of cysteine in a structural and 
functional context, therefore site-specific PCR mutagenesis was employed to 
synthesise DNA fragments in which cysteines 8 and 11 of RD1 were replaced 
with serines to determine whether these residues were critical in the conferment 
of membrane association by the unique splice region of the PDE4a RD1 upon 
the soluble bacterial enzyme chloramphenicol acetyltransferase (CAT).
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4.2 Site-Specific Mutagenesis of Cvsteine Residues in the
N-Terminus of RD1 
4.2.1 Overlap Extension Mutagenesis
The method of mutagenesis described by Ho etal (Ho et al. 1989) and 
outlined in Figure 4.2, was used to substitute serines for cysteines at positions 
8 and 11 in the RD1 specific sequence of the expression vector pGS7 (Scotland 
and Houslay 1995). The method made use of a pair of complementary primers 
(Figure 4.2, B & C) which contained the mutation of interest. Primer C, when 
paired with a sense PCR primer A, was used to generate a PCR fragment with 
complementary ends to a second fragment generated by pairing primer B 
(Figure 4.2) with an anti-sense primer D. By combining the reaction products 
of the two reactions in a further round of PCR, this time using only primers A 
& D, a hybrid fragment was generated by virtue of the complementary nature of 
the 3' ends of fragments synthesised in the first two reactions. The result is the 
generation of an almost 100% mutagenic PCR product which was cloned into 
pGS7 by the inclusion of Xbal and Xhol sites in the A and D primers 
respectively.
4.2.2 Generation of pGS9
The synthetic oligonucleotide primers
GSOL 10, 5'-CCAGTCACGACGTTGTAA-3' and
GSOL 6, 5'-GGTCTCGCTGAAGAAGT-3',
were used in a PCR reaction to generate a 96bp DNA fragment using pGS4 
(Scotland and Houslay 1995) as the template (Figure 4.3, lane 1). 
Simultaneously in a second reaction, the primers 
GSOL 1, 5'-ACTTCTTCAGCG AG ACC-3' and
GSOL 15, 5 -GGCTCCTCGAGCTTCCAGTGTGT-3'were used to generate a 
293bp fragment, again with pGS4 as the template DNA (Figure 4.3, lane 2).
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Post PCR, the reaction products were separated from the pGS4 template DNA 
by electrophoresis through a 1.75% LGT agarose gel as described in Materials 
and Methods. Both bands were excised from the gel and a fragment of each 
band was combined in a third PCR reaction this time in the presence only of 
primers GSOL 10 and GSOL 15. A hybrid 389bp DNA fragment was 
successfully generated by virtue of the complementary nature of the 3'-ends of 
each primary PCR product (Figure 4.4). After purification from the PCR 
reaction mixture this fragment was digested overnight with the restriction 
enzymes Xbal and Xhol as described in Materials and Methods. This resulted 
in the generation of two DNA fragments of 307bp and 72bp (Fig.4.5, lane 2). 
Following purification by gel electrophoresis to remove the minor digestion 
products the 307bp DNA fragment was substituted for the wild-type RD1 
fragment in the plasmid pGS4 (Scotland and Houslay 1995) resulting in the 
generation of an intermediate plasmid named pGS5 (not shown). That pGS5 
contained the Cys8Ser mutation was confirmed by Taq cycle sequencing 
(Figure 4.6) as described previously. pGS5 was digested with the restriction 
enzymes Xbal and Xhol to release the mutagenic 307bp RD1 fragment which 
was purified by gel electrophoresis and finally subcloned into pGS7 to replace 
the 'wild-type RD1 fragment. This vector, capable of transient expression in 
COS cells was designated pGS9.
4.2.3 Generation of pGS12
The same strategy was used in generating a plasmid containing the 
double Cys8,l lSer mutation by using pGS5 as template DNA and primers 
GSOL 10, 5'-CCAGTCACGACGTTGTAA-3' and
GSOL 16, 5'-CTTGGAGCTGGTCTCGC-3' to generate the 96bp fragment, 
and
GSOL 2, 5'-GCGAGACCAGCTCCAAG-3' paired with 
GSOL 15, 5 -GGCTCCTCGAGCTTCCAGTGTGT-3'
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in the reaction to synthesise the 293bp fragment. Following digestion and 
purification of the mutagenic fragment as above, the presence of the Cysll 
mutation was confirmed by sequencing (Figure 4.7) and the plasmid designated 
pGS12.
4.2.4 Generation of pGS14
Plasmid pGS14 containing the CysllSer mutation was constructed 
using the same oligonucleotides;
GSOL 10, 5'-CCAGTCACGACGTTGTAA-3' and
GSOL 16, 5'-CTTGGAGCTGGTCTCGC-3' to generate the 96bp fragment, 
and
GSOL 2, 5-GCGAGACCAGCTCCAAG-3' paired with
GSOL 15, 5-GGCTCCTCGAGCTTCCAGTGTGT-3'
but in this instance pGS4 (Scotland and Houslay 1995) served as the PCR
template. As before, the integrity of the mutation was confirmed by DNA
sequencing (data not shown).
Plasmids constructed, primers used and mutations generated are summarised in 
Table 4.1.
4.2.5 COS cell Expression of Plasmids Containing Cysteine 
Mutations
Plasmids pGS9, pGS12 and pGS14 containing the point mutations 
Cys8Ser, Cys8,l lSer and Cysl lSer respectively were transfected in COS cells 
as described in Materials and Methods. Post transfection, cells were harvested 
and high-speed pellet (P2) and supernatant (S2) fractions prepared as before. 
Each fraction was assayed for CAT activity and the distribution compared to 
CAT activity for cells transfected with the vector pGS7 expressing the 'wild- 
type' RD1 fragment. The distribution of CAT activity between the high-speed 
P2 pellet and S2 supernatant fractions was expressed as a percentage of total 
CAT activity.
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The results of these experiments are summarised in Table 4.2 When 
COS cells were transfected with pGS7, CAT activity was detected 
predominantly (64%± 3) in the high-speed P2 pellet fraction reflecting previous 
results obtained for cells expressing this construct (Ch. 3 section 3.2.1) Upon 
transfection of COS cells with the plasmid pGS9 containing the Cys8Ser 
mutation, the distribution of CAT activity was observed to be almost identical to 
that observed for the wild-type chimera with the majority of CAT activity (63% 
± 4) found in the P2 pellet, suggesting that this cysteine residue was not critical 
in determining membrane association of the RD1-CAT chimeric protein.
When COS cells were transfected with the plasmid pGS12 which 
contained the double cysteine to serine mutations at positions 8 and 11, a 
marked difference in the distribution of CAT activity was observed (Table 4). 
In cells expressing this construct, 88% ± 3 of the total enzyme activity was 
observed in the P2 pellet fraction with a concomitant decrease in the high-speed 
S2 supernatant. That this increase in membrane associated CAT activity was 
due to the double mutation substituting cysteines at positions 8 and 11 (Figure 
4.1), was demonstrated when COS cells were transfected with the plasmid 
pGS14. This plasmid encoded a mature chimeric protein species in which only 
the cysteine at position 11 was mutated to serine and it was noted that CAT 
activity data for this construct displayed the same distribution of enzyme activity 
previously observed for both pGS7 and pGS9 with 63% ± 3 associated with 
the P2 pellet fraction. It was therefore concluded that substitution of individual 
cysteine residues at positions 8 and 11 of RD1 by serine residues, did not 
hinder the ability of the RD1-CAT chimera to associate with membranes upon 
transient expression in COS cells, and suggested that neither residue was post- 
translationally modified by the addition of palmitic acid. Subsequent 
replacement of both cysteines by serines however, caused a dramatic increase in 
the percentage of CAT activity bound to membranes in the P2 pellet fraction.
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4.2.6 Cell-free Expression of Chimeric RD1-CAT Protein Species 
Containing Cysteine Mutations
Previously it has been demonstrated that plasmids encoding RD1 CAT 
chimeras can generate mature protein species in a cell-free enviroment which 
could associate with membranes which were added posttranslationally (Scotland 
and Houslay 1995). The method used in cell-free generation of proteins and 
subsequent membrane association assay as described in a previous chapter 
(Ch.3, section 3.2.5) was utilized to determine whether RD1-CAT chimeras 
carrying cysteine mutations within their N-terminal regions, could associate 
with membranes. Plasmids pGS9, pGS12 and pGS14 containing Cys8Ser, 
Cys8/llSer and CysllSer respectively, were used to programme protein 
synthesis in a coupled transcription/translation system in the presence of [3^ S] 
methionine. Postranslation, duplicate samples of the reaction mix were 
incubated in the absence (-membranes) and presence (+membranes) of COS cell 
P2 membranes. Following separation of membrane pellet and supernatant 
fractions by centrifugation, samples, including those to which no membranes 
hade been added, were loaded onto denaturing SDS acrylamide gels and the 
proteins separated by electrophoresis. The result of one a typical experiment is 
shown in Figure 4.8.
It has previously been shown that when pGS7 encoding the 'wild-type' 
RD1-CAT chimera was expressed in the cell-free system, three predominant 
protein species were observed of ~ 38kDa, ~35kDa and ~ 33kDa (Ch.3, fig.
3.11, lanes 4-6) which corresponded to full-length 1-100RD 1-CAT, 26- 
100RD1-CAT and 37-100RD1-CAT respectively and as was observed 
previously, only the 38kDa 1-100RD1-CAT protein species was able to 
associate whilst the membrane pellet fraction (Ch.3, fig. 3.11, lane 5) while the 
truncated 35kDa and 33kDa species were exclusively cytosolic (Ch.3, fig.
3.11, lane 6). When the reactions were programmed by pGS9 encoding 
Cys8Ser (Figure 4.8; lanes 1-3), pGS12 (Figure 4.8; lanes 4-6) and pGS14
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encoding cysl lser (Figure 4.8; lane7-9) the 38kDa full-length chimera was able 
to associate with added membranes in the same manner as 38kDa protein 
corresponding to 'wild-type' 1-100RD 1-CAT (Ch.3, fig. 3.11, lane 5). The 
smaller 35kDa and 33kDa protein species generated by pGS9 (Figure 4.8; lane 
3) and pGS14 (Figure 4.8; lane 9) remained wholely cytosolic as observed for 
those same chimeric species encoded by pGS7 (Ch.3, fig. 3.11, lane 6). When 
the plasmid pGS12 containing the double mutation of cysteines to serines at 
positions 8 and 11 was expressed in the coupled transcription/translation 
system, a band corresponding to ~38kDa was observed (Figure 4.8, lane 4). 
This, upon the post-translational addition of COS cell membranes, was found to 
associate with the membrane pellet fraction (Figure 4.8, lane 5) in the same 
manner as the 38kDa species generated by pGS9 and pGS14 (Figure 4.8, lanes 
2 & 8 respectively). However, in marked contrast to the plasmids expressing 
the cys8ser and cysl lser mutations, it was noted that there was an almost 
complete absence of both the 35kDa and 33kDa chimeric protein species (Figure 
4.8, lanes 4& 5). Moreover, the observation that the 38kDa band for each 
plasmid used in this experiment demonstrated a similar level of intensity, 
suggests that the the lack of the 35kDA and 33kDa protein species in the lanes 
corresponding to reactions programmed with pGS12 (Figure 4.8, lanes 4-6) 
was not the result of a non-specific reduction in the level of protein synthesis 
but was, in some way, related to the substitution of serines for cysteines at 
positions 8 and 11.
4.3 Conclusions
The PDE4A phosphodiesterase RD1 (RNPDE4A1) is found associated 
with the plasma membrane upon expression in transfected COS cells and also, 
for the native enzyme, in brain (McPhee et al. 1995; Shakur et al. 
1995). This occurs by virtue of information contained within the first 25 
amino acids at the extreme N-terminus (McPhee et al. 1995; Scotland and 
Houslay 1995; Shakur et al. 1993). Analysis of the amino acid sequence
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revealed the presence of two cysteine residues at positions 8 and 11. In order to 
ascertain whether post-translational or structural modification such as the 
formation of a disulphide bridge was necessary for membrane association of the 
enzyme, a series of plasmids based on the eukaryotic expression vector pGS7 
(Scotland and Houslay 1995) were generated in which both cysteines were 
substituted either sequentially or simultaneously with serines. Transfection of 
these plasmids in COS cells demonstrated that cysteine at either position 8 or 
position 11 made no difference to the ability of the 38kDa chimeric RD 1-CAT 
protein species to associate with the plasma membrane. Conversely however, 
mutation of both cysteines resulted in an apparent increase in the amount of the 
38kDa chimera protein associated with the plasma membrane fraction of 
transfected COS cells.
Subsequent expression of the same plasmids in a cell-free coupled 
transcription/translation system resulted in the generation of a mixture of full- 
length and truncated protein species due to multiple initiation events from 
internal methionine codons contained within sub optimal Kozak sequences 
(Craig et al. 1992; Kozak 1986; Promega 1993) and which has been reported 
previously for this system (Scotland and Houslay 1995; Smith et al. 1996). The 
post-translational addition of membranes to proteins synthesised in the cell-free 
system revealed that those protein species containing single cysteine/serine 
substitutions were able to associate with membranes in a manner identical to the 
'wild-type ' protein. The protein species containing mutations of cysteines at 
both positions 8 and 11 also demonstrated the same level of binding to 
membranes as the 'wild-type' chimera and those with single cysteine/serine 
substitutions. However, in marked contrast, it was evident upon expression of 
this plasmid that the level of synthesis of truncated protein species was greatly 
reduced. This observation suggests that the increased percentage of membrane 
CAT activity seen upon transfection and expression of pGS12 in COS cells was 
not due to an increased membrane association but likely to result from a
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decrease in expression of soluble truncated proteins located in the cytosolic 
fraction of the cells. Unfortunately it was not possible to obtain independent 
confirmation of this observation by immunoblotting as the anti-CAT antisera 
failed to identify the 1-100RD1-CAT chimera (ch. 3, section 3.2.4). Such a 
reduction in the expression of N-terminally truncated species is unlikely to 
reflect an artifact since this observation was made using two different 
expression systems, COS cells in which expression is driven by an SV40 
promoter and rabbit reticulocyte lysate where expression is directed by the SP6 
promoter. It is possible that a common explanation may account for the 
changes seen in both systems. Since transcription is initiated in each expression 
system from different promoters it is suggested that the reduction in the level of 
soluble truncated RD 1-CAT chimeras may reflect a change at the level of 
translation. One factor which can affect translation efficiency is the presence of 
secondary structure in the mRNA (Kozak 1994). Previous experiments with 
the RD1-CAT chimera expressing plasmids have shown the presence of 
multiple protein species thought to arise as a result of translation from internal 
methionine residues contained within sub-optimal Kozak sequences (Scotland 
and Houslay 1995) by means of leaky ribosome scanning (Kozak 1986; Kozak 
1990; Kozak 1994). It has been demonstrated that the presence of secondary 
structure in RNA can alter translation (Brierley et al. 1989; Jacks et al. 1988; 
Zinoni et al. 1990) and Kozak (Kozak 1990) has previously shown that 
recognition of an AUG codon in a suboptimal context improves with the 
introduction of a hairpin loop near the begining of the protein-coding sequence. 
Analysis of the DNA sequence encoding the N-terminal 25 amino acids of RD1 
does not reveal any significant propensity for secondary structure formation. 
However, mutation of the cysteines at positions 8 and 11 was achieved by 
substituting A for T (Figure 4.8, boxed residues) which forms the first base of 
the triplet codon corresponding to cysteine and it is therefore tentatively 
suggested that these substitutions are more favourable to the formation of a
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hairpin loop (Figure 4.8) beginning approximately 14 nucleotides downstream 
from the initiating methionine. This is in exellent agreement with the 
observations of Kozak (Kozak 1990). The presence of any such structure 
might be expected to cause the 40S ribosomal subunit to slow down resulting in 
more efficient translation from the upstream ATG codon.
In summary, a series of plasmids were generated containing mutations 
of cysteines located in the extreme N-terminal RD1 specific fragment in an 
attempt to determine whether these residues were post-translationally or 
structurally modified and thus confer plasma membrane association upon full- 
length RD1 and N-terminal RD1-CAT fusions. Expression of plasmids 
containing single cysteine mutations in both COS cells and a cell-free system 
displayed the same pattern of membrane association as the wild-type construct. 
Expression of the plasmid containing the double cysteine mutation revealed an 
apparent increase in membrane association in COS cells. This was shown 
however, in the cell-free system to be caused by a decrease in the amount of 
truncated soluble protein chimeras produced rather than a genuine increase in 
membrane association. An explanation for this observation is suggested which 
involves the formation of a secondary structural hairpin loop upstream of the 
internal methionine at position 26, due to the nucleotide substitutions involved 
in the cys8/llser double mutation which may result in an increased fidelity of 
translation from the initiating methionine.
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Figure 4.1: Amino Acid Sequence 1-25 of RD1
This figure shows the primary amino acid sequence (single letter 
code) for the unique N-terminal splice domain of RD1. Cysteines 8 and 11 
are shown underlined.
NH2-MPLVDFFCETCSKPWLVGWWDQFKR-COOH
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Figure 4.2: Schematic Diagram of Overlap-Extension Mutagenesis
Complementary oligonucleotide primers (B & C) designed to 
contain the mutation of interest are combined with a sense (A) and anti­
sense (D) primer to generate short DNA fragments in two separate PCR 
reactions. DNA fragments generated during the first round of PCR are 
combined in a second PCR reaction with the sense and anti-sense primers A 
and D but without the mutagenic primers. A full-length fragment containing 
the mutation of interest is then generated by virtue of the complementary 
nature of the two primary reaction products. Mutagenic fragments can be 
subcloned by designing restriction enzyme recognition sites into primers A 
and D.
B(1) A+C c  (2)
D
B+D
Nk V
AC
BD
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sk
AC+BD
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Figure 4.3: Generation of Primary Mutagenic PCR Products
The results of two PCR reactions visualized by ethidium bromide 
staining of an agarose gel are shown. Lane 1 shows the presence of a 96bp 
band which is the size predicted for a band generated using primers 
GSOL 10 and GSOL6 when the plasmid pSG4 was used as a template (ch. 
3, section 3.1.1). Lane 2 contains a band of 293bp corresponding to the 
size predicted for a band synthesised when primer GSOL1 was combined 
with GSOL15. Haelll digested bacteriophage O X174 DNA markers are 
indicated to the left of the gel. All sizes given are nucleotide base pairs.
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Figure 4.4: Generation of a Secondary Mutagenic PCR Product
The primary mutagenic PCR products shown in Fig.4.3 were 
combine in a second PCR reaction but in the absence of the mutagenic 
primers GSL1 and GSOL6. By virtue of the complementary nature of the 
3' ends of both fragments a 389bp full-length DNA fragment was generated 
using primers GSOL 10 and GSOL 15. Haelll digested bacteriophage <E> 
X I74 DNA was used as molecular weight markers as indicated on the left 
side of the gel.
271/281
310
234
389
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Figure 4.5: Digestion of the Mutagenic 389bp PCR Fragment prior
to Subcloning
The 389bp PCR product shown in Fig. 4.4 was digested by 
incubation at 37°C in the presence of the restriction enzymes Xbal and 
Xhol. This figure shows the successful generation of two bands of 307bp 
and 72bp as expected upon digestion of the 389bp fragment by these two 
enzymes.
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Figure 4.6: Confirmation of the Generation of the Cys8Ser Mutation
A mutagenic DNA fragment was generated in which the cysteine at 
position 8 of the RD1 specific sequence was mutated to serine. Shown here 
is a printout from an Applied Biosystems Model 373 automated DNA 
sequencer. The nucleotide substitution encoding the mutation is underlined.
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Figure 4.7: Confirmation of the Generation of the C ys8 /llS er
Mutation
Using plasmid pGS9 as template in a PCR reaction cysteine 11 was 
mutated to serine Shown here is a printout from an Applied Biosystems 
Model 373 automated DNA sequencer. The nucleotide substitutions 
encoding both mutations are indicated by arrows.
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Table 4.1 Summary of Plasmid Constructs Containing 
N-Terminal Cysteine Mutations
Site-specific mutagenesis was carried out essentially according to the 
method of overlap extension as described by Ho et al (Ho et al. 1989). 
Mutagenic fragments were subcloned into pGS7 following removal of the wild- 
type RD1 fragment. Successful generation of each mutation was confirmed by 
sequencing.
plasmid Primers Construct
pGS9 GSOL 1, 5'-ACTTCTTCAGCGAGACC-3' Cys8Ser
GSOL 6, 5'-GGTCTCGCTGAAGAAGT-3'
pGS12 GSOL 16, 5'-CTTGGAGCTGGTCTCGC-3' 
GSOL 2, 5-GCGAGACCAGCTCCAAG-3'
Cys8,llSer
pGS14 GSOL 16, 5'-CTTGGAGCTGGTCTCGC-3' 
GSOL 2, 5 -GCGAGACCAGCTCCAAG-3'
CysllSer
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Table 4.2 Distribution of CAT activity in COS Cells 
Transfected With Chimeras Containing N-Terminal 
Cysteine Mutations
COS cells were transfected with the indicated plasmid and then, after 48h, 
membrane and high speed supernatant fractions isolated as described in 
Methods. All CAT assays were performed in duplicate as described in the 
Methods section. The distribution between the membrane (pellet) and cytosol 
(high speed supernatant) fractions are given as percentages. These data 
provides the mean of three separate transfection experiments done on different 
occasions with errors as SEM. No CAT activity was evident in COS cells 
which were mock transfected with either the plasmids pSVL or pSPORT.
plasmid Construct Membrane (%) Cytosol (%)
pGS7 1-100RD CAT 64 ± 3 36 ±3
pGS9 Cys8SerRD CAT 63 ± 4 37 ± 4
pGS 12 Cys8,11 SerRD CAT 88 ±3 17 ±3
pGS13 CysllSer CAT 63 ± 2 37 ± 2
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Figure 4.8: Cell-Free Expression of Plasmids Encoding Cysteine
Mutations
Plasmids pGS9, pGS12 and pGS14 encoding cys8ser, cys8/llser 
and cysl lser respectively were expressed in the presence of radiolabelled 
methionine in a cell-free coupled transcription/translation system and used in 
a membrane association assay as described in Methods (section 2.12). 
Mature chimeric proteins generated from these plasmids were resolved by 
SDS-PAGE and analysed by phosphorimager. Lanes 1-3 represent pGS9, 
lanes 4-6 represent pGS12 and lanes 7-9 correspond to pGS14. All 
volumes and concentrations were normalized to allow direct comparison. 
The lanes are in sets of three where the first track shows the original product 
of the transcription/translation reaction, the second the high-speed 
membrane pellet and the third the soluble high-speed supernatant fraction. 
Thus lanes 1, 4 & 7 show the original material emanating from the 
transcription/translation experiment; lanes 2, 5 & 8 the high speed pellets 
after incubation in the presence of COS membranes and lanes 3, 6, & 9 the 
high speed supernatants obtained after centrifugation of the incubation 
mixture done in the presence of COS membranes. These data are typical of 
three separate experiments.
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Figure 4.9: Proposed Secondary Structure of the 5' Leader Sequence 
of Cys8/llSer RD1 mRNA
Shown here is the putative hairpin loop structure that may be 
adopted by RD1 mRNA encoding the double cys8/llser mutation. It is 
proposed that the base substitutions (boxed residues) favour the formation 
of this structure thus causing the ribosome to pause at the first methionine 
(double underlined) thus preventing translation from the second 
methinonine (single underlined).
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CHAPTER 5
Identification of Specific Amino Acid Residues 
Responsible for the Membrane Association of the PDE4
RD1
5.1 Introduction
The cyclic AMP specific phosphodiesterase RD1 (RNPDE4A1) was 
found to be associated with the synaptosomal plasma membrane in rat brain 
(McPhee et al. 1995; Shakur et al. 1995) and also upon transient expression in 
transfected COS cells (Shakur et al. 1993). By means of engineered deletions 
of the cDNA for RD1, Shakur et al (Shakur et al. 1993) have demonstrated that 
the extreme N-terminal may be involved in determining the subcellular 
localization of the enzyme. More recently, Scotland et al (Scotland and Houslay 
1995) were able to demonstrate that chimeric constructs containing the at least 
the first 25 amino acids of RD1 were sufficient to direct the normally soluble 
bacterial protein chloramphenicol acetyltransferase (CAT) to the plasma 
membrane upon tranfection in COS cells and also upon addition the addition of 
membranes to mature chimeric proteins generated in a cell-free rabbit 
reticulocyte lysate system. In contrast, chimeric protein species in which this 
first 25 amino acids were deleted exhibited an exclusively cytosolic CAT 
activity identical to native CAT (Scotland and Houslay 1995). Thus it was 
confirmed that the extreme N-terminal 25 amino acids were involved in 
determining membrane association upon the PDE4A RD1.
Shakur et al have previously shown that hydroxylamine was unable to cause the 
release of RD1 from either cerebellum or COS cell membranes and that [3H] 
palmitate was not incorporated into the RD1 protein immunoprecipitated from 
COS cells transfected with RD1 cDNA (Shakur et al. 1995). Furthermore, site- 
specific mutagenesis of N-terminal cysteines identified as potential sites for the 
addition of palmitate, failed to prevent association of the chimeric 1-100RD- 
CAT protein with membranes when expressed in COS cells or upon their 
addition to full-length chimeras generated in a cell-free expression system (Ch. 
4, section 4.1.5 & 4.1.6). Therefore it is suggested that the unique N-terminal 
splice region of the PDE4A RD1 contains discrete domains or linear amino acid
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sequences which are responsible for directing the soluble 'core' met26 RD1 and 
the bacterial protein CAT to membranes. In order to investigate this contention 
it was necessary to determine whether this splice region possessed the ability to 
adopt a structural conformation in the absence of the 'core' met26 RD1 enzyme. 
By means of a computer analysis program based on the algorithm of Chou and 
Fasman (Chou and Fasman 1978) for the determination of super-secondary 
structure from primary amino acid sequence, a putative structure was obtained 
which suggested that the unique splice region of the PDE4A RD1 consisted of a 
number of independently folded structural elements namely an N-terminal a- 
helix followed by a mobile hinge region and a  second a-helix (Fig.5.1). 
Furthermore, in a collaboration with Dr. J. Smith and Prof. I. Trayer 
(University of Birmingham) and Dr. J. Beattie (Hannah Research Institute, 
Ayr) a 25 amino acid peptide corresponding to the unique splice region of the 
PDE4A RD1 was synthesised and its structure determined by *H Nuclear 
Magnetic Resonance (JH NMR) spectroscopy. Analysis of this peptide 
provided confirmation of the structure observed by computer analysis, that the 
splice region was comprised of two independently folding helical regions. The 
first helical region was formed by an N-terminal amphipathic a-helix with an 
apolar section (residues 2-7), followed by a highly mobile 'hinge' region 
(residues 8-13), and a second helix consisting of multiple overlapping turns and 
containing a distinct compact, hydrophobic, tryptophan-rich domain (residues 
14-20) followed by a polar region encompassing residues 21-25 (Fig. 5.2 and 
Smith et al (Smith et al. 1996)). Based on the fact that two independent lines of 
inquiry provided essentially identical well defined structures I generated a series 
of deletion mutations and amino acid substitutions within this unique splice 
region in order to determine the role of individual structural features in 
conferrment of membrane association upon the PDE4A RD1 and the soluble 
bacterial enzyme chloramphenicol acteyltransferase (CAT).
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5.2 Generation and Expression of N-Terminal Deletion Mutation 
RD1-CAT Chimeras
5.2.1 Construction of Deletion Mutations
A modification of the method of overlapping extension mutagenesis 
described by Ho et al (Ho et al. 1989) and in some detail in the preceding 
chapter was used to successfully engineer various deletions within the 1-25 
amino acid RD1 N-terminal region. The PCR primers used and the mutations 
generated are summerised below 
Primer pairs
GSOL17, 5'-GGTCGACTCTAGAATGTGCGAGACCTGC-3' and 
GSOL18, 5 -GC AGGTCTCG CACATTCTAGAGTCGACC-3' 
were used to delete the hydrophobic residues P2-F7 (inclusive); 
GSOL27, 5'-GACTTCTTCC CCTGGCTGG-3' and 
GSOL28, 5-CCAGCCAGGGGAAGAAGTC-3' 
were used to delete the polar region of the first a-helix along with the 
hinge region C8-K13 (inclusive);
GSOL36, 5-CCTGCTCCAAGGACCAGTTCAAAAGG-3' and 
GSOL37, 5-CCTTTTGAAC TGGTCCTTGGAGCAGG-3' 
were used to delete the unique tryptophan-rich domain P14-W20 
(inclusive);
GSOL38, 5'-GCTGGTGGAT GCTGAACC-3’ and 
GSOL39, 5-GGTTCAGCATCCACCAGC-3' 
were used in the generation of the polar amino acids D21-R25 
(inclusive).
Following restriction enzyme digestion with Xbal and Xhol as before, 
PCR fragments were recovered from 1.75% low gelling temperature agarose 
gels and substituted for the 'wild type' RD1 N-terminal fragment of pGS7
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(Scotland and Houslay 1995) to create the plasmids pGSlO, pGS15, pGS17 
and pGS18 containing the deletions AP2-F7, AC8-K13, AP14-W20, 
AD21-R25. Confirmation of each deletion was obtained by DNA sequencing as 
described previously (Ch. 3).
5.2.2 Generation of the Plasmid pGS22
The method of overlap extension mutagenesis described previously by 
Ho etal (Ho et al. 1989) was used to insert a cassette of seven alanine residues 
(alay) between amino acid residues K13 and D14 of the tryptophan-rich deletion 
containing plasmid pGS17 by using the following primers,
GSOL61, 5 -CCTGCTCCAAGGCAGCAGCAGCAGCAGCAGCA
GACCAGTTCAAAAGG-3'
GSOL62, 5-CCTTTTGAACTGGTCTGCTGCTGCTGCTGC
TGCTGCCTTGGAGCAGG-3'
Subsequent confirmation of the successful generation of the insertion 
was obtained by Taq cycle sequencing as before and the resultant plasmid 
designated pGS22.
5.2.3 Expression of Deletion Mutations in COS Cells
Deletion mutation containing plasmids were transfected into COS cells 
as described in materials and methods (ch. 2 , section 2 .8 .1) and propagated for 
48 hours before harvesting and subsequent preparation of pellet and supernatant 
fractions. Samples of pellet and supernatant were assayed for CAT activity 
essentially by the method of Seed and Sheen (Seed and Sheen 1988) and 
described previously (ch. 2, section 2.9). As in the previous experiments to 
evaluate the effect of cysteine mutations upon membrane association of RD1- 
CAT chimeric protein species, the plasmid pGS7 was used as a positive 
control. The results of the individual deletion mutations generated are 
summarised in table 5.1.
When pellet and soluble fractions were prepared from COS cells 
transfected with pGSlO expressing the P2-F7 deletion, it was observed that
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almost 53% of CAT activity was associated with the membrane fraction (Table 
5.1). While this represents a decrease in membrane associated CAT activity 
when compared to cells transfected with the wild-type pGS7 (table 5.1) it is 
evident that deletion of the hydrophobic region of the first amphipathic a  helix 
failed to abolish membrane association of the major proportion of RD 1-CAT 
chimera.
The plasmid pGS15 was generated by replacing the DNA encoding for 
the wild-type 1-100 amino acid RD1 fragment by a PCR fragment containing an 
18bp deletion corresponding to the polar region of the first amphipathic a  helix 
combined with the mobile hinge region (residues C8-K13) identified by 
computer predictions and NMR analysis (Figs. 5.1; & 5.2; (Smith et al. 1996)). 
When pGS15 was transfected in COS cells a significant amount of CAT activity 
was detected (Table 5.1). Separation of membrane and soluble fractions 
showed that almost 56% of this CAT activity was associated with membranes 
(Table 5.1). Interestingly, that the deletion encoded by pGS15, which 
encompasses the cysteine residues at positions 8 and 11 , failed to prevent 
membrane association of the 1-100RD1-CAT chimeric protein confirms the 
contention investigated in chapter 4 (sections 4.1.5 & 4.1.6) that these residues 
are not directly responsible for the conferrment of membrane association upon 
RD1 by acting as sites for the covalent attachment of palmitate, nor through the 
formation of intra- or inter-molecular di-sulphide bridges. In marked contrast to 
the above results, when COS cells were transfected by the plasmid pGS17, in 
which the 1-100 amino acid RD1 fragment contained an engineered 21 bp 
deletion corresponding to the tryptophan-rich region from amino acids P14- 
W20, only 16% of the total CAT activity was found associated with the 
membrane fraction compared to almost 70% observed for cells transfected with 
pGS7 expressing the wild-type 1-100RD1-CAT chimera. This marked shift in 
the distribution of CAT activity from the membrane to the soluble fraction of 
COS cells transfected with pGS17 minors earlier results observed previously
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for cells transfected with both pGS8 expressing native CAT, and pG Sll 
encoding 26-100RD1-CAT which displayed 13% and 16% membrane 
associated CAT activity respectivly (results ch. 3, table 3.1 and Scotland & 
Houslay (Scotland and Houslay 1995)). The final polar region identified by 
computer analysis and NMR studies of the unique splice region of the type IVA 
PDE RD1 encompassed amino acid residues D21-R25 and therefore deletion of 
this region was engineered to generate the plasmid pGS18. As observed for the 
other deletion containing plasmids, pGS18 expressed CAT activity when 
transfected into COS cells (Table 5.1). However, analysis of the distribution of 
CAT activity between the membrane and cytosolic fractions of pGS18 
transfected COS cells showed a decrease in membrane associated CAT activity 
from 6 6 % seen for full-length RD1-CAT to 32% for the deletion D21-R25 
(Table 5.1). A possible explanation for this observation, while by no means 
conclusive proof, is offered. Smith et al (Smith et al. 1996) through NMR 
studies on a peptide corresponding to the unique splice region of the type IVA 
PDE RD1 demonstrated that the while the tryptophan-rich region was located at 
the NH2-terminus of an amphipathic a-helix it adopted a somewhat loose 
conformation due to the presence of amino acids containing large aromatic side- 
chains. Perhaps by adopting this conformation a hydrophobic patch is provided 
through which membrane association takes place, indeed such a phenomenon 
has been described for the association of the 'loose-binding form' of rat liver 
cytochrome^ 5 with liposomes (Vergeres et al. 1995). It may be the case then 
that deletion of the amino acids directly downstream of the tryptophan-rich 
region of RD1 causes it to lose this unusual conformation and thereby decrease 
its ability to efficiently direct membrane association. It is also interesting to note 
that this deletion encompassed the positively charged residues lysine and 
arginine (K24-R25) which have been implicated as stop transfer sequences in a 
number of membrane associated proteins such as H+,K+-ATPase (Bamberg 
and Sachs 1994) and deiodinase (Toyoda et al. 1995). Whether an analogous
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role is served by these residues in RD1 is undetermined although it is unlikely 
as the N-terminus of RD1 does not appear to contain an a-helix large enough to 
span the lipid bilayer.
5.2.4 COS cell Expression of Alanine Cassette Containing 
Plasmid pGS22
Previous results have demonstrated that deletion of the hydrophobic 
tryptophan-rich region P14-W20 in the unique N-terminal splice region of the 
type IVA PDE RD1 abolished membrane association of mature chimeric RD1- 
CAT protein species when expressed in transfected COS cells. In order to 
ascertain whether membrane association was conferred by hydrophobic 
interaction alone or whether it was due to the presence of specific amino acid 
residues, amino acids P14-W20 were substituted by an equally hydrophobic 
'cassette' comprised of 7 consecutive alanines which was inserted between 
residues K13 and D14 in the RD1 specific sequence of the plasmid pGS17 by 
means of overlap extension mutagenesis (Ho et al. 1989). The resultant 
plasmid, which was confirmed to contain the alanine cassette was designated 
pGS22. The use of alanine substitutions and scanning alanine mutagenesis has 
been well documented in the literature in, for example determining the role 
played by di-leucine motifs in lysosomal targeting (Haft et al. 1994; Hunziker 
and Fumey 1994; Leteourneur and Klausner 1992; Ogata and Fukuda 1994; 
Pond et al. 1995) and endoplasmic reticulum targeting (Vergeres et al. 1995).
Upon transfection and subsequent expression of pGS22 in COS cells it 
was noted that approximately 23% of CAT activity was associated with the 
membrane fraction compared to 6 6 % for full-length 1-100RD 1-CAT encoded 
by pGS7 (Table 5.1) thus leading to the conclusion that substitution of amino 
acids P14-W20 by a stretch of similarly hydophobic amino acids was not not 
sufficient to reconstitute membrane association lost by deletion of this region. 
Although membrane association was not completely abolished it was reduced to 
a level similar to that previously observed for the 26-100RD1-CAT protein
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chimera expressed by pGSll (results ch. 3, table 3.1 and Scotland & Houslay 
(Scotland and Houslay 1995)).
5.2.5 Cell-free Expression of Deletion Mutation Containing 
Plasmids
Plasmids pGSlO, pGS15, pGS17 and pGS18 containing the mutations 
AP2-F7, AC8-K13, AP14-W20, AD21-R25 respectively, were used to 
programme sysnthesis of mature chimeric protein species in a cell-free coupled 
transcription/translation system and used in the membrane association assay 
described previously in some detail (Scotland and Houslay 1995) and Ch. 3, 
section 3.2.5. Briefly, duplicate samples of each reaction were incubated with 
either buffer (minus membranes) or buffer containing COS membranes (plus 
membranes) followed by separation of the membrane pellet and supernatant 
fractions. Following SDS-PAGE, gels were visualized by phosphorimager. 
When the reaction was programmed with either pGSlO (Fig. 5.3, lanes 4-6) or 
pGS15 (Fig. 5.3, lanes 7-9) it was noted that the major chimeric protein species 
of ~38kDa was found in the membrane pellet fraction in a manner identical to 
the reaction programmed by pGS7 expressing the wild-type plasmid (Fig. 5.3, 
lanes 1-3). In marked contrast to this, the mutant chimera expressing the 
deletion AP14-W20 encoded by the plasmid pGS17 was unable to become 
associated with membranes and remained completely cytosolic (Fig. 5.3, lanes 
10-12) thus mirroring the results obtained when this construct was transiently 
expressed in COS cells. When pGS18 encoding the deletion D21-R25 was 
expressed in the cell-free system it was noticed that whilst the mutation was still 
able to associate with membranes it did so with a much lower affinity (Fig. 5.3, 
lanes 13-15) than either wild-type 1-100RD1-CAT, AP2-F7 or AC8-K13 
(Fig.5.3, lanes 1-3, 4-6 and 7-9 respectively). This result was also observed to 
mirror the result obtained for transient expression of pGS18 in COS cells.
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5.2.6 Cell-free Expression of the Alanine Cassette Containing
Plasmid pGS22
In order to investigate whether plasma membrane association of RD1 
was determined by specific amino acids located within its amino terminal 25 
amino acids, or if this was merely a function of the extremely hydrophobic 
nature of this region, a plasmid was constructed in which residues 14-20 
(inclusive) were replaced by an alanine cassette (ala7) resulting in the generation 
of pGS22. Utilising the same strategy as for the deletion mutation containing 
plasmids pGSlO, pGS15, pGS17 and pGS18, mature chimeric proteins were 
synthesized by means of cell-free coupled transcription/translation system in the 
presence of radiolabelled [-^ 5S] methionine according to Materials and methods 
(Ch.2, section 2.11.1) and evaluated for their ability to associate with added 
membranes. The result of one such experiment is shown in figure 5.4. As in 
previous experiments, the plasmid pGS7 encoding the wild-type 1-100RD1- 
CAT was employed as a positive control for membrane association (Fig.5.4, 
lanes 1-3). Lanes 4-6 (Fig.5.4) represent pGS17 encoding the P14-W20 
deletion and as before this construct does not associate with added membranes 
(Fig. 5.4, lane 5) but remains associated with the supernatant fraction (Fig. 5.4, 
lane 6). Substitution of the P14-W20 region with the alanine cassette did not 
restore the ability of the mature chimeric protein to associate with membranes 
(Fig. 5.4, lanes 7-9).
Conclusions
Computer based analyses and NMR spectroscopy determined that the unique N- 
terminal splice domain of RD1 was comprised of a series of distinct structural 
elements. Deletion mutagenesis was employed to generate a series of plasmids 
containing deletions encompassing the entire splice domain expressed as a 
fusion with CAT. Expression of mutagenic plasmids in both COS cells and a 
cell-free system revealed that membrane association of RD 1-CAT chimeras was
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determined by a unique tryptophan-rich motif contained within amino acids 14- 
20 .
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Figure 5.1: Computer Prediction of the Secondary Structure of the
N-Terminal 1-25 Amino Acids of RD1
The supersecondary structure of the N-terminal splice domain of 
RD1 as predicted by DNASTAR software based upon the algorithm of 
Chou and Fasman (Chou and Fasman. 1978). These indicate two regions 
of putative a  helix (depicted in red), the first extending from Leu3 to Thr10 
and the second extending from Gin22 to Arg25. Sandwiched between these 
two putative helical domains are a putative region of turn (depicted in blue) 
and a putative region of [3-sheet (depicted in green).
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Figure 5.2: Structure of the N-Terminus of RD1 as Determined by
Hi-NM R
The figure shows the two orientations of the mean calculated 
structure for a peptide corresponding to 1-25 RD1. On the left-hand side, 
both backbone and side chains atoms are shown ( no hydrogen atoms) for 
all residues. The helical path of the backbone is emphasised by the white 
ribbon. Certain residues are labelled. On the right-hand side, molecular 
surface maps are shown in the corresponding orientations. The surface is 
coloured according to charge {red, negative; blue, positive). Hydrophobic 
residues are shown in white. This figure was reproduced by kind 
permission of Dr. J. Smith (Univ. of Birmingham)
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Table 5.1 Distribution of CAT activity in COS Cells 
Transfected With Chimeras Containing N-Terminal 
Deletion Mutations
COS cells were transfected with the indicated plasmid and then, after 48h, 
membrane and high speed supernatant fractions isolated as described in 
Methods. All CAT assays were performed in duplicate as described in the 
Methods section. The distribution between the membrane (pellet) and cytosol 
(high speed supernatant) fractions are given as percentages. These data 
provides the mean of three separate transfection experiments done on different 
occasions with errors as SEM.
plasmid Construct Membrane ( %)  Cytosol ( %)
pGS7 1-100RD CAT 65.0 ± 1.5 34.0 ± 1.5
pGSlO AP2-F7RD CAT 52.5 ± 2.5 47.5 ± 2.5
pGS15 AC8-K13RD CAT 55.5 ± 1.5 44.5 ± 1.5
pGS 17 AP14-W20RD CAT 16.0 ± 2.6 84.0 ± 2.6
pGS18 AD21-R25RD CAT 32.0 ± 2.4 68.0 ± 2.4
pGS22 ala7( 14-20) 22.6 ± 1.8 77.4 ± 1.8
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Figure 5.3: Cell-Free Expression of Plasmids Encoding RD1
Deletion Mutations
Plasmids pGS7, pGSlO, pGS15, pGS17 and pGS18 encoding 1- 
100RD1-CAT and deletion mutations A P2-F7, AC8-K13, AP14-W20 and 
AD21-R25 respectively, were used to prime a coupled 
transcription/translation system to produce mature chimeric CAT species in 
an in vitro system. This was done in the presence of 35S-methionine to 
produce radioactive products. Following transcription/translation duplicate 
sample were incubated in the absence and presence of COS membranes.
After incubation a high speed supernatant (soluble) fraction and a membrane 
fraction were isolated. These two fractions, and that of the original product 
of the transcription/translation reaction, were subjected to SDS-PAGE. 
Identification of the radioactive species was done using a phosphorimager.
All fraction were normalized for volume and concentration. Lanes 1-3 
represent pGS7, lanes 4-6 represent pGSlO, lanes 7-9 correspond to 
pGS15, lanes 10-12 represent pGS17 and lanes 13-15 correspond to 
pGS18. The lanes are in sets of three, where the first track shows the 
original products of the transcription/translation reaction, the second the 
membrane (high speed pellet) fraction and the third the soluble (high speed 
supernatant) fraction. Thus lanes 1, 4, 7, 10 & 13 show the original 
material emanating from the transcription/translation experiment; lanes 2, 5,
8,11 and 14 the high speed pellets after incubation in the presence of COS 
membranes and lanes 3, 6 , 9, 12 and 15 the high speed supernatants 
obtained after centrifugation of the incubation mixture done in the presence 
of COS membranes. These data are typical of an experiment done three 
times.
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Figure 5.4: Cell-Free Expression of PlasmidpGS22 Encoding the
mutation (a/«7(14-20))
Plasmids pGS7 pGS17 and pGS22 encoding wild-type 1-100RD1- 
CAT, AP14-W20 and alay( 14-20) respectively, were used to prime a 
coupled transcription/translation system to produce mature chimeric CAT 
species in an in vitro system. This was done in the presence of 35S- 
methionine to produce radioactive products as described (Methods, section 
2.12). Following transcription/translation duplicate samples were incubated 
in the absence and presence of COS membranes. After incubation a high 
speed supernatant (soluble) fraction and a membrane fraction were isolated.
These two fractions, and that of the original product of the 
transcription/translation reaction, were subjected to SDS-PAGE. 
Identification of the radioactive species was done using a phosphorimager.
All fraction were normalized for volume and concentration. Lanes 1-3 
represent pGS7, lanes 4-6 represent pGS17 and lanes 7-9 correspond to 
pGS22. The lanes are in sets of three, where the first track shows the 
original products of the transcription/translation reaction, the second the 
membrane (high speed pellet) fraction and the third the soluble (high speed 
supernatant) fraction. Thus lanes 1, 4 & 7 show the original material 
emanating from the transcription/translation experiment; lanes 2, 5 & 8 the 
high speed pellets after incubation in the presence of COS membranes and 
lanes 3, 6 & 9 the high speed supernatants obtained after centrifugation of 
the incubation mixture done in the presence of COS membranes. These data 
are typical of an experiment done three times.
1 2 3 |  ^ 5 6 | 7 8 9
167
CHAPTER 6 
Conclusions & Perspectives
cAMP phosphodiesterases are a family of enzymes encoded by four 
distinct genes that display an additional level of complexity through the 
existence of multiple splice variants (Beavo 1995). They show high 
homology within a central domain of approximately 270 amino acids that is 
believed to encompass their active site. This degree of homology is particularly 
high within specific sub families. Although the C-termini are conserved in a 
gene specific fashion, the N-termini demonstrate little or no sequence 
homology. It has been suggested that, in the case of the type-IVA PDE, RD1 
(Shakur et al. 1993) and in the case of the type-IVB enzyme, PDE-4 (Lobban et 
al. 1994) that their respective N-terminal domains may be involved in regulation 
in addition to conferring membrane association.
The extreme N-terminal domain of RD1 comprises a sequence of 25 
amino acids that is unique amongst all PDEs that have been cloned to date. 
Deletion of this domain by engineered truncation has been shown to render RD1 
as a fully soluble enzyme that is found as an active species in the cytosol of 
transfected COS cells (Lobban et al. 1994; Shakur et al. 1993). The contention 
that this domain can confer membrane association upon an essentially soluble 
protein (Shakur et al. 1993) has been investigated here. A plasmid vector was 
designed and constructed which facilitated the generation of in-frame fusions 
between the amino terminus of the soluble bacterial reporter enzyme 
chloramphenicol acetyltransferase and various N-terminal RD1 fragments that 
could be transiently expressed in COS cells under control of the SV40 early 
promoter. Moreover, by including the SP6 promoter in the plasmid it was 
possible to generate mature RD1-CAT chimeras in a cell-free environment using 
an in vitro transcription/translation system. This, in turn, led to the 
development of a novel assay where mature chimeras were assessed for their 
ability to associate with added membranes.
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Expression of RD1-CAT chimeras in COS cells showed that only those 
protein species that contained the extreme amino terminal 1-25 fragment of 
RD1, 1-100RD1CAT and 1-25RD1-CAT were associated with the plasma 
membrane. In contrast, chimeras missing this region, namely 26-100RD1- 
CAT, were shown to be were exclusively cytosolic in a manner identical to that 
observed for native CAT. Furthermore, independent confirmation of the ability 
of the 1-100RD1CAT and 1-25RD1-CAT chimera to associate with membranes 
was obtained following synthesis in the cell-free system. As observed for the 
COS cell expression studies, chimeric RD1-CAT species devoid of the unique 
amino terminal region were found in the soluble fraction in a manner 
reminiscent of native CAT. Thus it can be concluded that the N-terminal 25 
amino acids of RD1 contain structural information that allows for membrane 
association even after the biosynthesis of the mature protein.
The original observation made by Shakur et al (Shakur et al. 1993) 
suggested that when COS cells were transiently transfected with the cDNA for 
RD1, approximately 85% of the total PDE activity was found associated with 
the P2 pellet fraction while the remainder was observed in the soluble S2 cell 
fraction. This was in contrast to the distribution observed for native RD1 
expressed in cerebellum which was exclusively associated with the membrane 
fraction (Shakur et al. 1995). This suggested to me that the soluble fraction 
observed in transfected COS cells may be a feature of the transient expression 
and test system employed here. Expression of RD1-CAT chimeras in the cell- 
free system demonstrated that in addition to full-length species, a series of 
truncated proteins are also synthesised. It is thought that the most likely 
explanation for the generation of such soluble truncated species may be as a 
result of multiple translation initiation events from internal methionines when 
the first initiating codon fell within a suboptimal Kozak sequence (Kozak 1986; 
Kozak 1991; Kozak 1995). This gives rise to the production of catalytically 
active N-terminally truncated RD1-CAT chimeras which, lacking the extreme 1-
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25 amino acids of RD1, were found exclusively in the cytosol. On this basis it 
would seem that the generation of such soluble truncated RD1-CAT chimeric 
protein species in transfected COS cells could account for the CAT activity 
associated with the S2 high-speed supernatant fraction. Indeed, 
immunoblotting data obtained previously for the 1-25RD1-CAT chimera 
(chapter 3, section 3.2.4, Fig. 3.10) has shown that two immunoreactive 
protein species were identified by an anti-CAT antibody but that only the larger 
species corresponding to 1-25RD1CAT was found in the membrane fraction. 
In contrast, the smaller species corresponding to native CAT was completely 
cytosolic. Subsequent to this, McPhee et al (McPhee et al. 1995) have shown 
that the soluble, truncated met26RDl could also be generated in COS cells 
transfected with the full-length cDNA for RD1, in a similar fashion to that 
observed here for RD1-CAT chimera transfection. The realisation that soluble 
"RD1" in RD1 transfected COS cells was, in fact, the N-terminally truncated 
met26RDl provided further evidence that membrane association of RD1 is a 
function of information contained within its first 25 amino acid residues.
How then might this domain confer membrane association upon a 
soluble protein? Certainly, in the case of RD1, it is unlikely that this region 
serves as a cleavable N-terminal signal sequence. There are a number of 
reasons for this which include (i) analysis of the amino acid sequence fails to 
reveal a stretch of amino acids that is sufficiently hydrophobic that it could 
function as a transmembrane domain, (ii) that the engineered deletion of amino 
acids 1 to 25 to produce met26RDl results in the synthesis and expression of a 
fully active, and therefore correctly folded, soluble enzyme (Shakur et al. 
1993). Indeed, its activity is some 2-fold greater than native RD1 (Shakur et al. 
1993). If RD1 was a transmembrane integral protein with a cleaved signal 
sequence, then one might have expected to generate an inactive enzyme due to 
incorrect folding, (iii), in addition, membrane-associated RD1 in both 
transfected COS cells (Shakur et al. 1993) and in brain (Lobban et al. 1994) are
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greater in size than met26RDl implying that they are indeed distinct species, (iv) 
that the membrane-associating 1-25RD1-CAT and 1-100RD1-CAT chimera are 
of the predicted size and (v) that these two chimera can be synthesised in vitro 
to yield mature products which demonstrate selective association with 
membranes.
However, while the presence of a conventional signal peptide can be 
effectively ruled out as the method by which RD1 associates with membranes, 
it should be noted that some proteins do possess N-terminal signal sequences 
that are not cleaved but can themselves function as membrane anchors by 
insertion across the lipid bilayer (see von Heijne (1990) and section 1.7.1). 
Moreover, it is worth noting that amongst proteins associated with membranes 
by means of membrane anchors, there is a low degree of amino acid sequence 
conservation between signal sequences (von Heijne 1990). However, certain 
features of secondary structure appear to be common. These take the form of 
three distinct domains; at the extreme N-terminus is a positively charged region 
of 1-5 amino acids, followed by a central hydrophobic domain of 7-15 amino 
acids and then a more polar carboxy terminal domain of 3-7 amino acids which, 
if applicable, contains the site for cleavage by the signal peptidase. Application 
of the above criteria to the 1-25 amino acid N-terminal domain of RD1 shows 
an absence of any such features. Missing, in particular, is the characteristic 
positive charged polar sequence at the extreme N-terminus required for a signal 
peptide. Furthermore, although there are distinct hydrophobic regions within 
this domain, such as from leu3 to phe7 and from trpl5 to trp20, it should be 
noted that neither of these regions is contains -19 hydrophobic amino acids 
required to constitute a membrane spanning anchor.
One means of attachment of essentially soluble proteins to membranes is 
through hydrophobic interaction, via N-terminal acylation using either myristoyl 
(Mcllhinney et al. 1987) or palmitoyl (Spiegel et al. 1991b) residues. The 
theory that such a modification may serve to anchor RD1 to the plasma
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membrane can be regarded as untenable since analysis of the amino acid 
sequence confirms that there is no putative myristoylation site (glycine) to be 
found at position 2 within this N-terminal region. Thus the only other 
possibility is palmitoylation of cysteine residues located at positions 8 and 11 . 
While most investigators have regarded palmitoylation as a C-terminal 
phenomenon (Grand 1989; Peter et al. 1992) several groups have published 
evidence that N-terminal cysteines may also be modified by the addition of 
palmitate. Skene and Virag (Skene and Virag 1989) and Zuber and colleagues 
(Zuber et al. 1989) have demonstrated that the neuronal growth-cone protein 
GAP-43 is membrane associated by palmitoylation of its N-terminal cysteines, 
and more recently it has been shown that some G protein a  subunits 
palmitoylated on N-terminal cysteines (Grassie et al. 1994; McCallum et al. 
1995a; McCallum et al. 1995b; Parenti et al. 1993). Analysis of the amino 
terminus of RD1 show that there are two cysteines at positions 8 and 11 that 
may serve as sites for palmitoylation. However, investigations made during the 
course of this study tend to suggest that this mode of attachment is extremely 
unlikely to determine membrane association upon RD1. Firstly, efficient 
membrane association has been observed for both the 1-25RD 1-CAT and 1- 
100RD1-CAT chimeras that had been synthesised in a cell-free system. 
Secondly, site specific mutagenesis was employed to substitute cys8 and cysll 
for serines. Upon expression in transfected COS cells the majority of CAT 
activity of such mutant forms, as determined by CAT assay, was associated 
with the P2 pellet fraction in a manner similar to that previously observed for 
the wild-type 1-100RD 1-CAT chimera
Furthermore, during the course of this research, Shakur et al (Shakur et 
al. 1995) published results which showed that not only was COS cell expressed 
RD1 unable to incorporate [35S] labelled palmitate, but incubation in the 
presence of hydroxylamine, which has been shown to cause the release of 
covalently associated palmitate, was unable to cause the release of RD1 from
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isolated membranes of either cerebellum or transiently transfected COS cells 
(Lobban et al. 1994).
While mutation of neither cys8 or cysl 1 affected membrane association, 
it was observed that this was not the case for a chimera expressing mutations of 
both cysteines, rather it appeared that this mutation caused an increase in the 
fraction of CAT activity found to be associated with the P2 membrane fraction. 
In this instance, approximately 90% of the CAT activity, as determined by 
enzyme assay, was found associated with the P2 pellet fraction of transiently 
transfected COS cells. This was in contrast to the 70% level of association 
observed for the wild-type 1-100RD1-CAT chimera.
An explanation for this apparent increase in membrane localisation of 
the RD1-CAT chimera came from analysis of the cell-free coupled 
transcription/translation data. It was noted that when plasmids containing the 
individually mutated cysteines were used to direct protein synthesis, these gave 
rise to a mixture of membrane associated and soluble chimeric protein species in 
an identical manner to that previously observed for the wild-type 1-100RD1- 
CAT chimera (Ch. 3, fig. 3.11). However, only the full-length chimera was 
found to associate with added membranes whereas the truncated chimeras 
remained in the soluble fraction. When cell-free protein expression was driven 
by the plasmid containing the double cys8/l 1 mutation it became apparent that 
using the double cysteine mutation the levels of the truncated soluble protein 
species were much lower than those observed using a plasmid encoding either 
the individual cysteine mutations or the non-mutated 1-100RD 1-CAT chimera. 
This suggests that the distribution of CAT activity observed in transfected COS 
cells expressing the double cysteine mutation does not involve an actual increase 
in the amount of enzyme associated with the membrane fraction, rather this is 
directly related to the reduced expression of non-membrane associating, 
truncated chimera. These necessarily will result in a decrease in the amount of 
soluble CAT activity that can be measured in the cytosol.
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The reason why such a unique pattern of protein expression should be 
solely confined to the plasmid construct encoding the double cysteine mutation 
remains elusive. However, there are certain factors which rule out the 
possibility that this is due to an experimental artefact. Since the same pattern of 
expression has been observed in two entirely separate expression systems, 
where protein synthesis is directed by two unrelated promoters, it is highly 
improbable that the effect is modulated at the level of transcription. This would 
seem to implicate that the reduced level of soluble proteins synthesised is 
controlled at the level of translation. One factor that has been shown to affect 
translation is the presence of secondary structure in the mRNA (Brierley et al. 
1989; Zinoni et al. 1990). Formation of a hairpin loop near the beginning of a 
protein-coding sequence has been demonstrated to cause the ribosome to pause 
for longer at an AUG codon presented in a suboptimal context, thus allowing 
more efficient translation than would normally be expected (Kozak 1990). 
Mutation of cysteine to serine involves changing the first nucleotide of the triplet 
codon (TGC) from T to A. It is suggested that when the RD 1-CAT gene fusion 
was engineered in which cys8 and cysll were both mutated to serines, the 
substitution of T for A in both triplet codons altered the nucleotide composition 
sufficiently to favour the formation of a hairpin loop structure. It is highly 
unlikely that such a structure could form if only one triplet codon was modified. 
Furthermore, it is postulated that the hairpin loop would form approximately 14 
nucleotides downstream of the initiating AUG codon and thus corresponds to 
the optimal distance between the leading edge of the ribosome and its AUG- 
recognition centre (Kozak 1990). The functional consequence of this would be 
to slow ribosomal scanning of the mRNA, thus allowing more time for 
recognition of the AUG codon. However, it should be emphasised that while 
the hairpin loop structure may provide an interesting explanation as to why the 
double cysteine mutation containing RD1-CAT chimera gives rise to less of the 
soluble truncated proteins species than the non-mutated form, it must be pointed
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out that, at this stage, it is purely conjecture and would require extensive 
experimental investigation currently outwith the scope of this study to provide 
confirmation.
Since the available evidence obtained during the course of this study 
effectively rules out the possibility that RD1 is membrane associated through a 
mechanism involving palmitoylation of N-terminal cysteines then it stands to 
reason that membrane association and, therefore subcellular localisation, is 
conferred by some other information contained within this unique region. 
Several proteins are targeted or retained in specific intracellular compartments 
by means of linear peptide sequences, examples of which have previously been 
discussed at length (Introduction, section 1.7). A computer program (Protean, 
DNASTAR) based upon the algorithm of Chou and Fasman (Chou and Fasman 
1978) which can be employed to predict a protein super-secondary structure 
from its primary amino acid sequence was used in an attempt to determine 
whether the N-terminal 1-25 amino acids of RD1 could adopt a specific 
structural conformation when considered in an independent context to the full- 
length protein. By using this approach a putative structure was obtained 
suggesting that the N-terminal region of RD1 may contain a number of 
independently folded structural motifs comprised of two a  helices separated by 
a mobile hinge region (Ch. 5, fig. 5.1). While computer programs may provide 
valuable information about protein structures, the very multitude of existence of 
such methods tends to suggest that no single algorithm can be regarded as 
completely satisfactory. As such an accurate determination of protein structure 
can only be obtained by the experimental methodology such as X-ray diffraction 
crystallography or Nuclear Magnetic Resonance spectroscopy (NMR). In 
collaboration with Dr. James Beattie from the Hannah Research Institute, Ayr 
and Dr. John Smith at University of Birmingham, a 25 amino acid peptide was 
synthesised to correspond to extreme N-terminus of RD1. This peptide was 
subjected to investigation by (*H-NMR) as an alternative strategy to provide an
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independent structural determination. Adoption of this approach confirmed the 
previously generated computer prediction that the N-terminus of RD1 is 
composed of two distinct helical structures separated by a mobile 'hinge' region 
(Smith et al. 1996). This gives support to the contention that this region has 
distinct functional properties (Houslay et al. 1995; McPhee et al. 1995; Shakur 
et al. 1993; Shakur et al. 1995), identified as an ability to attenuate the Vmax of 
RD1 and to locate this enzyme exclusively to membranes. The first helical 
domain was found to be comprised a well formed amphipathic a-helix 
encompassing amino acid residues 2-8, whereas the second helical region 
contains a distinct, compact, highly hydrophobic domain (residues 14-20) 
followed by a polar region (residues 21-25). The structure obtained by NMR 
spectroscopy suggested that residues 14-20 favoured the formation of a 
distorted helical structure. While the presence of so many hydrophobic amino 
acids containing large bulky side chains in an a  helical conformation is unusual, 
nevertheless, such a structure has been observed previously for the cytoskeletal 
protein actin (Kabsh et al. 1990).
In order to address whether membrane association was attributable to 
one of these distinct structural domains, overlap extension mutagenesis (Ho et 
al. 1989) was employed to engineer deletions in the unique splice region of 
RD1. Four truncations were selected to probe functional attributes. These 
were (i) deletion of the hydrophobic region of the N-terminal a-helical domain 
(residues 2-7), (ii) deletion of the polar region of this a-helical domain together 
with the 'hinge' region (residues 8-13), (iii) deletion of the distinct 
hydrophobic, tryptophan-rich domain formed within the second helical region 
(residues 14-20) and (iv) deletion of the polar end of the second helical region 
(residues 21-25). Expression of these constructs in both COS cells and the cell- 
free system demonstrated that mature chimeric proteins containing the deletions 
AP2-F7, AC8-K13 and AD21-R25 all became membrane associated. In marked 
contrast to this, the mutant chimera expressing the deletion AP14-W20 was
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unable to become associated with membranes in the cell-free expression system 
and showed a marked reduction in membrane association when expressed in 
COS cells. This suggests that the information which is critical for membrane 
association lies within this distinct, strongly hydrophobic, tryptophan-rich 
domain. ^-N M R  analysis showed that the stretch of amino acids given by 
14pro-19trp forms a discrete domain which is stabilised by hydrogen bonding 
and Van der Waals interactions (Smith et al. 1996). This is an intensely 
hydrophobic domain. Thus, in order to investigate whether membrane 
association was a function of the hydrophobicity of this domain per se , 
residues 14pro-20trp were replaced with a 'cassette' of seven alanine residues. 
Expression of this mutant chimera showed that it failed to become membrane 
associated. This further strengthens the case against the N-terminal domain 
adopting a transmembrane helical structure, since such a string of alanines 
would be expected to favour the adoption of a more rigid helical structure than 
that observed for the wild type domain (Vergeres et al. 1995). Thus the ability 
of RD1 to become membrane-associated is not due to a non-specific 
hydrophobic interaction at this point within the splice region. Rather, it would 
appear to be determined by the unique structural properties of this tryptophan 
rich domain bounded by 14pro-20trp.
The N-terminal 1-25 amino acid domain is an amphipathic structure and 
it is possible that it could fold to yield a hydrophobic loop able to partition into 
the lipid bilayer in a similar fashion to that proposed (Houslay et al. 1995) for 
the initial insertion of the hydrophobic domain of anchoring signal peptides and 
for the cytochrome b5 as suggested by the observations of Vergeres et al 
(Vergeres et al. 1995). Certainly such a mode of attachment would be 
consistent with our observations that membrane bound RD 1-CAT chimeras, 
and RD1 itself (Lobban et al. 1994; Shakur et al. 1993), are solubilized only 
with Triton X-100 and not by high ionic strength, implying that ionic 
interactions do not solely, if at all, determine the anchoring reaction. However,
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that both RD1 (Lobban et al. 1994; Shakur et al. 1993) and the RD 1-CAT 
chimeras appear to show specificity as regards membrane association, with 
preferential association with the plasma membrane, militates against a simple 
partition of this anchor into the lipid milieu as either part of or the sole means of 
membrane association unless it interacted with a specific lipid species showing a 
highly restricted subcellular distribution.
The PDE4A isoform, RD1 appears then to possess information 
contained within the unique domain formed from the first 25 amino acids of the 
protein that allows it to become membrane-associated. That deletion of this 
domain from RD1 produces a fully active soluble enzyme (Lobban et al. 
1994; Shakur et al. 1993) and that this domain can confer membrane 
association upon CAT suggests that RD1 is formed from a core soluble protein 
together with an N-terminal anchoring domain. It is my contention that RD1, 
through this N-terminal domain, becomes membrane-anchored by interacting 
with a membrane-associated protein via an interaction which is predominantly 
hydrophobic in nature. Such a specific targeting may be intimately related to the 
biological functioning of this particular type-IVA PDE splice variant, one likely 
consequence of which relates to the conferment of specific intracellular 
targeting.
Further studies are needed however, to define (i) the precise residues 
involved in targeting, (ii) the components of the targeting mechanism and (iii) 
the biological consequences of targeting of RD1.
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